<author><surname>Armstrong</surname> <given-names>RW</given-names></author> <author><surname>Bolding</surname> <given-names>F</given-names></author> <author><surname>Joseph</surname> <given-names>R</given-names></author> <title>Septic arthritis following arthroscopy: clinical syndromes and analysis of risk factors</title> <source>Arthroscopy</source> <year>1992</year> <volume>8</volume> <fpage>213</fpage> - <lpage>31</lpage>
<author><surname>Charalambous</surname> <given-names>CP</given-names></author> <author><surname>Tryfonidis</surname> <given-names>M</given-names></author> <author><surname>Sadiq</surname> <given-names>S</given-names></author> <author><surname>Hirst</surname> <given-names>P</given-names></author> <author><surname>Paul</surname> <given-names>A</given-names></author> <title>Septic arthritis following intra-articular steroid injection of the knee &#8212; a survey of current practice regarding antiseptic technique used during intra-articular steroid injection of the knee</title> <source>Clin Rheumatol</source> <year>2003</year> <volume>22</volume> <fpage>386</fpage> - <lpage>90</lpage>
<author><surname>von Essen</surname> <given-names>R</given-names></author> <author><surname>Savolainen</surname> <given-names>HA</given-names></author> <title>Bacterial infection following intra-articular injection &#8212; a brief review</title>. <source>Scan J Rheumatol</source> <year>1989</year> <volume>18</volume> <fpage>7</fpage> - <lpage>12</lpage>
<author><surname>Kalteis</surname> <given-names>T</given-names></author> <author><surname>L&#252;ring</surname> <given-names>C</given-names></author> <author><surname>Schaumburger</surname> <given-names>J</given-names></author> <author><surname>Perlicl</surname> <given-names>L</given-names></author> <author><surname>B&#228;this</surname> <given-names>H</given-names></author> <author><surname>Grifka</surname> <given-names>J</given-names></author> <title>Gewebetoxizit&#228;t lokaler</title> <source>Antiseptika. Z Orthop</source> <year>2003</year> <volume>141</volume> <fpage>233</fpage> - <lpage>8</lpage>
<author><surname>Schaumburger</surname> <given-names>J</given-names></author> <author><surname>Beckmann</surname> <given-names>J</given-names></author> <author><surname>Springorum</surname> <given-names>HR</given-names></author> <author><surname>Handel</surname> <given-names>M</given-names></author> <author><surname>Anders</surname> <given-names>S</given-names></author> <author><surname>Kalteis</surname> <given-names>T</given-names></author> <title>Toxitit&#228;t lokaler Antiseptika auf Chondrozyten in vitro</title> <source>Z Orthop Unfall</source> <year>2010</year> <volume>148</volume> <fpage>39</fpage> - <lpage>43</lpage>
<author><surname>Riegels-Nielsen</surname> <given-names>P</given-names></author> <author><surname>Frimodt-M&#246;ller</surname> <given-names>N</given-names></author> <author><surname>Jensen</surname> <given-names>J</given-names></author> <title>Rabbit model of septic arthritis</title> <source>Acta Orthop Scand</source> <year>1987</year> <volume>58</volume> <fpage>14</fpage> - <lpage>9</lpage>
<author><surname>Ryan</surname> <given-names>MJ</given-names></author> <author><surname>Kavanagh</surname> <given-names>R</given-names></author> <author><surname>Wall</surname> <given-names>PG</given-names></author> <author><surname>Hazleman</surname> <given-names>BL</given-names></author> <title>Bacterial joint infection in England and Wales: analysis of bacterial isolates over a four year period</title> <source>Br J Rheumatol</source> <year>1997</year> <volume>36</volume> <fpage>370</fpage> - <lpage>3</lpage>
<author><surname>Smith</surname> <given-names>M</given-names></author> <title>Arthroscopic treatment of the septic knee</title> <source>Arhtroscopy</source> <year>1986</year> <volume>2</volume> <fpage>30</fpage> - <lpage>4</lpage>
<author><surname>Muir</surname> <given-names>H</given-names></author> <title>The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules</title> <source>Bioessays</source> <year>1995</year> <volume>17</volume> <fpage>1039</fpage> - <lpage>48</lpage>
<author><surname>Goldring</surname> <given-names>MB</given-names></author> <title>The role of the chondrocytes in osteoarthritis</title> <source>Arthritis Rheum</source> <year>2000</year> <volume>43</volume> <fpage>1916</fpage> - <lpage>26</lpage>
<author><surname>Newman</surname> <given-names>AP</given-names></author> <title>Articular cartilage repair</title> <source>Am J Sports Med</source> <year>1998</year> <volume>26</volume> <fpage>309</fpage> - <lpage>24</lpage>
<author><surname>de Crombrugghe</surname> <given-names>B</given-names></author> <author><surname>Lefebvre</surname> <given-names>V</given-names></author> <author><surname>Behringer</surname> <given-names>RR</given-names></author> <author><surname>Bi</surname> <given-names>W</given-names></author> <author><surname>Murakami</surname> <given-names>S</given-names></author> <author><surname>Huang</surname> <given-names>W</given-names></author> <title>Transcriptional mechanisms of chondrocytes differentiation</title> <source>Matrix Biol</source> <year>2000</year> <volume>9</volume> <fpage>389</fpage> - <lpage>94</lpage>
<author><surname>Goldring</surname> <given-names>MB</given-names></author> <title>Update on the biology of the chondrocyte and new approaches to treating cartilage disease</title> <source>Best Pract Res Clin Rheumatol</source> <year>2006</year> <volume>20</volume> <fpage>1003</fpage> - <lpage>25</lpage>
<author><surname>M&#252;ller</surname> <given-names>G</given-names></author> <author><surname>Kramer</surname> <given-names>A</given-names></author> <title>Effect of selected wound antiseptics on adult articular cartilage (bovine sesamoid bone) in the presence of Escherichia coli and Staphylococcus aureus</title> <source>J Orth Res</source> <year>2005</year> <volume>23</volume> <fpage>127</fpage> - <lpage>33</lpage>
<author><surname>Bates</surname> <given-names>EJ</given-names></author> <author><surname>Johnson</surname> <given-names>CC</given-names></author> <author><surname>Lowther</surname> <given-names>DA</given-names></author> <title>Inhibition of proteoglycan synthesis by hydrogen peroxide in cultured bovine articular cartilage</title> <source>Biochimica Biophysica Acta</source> <year>1984</year> <volume>838</volume> <fpage>221</fpage> - <lpage>8</lpage>
<author><surname>R&#246;hner</surname> <given-names>E</given-names></author> <author><surname>Detert</surname> <given-names>J</given-names></author> <author><surname>Kolar</surname> <given-names>P</given-names></author> <author><surname>Hocke</surname> <given-names>A</given-names></author> <author><surname>N&#8217;Guessan</surname> <given-names>P</given-names></author> <author><surname>Matziolis</surname> <given-names>G</given-names></author> <title>Induced apoptosis of chondrocytes by Porphyromonas gingivalis as a possible pathway for cartilage loss in rheumatoid arthritis</title> <source>Cal Tiss Int</source> <year>2010</year> <volume>87</volume> <fpage>333</fpage> - <lpage>40</lpage>
<author><surname>Pischon</surname> <given-names>N</given-names></author> <author><surname>R&#246;hner</surname> <given-names>E</given-names></author> <author><surname>Hocke</surname> <given-names>A</given-names></author> <author><surname>N&#8217;Guessan</surname> <given-names>P</given-names></author> <author><surname>M&#252;ller</surname> <given-names>HC</given-names></author> <author><surname>Matziolis</surname> <given-names>G</given-names></author> <title>Effects of Porphyromonas gingivalis on cell cycle progression and apoptosis of primary human chondrocytes</title> <source>Ann Rheum Dis</source> <year>2009</year> <volume>68</volume> <fpage>1902</fpage> - <lpage>7</lpage>
<author><surname>Stutz</surname> <given-names>G</given-names></author> <author><surname>G&#228;chter</surname> <given-names>A</given-names></author> <title>Diagnostik und stadiengerechte</title> <source>Therapie von Gelenkinfekten Unfallchirurg</source> <year>2001</year> <volume>104</volume> <fpage>682</fpage> - <lpage>6</lpage>
<author><surname>Ince</surname> <given-names>A</given-names></author> <author><surname>Sch&#252;tze</surname> <given-names>N</given-names></author> <author><surname>Hendrich</surname> <given-names>C</given-names></author> <author><surname>Jakob</surname> <given-names>F</given-names></author> <author><surname>Eulert</surname> <given-names>J</given-names></author> <author><surname>L&#246;hr</surname> <given-names>JF</given-names></author> <title>Effect of polyhexanide and gentamicin on human osteoblasts and endothelial cells</title> <source>Swiss Med Wkly</source> <year>2007</year> <volume>137</volume> <fpage>139</fpage> - <lpage>45</lpage>
<author><surname>Berg</surname> <given-names>K</given-names></author> <author><surname>Carmichael</surname> <given-names>WW</given-names></author> <author><surname>Skulberg</surname> <given-names>OM</given-names></author> <author><surname>Benestad</surname> <given-names>C</given-names></author> <author><surname>Underdal</surname> <given-names>B</given-names></author> <title>Investigation of a toxic water-bloom of Microcystis aeruginosa (Cyanophyaceae) in Lake Akersvatn, Norway</title> <source>Hydrobiologia</source> <year>1987</year> <volume>144</volume> <issue>2</issue> <fpage>97</fpage> - <lpage>103</lpage>
<author><surname>Botha</surname> <given-names>N</given-names></author> <author><surname>Gehringer</surname> <given-names>MM</given-names></author> <author><surname>Downing</surname> <given-names>TG</given-names></author> <author><surname>Venter</surname> <given-names>M</given-names></author> <author><surname>Shephard</surname> <given-names>EG</given-names></author> <title>The role of microcystin-LR in the induction of apoptosis and oxidative stress in Caco2 cells</title> <source>Toxicon</source> <year>2004</year> <volume>43</volume> <fpage>85</fpage> - <lpage>92</lpage>
<author><surname>Burja</surname> <given-names>AM</given-names></author> <author><surname>Banaigs</surname> <given-names>B</given-names></author> <author><surname>Abou-Mansour</surname> <given-names>E</given-names></author> <author><surname>Burgess</surname> <given-names>JG</given-names></author> <author><surname>Wright</surname> <given-names>PC</given-names></author> <title>Marine cyanobacteria&#8212;a prolific source of natural products</title> <source>Tetrahedron</source> <year>2001</year> <volume>57</volume> <fpage>9347</fpage> - <lpage>9377</lpage>
<author><surname>Castenholz</surname> <given-names>RW</given-names></author> <author><surname>Garrity</surname> <given-names>GM</given-names></author> <title>Cyanobacteria Bergey"s manual of systematic bacteriology. Volume 1, the Archaea and the deeply branching phototrophic</title> <source>Bacteria</source> <year>2001</year> <other>Berlin Heidelberg New York</other> <publisher>Springer</publisher> <fpage>473</fpage> - <lpage>599</lpage>
<author><surname>Chang</surname> <given-names>W</given-names></author> <author><surname>McClain</surname> <given-names>CJ</given-names></author> <author><surname>Liu</surname> <given-names>MC</given-names></author> <author><surname>Barve</surname> <given-names>SS</given-names></author> <author><surname>Chen</surname> <given-names>TS</given-names></author> <title>Effects of 2 (rs)-n-propylthiazolidine-4 (r)-carboxylic acid on 4-hydroxy-2-nonenal-induced apoptotic cell death</title> <source>J Nutr Biochem</source> <year>2008</year> <volume>19</volume> <fpage>184</fpage> - <lpage>192</lpage>
<author><surname>Chorus</surname> <given-names>I</given-names></author> <author><surname>Falconer</surname> <given-names>IR</given-names></author> <author><surname>Salas</surname> <given-names>HJ</given-names></author> <author><surname>Bartram</surname> <given-names>J</given-names></author> <title>Health risks caused by freshwater cyanobacteria in recreational waters</title> <source>J Toxicol Environ Health</source> <year>2000</year> <volume>3</volume> <fpage>323</fpage> - <lpage>347</lpage>
<author><surname>Codd</surname> <given-names>GA</given-names></author> <author><surname>Lindsay</surname> <given-names>J</given-names></author> <author><surname>Young</surname> <given-names>FM</given-names></author> <author><surname>Morrison</surname> <given-names>LF</given-names></author> <author><surname>Metcalf</surname> <given-names>JS</given-names></author> <author><surname>Huisman</surname> <given-names>J</given-names></author> <title>Matthijs HCP, Visser PM Harmful cyanobacteria</title> <source>Harmful cyanobacteria</source> <year>2005</year> <other>Berlin Heidelberg New York</other> <publisher>Springer</publisher> <fpage>1</fpage> - <lpage>23</lpage>
<author><surname>Cohen</surname> <given-names>P</given-names></author> <author><surname>Alemany</surname> <given-names>S</given-names></author> <author><surname>Hemmings</surname> <given-names>BA</given-names></author> <author><surname>Resink</surname> <given-names>TJ</given-names></author> <author><surname>Str&#229;lfors</surname> <given-names>P</given-names></author> <author><surname>Tung</surname> <given-names>HY</given-names></author> <title>Protein phosphatase-1 and protein phosphatase-2a from rabbit skeletal muscle</title> <source>Methods Enzymol</source> <year>1988</year> <volume>159</volume> <fpage>390</fpage> - <lpage>408</lpage>
<author><surname>Edvardsen</surname> <given-names>B</given-names></author> <author><surname>Skulberg</surname> <given-names>R</given-names></author> <author><surname>Skulberg</surname> <given-names>OM</given-names></author> <title>NIVA Culture Collection of Algae&#8212;microalgae for science and technology</title> <source>Nova Hedwig Beih</source> <year>2004</year> <volume>79</volume> <fpage>99</fpage> - <lpage>114</lpage>
<author><surname>Fischbach</surname> <given-names>MA</given-names></author> <author><surname>Walsh</surname> <given-names>CT</given-names></author> <title>Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: logic, machinery and mechanisms</title> <source>Chem Rev</source> <year>2006</year> <volume>106</volume> <fpage>3468</fpage> - <lpage>3496</lpage>
<author><surname>Fischer</surname> <given-names>WJ</given-names></author> <author><surname>Altheimer</surname> <given-names>S</given-names></author> <author><surname>Cattori</surname> <given-names>V</given-names></author> <author><surname>Meier</surname> <given-names>PJ</given-names></author> <author><surname>Dietrich</surname> <given-names>DR</given-names></author> <author><surname>Hagenbuch</surname> <given-names>B</given-names></author> <title>Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin</title> <source>Toxicol Appl Pharmacol</source> <year>2005</year> <volume>203</volume> <fpage>257</fpage> - <lpage>263</lpage>
<author><surname>Fladmark</surname> <given-names>KE</given-names></author> <author><surname>Brustugun</surname> <given-names>OT</given-names></author> <author><surname>Hovland</surname> <given-names>R</given-names></author> <author><surname>Boe</surname> <given-names>R</given-names></author> <author><surname>Gjertsen</surname> <given-names>BT</given-names></author> <author><surname>Zhivotovsky</surname> <given-names>B</given-names></author> <author><surname>Doskeland</surname> <given-names>SO</given-names></author> <title>Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors</title> <source>Cell Death Differ</source> <year>1999</year> <volume>6</volume> <fpage>1099</fpage> - <lpage>1108</lpage>
<author><surname>Fladmark</surname> <given-names>KE</given-names></author> <author><surname>Serres</surname> <given-names>MH</given-names></author> <author><surname>Larsen</surname> <given-names>NL</given-names></author> <author><surname>Yasumoto</surname> <given-names>T</given-names></author> <author><surname>Aune</surname> <given-names>T</given-names></author> <author><surname>Doskeland</surname> <given-names>SO</given-names></author> <title>Sensitive detection of apoptogenic toxins in suspension cultures of rat and salmon hepatocytes</title> <source>Toxicon</source> <year>1998</year> <volume>36</volume> <issue>8</issue> <fpage>1101</fpage> - <lpage>1114</lpage>
<author><surname>Foulds</surname> <given-names>LM</given-names></author> <author><surname>Boysen</surname> <given-names>RI</given-names></author> <author><surname>Crane</surname> <given-names>M</given-names></author> <author><surname>Yang</surname> <given-names>Y</given-names></author> <author><surname>Muir</surname> <given-names>JA</given-names></author> <author><surname>Smith</surname> <given-names>AI</given-names></author> <author><surname>Kretser</surname> <given-names>DM</given-names></author> <author><surname>Hearn</surname> <given-names>MT</given-names></author> <author><surname>Hedger</surname> <given-names>MP</given-names></author> <title>Molecular identification of lysoglycerophosphocholines as endogenous immunosuppressives in bovine and rat gonadal fluids</title> <source>Biol Reprod</source> <year>2008</year> <volume>79</volume> <fpage>525</fpage> - <lpage>536</lpage>
<author><surname>Gausdal</surname> <given-names>G</given-names></author> <author><surname>Gjertsen</surname> <given-names>BT</given-names></author> <author><surname>McCormack</surname> <given-names>E</given-names></author> <author><surname>Damme</surname> <given-names>P</given-names></author> <author><surname>Hovland</surname> <given-names>R</given-names></author> <author><surname>Krakstad</surname> <given-names>C</given-names></author> <author><surname>Bruserud</surname> <given-names>O</given-names></author> <author><surname>Gevaert</surname> <given-names>K</given-names></author> <author><surname>Vanderkerckhove</surname> <given-names>J</given-names></author> <author><surname>Doskeland</surname> <given-names>SO</given-names></author> <title>Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death</title> <source>Blood</source> <year>2008</year> <volume>111</volume> <fpage>2866</fpage> - <lpage>2877</lpage>
<author><surname>Gjertsen</surname> <given-names>BT</given-names></author> <author><surname>Cressey</surname> <given-names>LI</given-names></author> <author><surname>Ruchaud</surname> <given-names>S</given-names></author> <author><surname>Houge</surname> <given-names>G</given-names></author> <author><surname>Lanotte</surname> <given-names>M</given-names></author> <author><surname>Doskeland</surname> <given-names>SO</given-names></author> <title>Multiple apoptotic death types triggered through activation of separate pathways by cAMP and inhibitors of protein phosphatases in one (IPC leukemia) cell line</title> <source>J Cell Sci</source> <year>1994</year> <volume>107</volume> <issue>Pt 12</issue> <fpage>3363</fpage> - <lpage>3377</lpage>
<author><surname>Herfindal</surname> <given-names>L</given-names></author> <author><surname>Oftedal</surname> <given-names>L</given-names></author> <author><surname>Selheim</surname> <given-names>F</given-names></author> <author><surname>Wahlsten</surname> <given-names>M</given-names></author> <author><surname>Sivonen</surname> <given-names>K</given-names></author> <author><surname>Doskeland</surname> <given-names>SO</given-names></author> <title>A high proportion of Baltic Sea benthic cyanobacterial isolates contain apoptogens able to induce rapid death of isolated rat hepatocytes</title> <source>Toxicon</source> <year>2005</year> <volume>46</volume> <issue>3</issue> <fpage>252</fpage> - <lpage>260</lpage>
<author><surname>Hoeger</surname> <given-names>SJ</given-names></author> <author><surname>Shaw</surname> <given-names>G</given-names></author> <author><surname>Hitzfeld</surname> <given-names>BC</given-names></author> <author><surname>Dietrich</surname> <given-names>DR</given-names></author> <title>Occurrence and elimination of cyanobacterial toxins in two Australian drinking water treatment plants</title> <source>Toxicon</source> <year>2004</year> <volume>43</volume> <fpage>639</fpage> - <lpage>649</lpage>
<author><surname>Jaspars</surname> <given-names>M</given-names></author> <author><surname>Lawton</surname> <given-names>LA</given-names></author> <title>Cyanobacteria-a novel source of pharmaceuticals</title> <source>Curr Opin Drug Discov Devel</source> <year>1998</year> <volume>1</volume> <fpage>77</fpage> - <lpage>84</lpage>
<author><surname>Jun</surname> <given-names>DY</given-names></author> <author><surname>Kim</surname> <given-names>JS</given-names></author> <author><surname>Park</surname> <given-names>HS</given-names></author> <author><surname>Song</surname> <given-names>WS</given-names></author> <author><surname>Bae</surname> <given-names>YS</given-names></author> <author><surname>Kim</surname> <given-names>YH</given-names></author> <title>Cytotoxicity of diacetoxyscirpenol is associated with apoptosis by activation of caspase-8 and interruption of cell cycle progression by down-regulation of Cdk4 and cyclin B1 in human Jurkat T cells</title> <source>Toxicol Appl Pharmacol</source> <year>2007</year> <volume>222</volume> <fpage>190</fpage> - <lpage>201</lpage>
<author><surname>Lacaze</surname> <given-names>N</given-names></author> <author><surname>Gombaud-Saintonge</surname> <given-names>G</given-names></author> <author><surname>Lanotte</surname> <given-names>M</given-names></author> <title>Conditions controlling long-term proliferation of Brown Norway rat promyelocytic leukemia in vitro: primary growth stimulation by microenvironment and establishment of an autonomous Brown Norway &#8216;leukemic stem cell line&#8217</title>; <source>Leuk Res</source> <year>1983</year> <volume>7</volume> <issue>2</issue> <fpage>145</fpage> - <lpage>154</lpage>
<author><surname>Lu</surname> <given-names>H</given-names></author> <author><surname>Choudhuri</surname> <given-names>S</given-names></author> <author><surname>Ogura</surname> <given-names>K</given-names></author> <author><surname>Csanaky</surname> <given-names>IL</given-names></author> <author><surname>Lei</surname> <given-names>XH</given-names></author> <author><surname>Cheng</surname> <given-names>XG</given-names></author> <author><surname>Song</surname> <given-names>PZ</given-names></author> <author><surname>Klassen</surname> <given-names>CD</given-names></author> <title>Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR</title> <source>Toxicol Sci</source> <year>2008</year> <volume>103</volume> <fpage>35</fpage> - <lpage>45</lpage>
<author><surname>Mann</surname> <given-names>J</given-names></author> <title>Natural products as immunosuppressive agents</title> <source>Nat Prod Rep</source> <year>2001</year> <volume>18</volume> <fpage>417</fpage> - <lpage>430</lpage>
<author><surname>McCormack</surname> <given-names>E</given-names></author> <author><surname>Bruserud</surname> <given-names>O</given-names></author> <author><surname>Gjertsen</surname> <given-names>BT</given-names></author> <title>Animal models of acute myelogenous leukaemia-development, application and future perspectives</title> <source>Leukemia</source> <year>2005</year> <volume>19</volume> <fpage>687</fpage> - <lpage>706</lpage>
<author><surname>Mellgren</surname> <given-names>G</given-names></author> <author><surname>Vintermyr</surname> <given-names>OK</given-names></author> <author><surname>Doskeland</surname> <given-names>SO</given-names></author> <title>Okadaic acid, cAMP, and selected nutrients inhibit hepatocyte proliferation at different stages in G1: modulation of the cAMP effect by phosphatase inhibitors and nutrients</title> <source>J Cell Physiol</source> <year>1995</year> <volume>162</volume> <issue>2</issue> <fpage>232</fpage> - <lpage>240</lpage>
<author><surname>Newman</surname> <given-names>DJ</given-names></author> <author><surname>Cragg</surname> <given-names>GM</given-names></author> <title>Marine natural products and related compounds in clinical and advanced preclinical trials</title> <source>J Nat Prod</source> <year>2004</year> <volume>67</volume> <fpage>1216</fpage> - <lpage>1238</lpage>
<author><surname>Rasool</surname> <given-names>M</given-names></author> <author><surname>Sabina</surname> <given-names>EP</given-names></author> <title>Appraisal of immunomodulatory potential of Spirula fusiformis: an in vivo and in vitro study</title> <source>Nat Med (Tokyo)</source> <year>2009</year> <volume>63</volume> <fpage>169</fpage> - <lpage>175</lpage>
<author><surname>Sandal</surname> <given-names>T</given-names></author> <author><surname>Aumo</surname> <given-names>L</given-names></author> <author><surname>Hedin</surname> <given-names>L</given-names></author> <author><surname>Gjertsen</surname> <given-names>BT</given-names></author> <author><surname>Doskeland</surname> <given-names>SO</given-names></author> <title>Irod/Ian5: an inhibitor of gamma-radiation and okadaic acid-induced apoptosis</title> <source>Mol Biol Cell</source> <year>2003</year> <volume>14</volume> <fpage>3292</fpage> - <lpage>3304</lpage>
<author><surname>Seglen</surname> <given-names>PO</given-names></author> <author><surname>Prescott</surname> <given-names>DM</given-names></author> <title>Preparation of isolated rat liver cells</title> <source>Methods in cell biology</source> <year>1976</year> <other>New York</other> <publisher>Academic Press</publisher> <fpage>29</fpage> - <lpage>83</lpage>
<author><surname>Shen</surname> <given-names>C</given-names></author> <author><surname>Maerten</surname> <given-names>P</given-names></author> <author><surname>Geboes</surname> <given-names>K</given-names></author> <author><surname>Assche</surname> <given-names>G</given-names></author> <author><surname>Rutgeerts</surname> <given-names>P</given-names></author> <author><surname>Ceuppens</surname> <given-names>JL</given-names></author> <title>Infliximab induces apoptosis of monocytes and T lymphocytes in human-mouse chimeric model</title> <source>Clin Immunol</source> <year>2005</year> <volume>115</volume> <fpage>250</fpage> - <lpage>259</lpage>
<author><surname>Simmons</surname> <given-names>TL</given-names></author> <author><surname>Andrianasolo</surname> <given-names>E</given-names></author> <author><surname>McPhail</surname> <given-names>K</given-names></author> <author><surname>Flatt</surname> <given-names>P</given-names></author> <author><surname>Gerwick</surname> <given-names>WH</given-names></author> <title>Marine natural products as anticancer drugs</title> <source>Mol Cancer Ther</source> <year>2005</year> <volume>4</volume> <fpage>333</fpage> - <lpage>342</lpage>
<author><surname>Simo</surname> <given-names>C</given-names></author> <author><surname>Moreno-Arribas</surname> <given-names>MV</given-names></author> <author><surname>Cifuentes</surname> <given-names>A</given-names></author> <title>Ion-trap versus time-of-flight mass spectrometry coupled to capillary electrophoresis to analyze biogenic amines in wine</title> <source>J Chromatogr A</source> <year>2008</year> <volume>1195</volume> <issue>1&#8211;2</issue> <fpage>150</fpage> - <lpage>156</lpage>
<author><surname>Sivonen</surname> <given-names>K</given-names></author> <author><surname>B&#246;rner</surname> <given-names>T</given-names></author> <author><surname>Herrero</surname> <given-names>A</given-names></author> <author><surname>Flores</surname> <given-names>E</given-names></author> <title>Bioactive compounds produced by cyanobacteria The cyanobacteria. Molecular biology, genomics</title> <source>and evolution</source> <year>2008</year> <other>Norfolk Caister</other> <publisher>Academic Press</publisher> <fpage>159</fpage> - <lpage>197</lpage>
<author><surname>Sivonen</surname> <given-names>K</given-names></author> <author><surname>Jones</surname> <given-names>G</given-names></author> <author><surname>Chorus</surname> <given-names>I</given-names></author> <author><surname>Bartram</surname> <given-names>J</given-names></author> <title>Cyanobacterial toxins Toxic cyanobacteria in water. A guide to their public health consequences, monitoring</title> <source>and management</source> <year>1999</year> <other>London</other> <publisher>E &amp; FN Spon</publisher> <fpage>41</fpage> - <lpage>111</lpage>
<author><surname>Skulberg</surname> <given-names>OM</given-names></author> <author><surname>Carmichael</surname> <given-names>WW</given-names></author> <author><surname>Andersen</surname> <given-names>RA</given-names></author> <author><surname>Matsunaga</surname> <given-names>S</given-names></author> <author><surname>Moore</surname> <given-names>RE</given-names></author> <author><surname>Skulberg</surname> <given-names>R</given-names></author> <title>Investigation of a neurotoxic Oscillatoriales strain (Cyanophyceae) and its toxin. Isolation and characterization of homoanatoxin-a</title> <source>Environ Toxicol Chem</source> <year>1992</year> <volume>11</volume> <fpage>321</fpage> - <lpage>329</lpage>
<author><surname>Tan</surname> <given-names>LT</given-names></author> <title>Bioactive natural products from marine cyanobacteria for drug discovery</title> <source>Phytochemistry</source> <year>2007</year> <volume>68</volume> <fpage>958</fpage> - <lpage>979</lpage>
<author><surname>Rockstroh</surname> <given-names>JK</given-names></author> <author><surname>Mocroft</surname> <given-names>A</given-names></author> <author><surname>Soriano</surname> <given-names>V</given-names></author> <author><surname>Tural</surname> <given-names>C</given-names></author> <author><surname>Losso</surname> <given-names>MH</given-names></author> <author><surname>Horban</surname> <given-names>A</given-names></author> <author><surname>Kirk</surname> <given-names>O</given-names></author> <author><surname>Phillips</surname> <given-names>A</given-names></author> <author><surname>Ledergerber</surname> <given-names>B</given-names></author> <author><surname>Lundgren</surname> <given-names>J</given-names></author> <title>Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy</title> <source>J Infect Dis</source> <year>2005</year> <volume>192</volume> <fpage>992</fpage> - <lpage>1002</lpage>
<author><surname>Abdala</surname> <given-names>N</given-names></author> <author><surname>Carney</surname> <given-names>JM</given-names></author> <author><surname>Durante</surname> <given-names>AJ</given-names></author> <author><surname>Klimov</surname> <given-names>N</given-names></author> <author><surname>Ostrovski</surname> <given-names>D</given-names></author> <author><surname>Somlai</surname> <given-names>AM</given-names></author> <author><surname>Kozlov</surname> <given-names>A</given-names></author> <author><surname>Heimer</surname> <given-names>R</given-names></author> <title>Estimating the prevalence of syringe-borne and sexually transmitted diseases among injection drug users in St Petersburg, Russia</title> <source>Int J STD AIDS</source> <year>2003</year> <volume>14</volume> <fpage>697</fpage> - <lpage>703</lpage>
<author><surname>Thomas</surname> <given-names>DL</given-names></author> <author><surname>Vlahov</surname> <given-names>D</given-names></author> <author><surname>Solomon</surname> <given-names>L</given-names></author> <author><surname>Cohn</surname> <given-names>S</given-names></author> <author><surname>Taylor</surname> <given-names>E</given-names></author> <author><surname>Garfein</surname> <given-names>R</given-names></author> <author><surname>Nelson</surname> <given-names>KE</given-names></author> <title>Correlates of hepatitis C virus infections among injection drug users in Baltimore</title> <source>Medicine</source> <year>1995</year> <volume>74</volume> <fpage>212</fpage> - <lpage>220</lpage>
<author><surname>Lincoln</surname> <given-names>D</given-names></author> <author><surname>Petoumenos</surname> <given-names>K</given-names></author> <author><surname>Dore</surname> <given-names>GJ</given-names></author> <title>HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy</title> <source>HIV Med</source> <year>2003</year> <volume>4</volume> <fpage>241</fpage> - <lpage>249</lpage>
<author><surname>Solomon</surname> <given-names>SS</given-names></author> <author><surname>SriKrishnan</surname> <given-names>AK</given-names></author> <author><surname>Mehta</surname> <given-names>SH</given-names></author> <author><surname>Vasudevan</surname> <given-names>CK</given-names></author> <author><surname>Murugavel</surname> <given-names>KG</given-names></author> <author><surname>Thamburaj</surname> <given-names>E</given-names></author> <author><surname>Anand</surname> <given-names>S</given-names></author> <author><surname>Kumar</surname> <given-names>MS</given-names></author> <author><surname>Latkin</surname> <given-names>C</given-names></author> <author><surname>Solomon</surname> <given-names>S</given-names></author> <author><surname>Celentano</surname> <given-names>DD</given-names></author> <title>High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern</title> <source>J Acquir Immune Defic Syndr</source> <year>2008</year> <volume>49</volume> <fpage>327</fpage> - <lpage>332</lpage>
<author><surname>Quan</surname> <given-names>VM</given-names></author> <author><surname>Go</surname> <given-names>VF</given-names></author> <author><surname>Nam</surname> <given-names>LV</given-names></author> <author><surname>Bergenstrom</surname> <given-names>A</given-names></author> <author><surname>Thuoc</surname> <given-names>NP</given-names></author> <author><surname>Zenilman</surname> <given-names>J</given-names></author> <author><surname>Latkin</surname> <given-names>C</given-names></author> <author><surname>Celentano</surname> <given-names>DD</given-names></author> <title>Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study</title> <source>AIDS Care</source> <year>2009</year> <volume>21</volume> <fpage>7</fpage> - <lpage>16</lpage>
<author><surname>Tan</surname> <given-names>Y</given-names></author> <author><surname>Wei</surname> <given-names>QH</given-names></author> <author><surname>Chen</surname> <given-names>LJ</given-names></author> <author><surname>Chan</surname> <given-names>PC</given-names></author> <author><surname>Lai</surname> <given-names>WS</given-names></author> <author><surname>He</surname> <given-names>ML</given-names></author> <author><surname>Kung</surname> <given-names>HF</given-names></author> <author><surname>Lee</surname> <given-names>SS</given-names></author> <title>Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China</title> <source>PLoS ONE</source> <year>2008</year> <volume>3</volume> <fpage>e3608</fpage>
<author><surname>Garten</surname> <given-names>RJ</given-names></author> <author><surname>Lai</surname> <given-names>S</given-names></author> <author><surname>Zhang</surname> <given-names>J</given-names></author> <author><surname>Liu</surname> <given-names>W</given-names></author> <author><surname>Chen</surname> <given-names>J</given-names></author> <author><surname>Vlahov</surname> <given-names>D</given-names></author> <author><surname>Yu</surname> <given-names>XF</given-names></author> <title>Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China</title> <source>Int J Epidemiol</source> <year>2004</year> <volume>33</volume> <fpage>182</fpage> - <lpage>188</lpage>
<author><surname>McGovern</surname> <given-names>BH</given-names></author> <author><surname>Wurcel</surname> <given-names>A</given-names></author> <author><surname>Kim</surname> <given-names>AY</given-names></author> <author><surname>Schulze zur</surname> <given-names>WJ</given-names></author> <author><surname>Bica</surname> <given-names>I</given-names></author> <author><surname>Zaman</surname> <given-names>MT</given-names></author> <author><surname>Timm</surname> <given-names>J</given-names></author> <author><surname>Walker</surname> <given-names>BD</given-names></author> <author><surname>Lauer</surname> <given-names>GM</given-names></author> <title>Acute hepatitis C virus infection in incarcerated injection drug users</title> <source>Clin Infect Dis</source> <year>2006</year> <volume>42</volume> <fpage>1663</fpage> - <lpage>1670</lpage>
<author><surname>Holsen</surname> <given-names>DS</given-names></author> <author><surname>Harthug</surname> <given-names>S</given-names></author> <author><surname>Myrmel</surname> <given-names>H</given-names></author> <title>Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway</title> <source>Eur J Clin Microbiol Infect Dis</source> <year>1993</year> <volume>12</volume> <fpage>673</fpage> - <lpage>676</lpage>
<author><surname>Sulkowski</surname> <given-names>MS</given-names></author> <author><surname>Thomas</surname> <given-names>DL</given-names></author> <author><surname>Hepatitis</surname> <given-names>C</given-names></author> <title>in the HIV-infected patient</title> <source>Clin Liver Dis</source> <year>2003</year> <volume>7</volume> <fpage>179</fpage> - <lpage>194</lpage>
<author><surname>Danta</surname> <given-names>M</given-names></author> <author><surname>Brown</surname> <given-names>D</given-names></author> <author><surname>Bhagani</surname> <given-names>S</given-names></author> <author><surname>Pybus</surname> <given-names>OG</given-names></author> <author><surname>Sabin</surname> <given-names>CA</given-names></author> <author><surname>Nelson</surname> <given-names>M</given-names></author> <author><surname>Fisher</surname> <given-names>M</given-names></author> <author><surname>Johnson</surname> <given-names>AM</given-names></author> <author><surname>Dusheiko</surname> <given-names>GM</given-names></author> <title>Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours</title> <source>AIDS</source> <year>2007</year> <volume>21</volume> <fpage>983</fpage> - <lpage>991</lpage>
<author><surname>Fierer</surname> <given-names>DS</given-names></author> <author><surname>Uriel</surname> <given-names>AJ</given-names></author> <author><surname>Carriero</surname> <given-names>DC</given-names></author> <author><surname>Klepper</surname> <given-names>A</given-names></author> <author><surname>Dieterich</surname> <given-names>DT</given-names></author> <author><surname>Mullen</surname> <given-names>MP</given-names></author> <author><surname>Thung</surname> <given-names>SN</given-names></author> <author><surname>Fiel</surname> <given-names>MI</given-names></author> <author><surname>Branch</surname> <given-names>AD</given-names></author> <title>Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study</title> <source>J Infect Dis</source> <year>2008</year> <volume>198</volume> <fpage>683</fpage> - <lpage>686</lpage>
<author><surname>van de Laar</surname> <given-names>T</given-names></author> <author><surname>Pybus</surname> <given-names>O</given-names></author> <author><surname>Bruisten</surname> <given-names>S</given-names></author> <author><surname>Brown</surname> <given-names>D</given-names></author> <author><surname>Nelson</surname> <given-names>M</given-names></author> <author><surname>Bhagani</surname> <given-names>S</given-names></author> <author><surname>Vogel</surname> <given-names>M</given-names></author> <author><surname>Baumgarten</surname> <given-names>A</given-names></author> <author><surname>Chaix</surname> <given-names>ML</given-names></author> <author><surname>Fisher</surname> <given-names>M</given-names></author> <author><surname>Gotz</surname> <given-names>H</given-names></author> <author><surname>Matthews</surname> <given-names>GV</given-names></author> <author><surname>Neifer</surname> <given-names>S</given-names></author> <author><surname>White</surname> <given-names>P</given-names></author> <author><surname>Rawlinson</surname> <given-names>W</given-names></author> <author><surname>Pol</surname> <given-names>S</given-names></author> <author><surname>Rockstroh</surname> <given-names>J</given-names></author> <author><surname>Coutinho</surname> <given-names>R</given-names></author> <author><surname>Dore</surname> <given-names>GJ</given-names></author> <author><surname>Dusheiko</surname> <given-names>GM</given-names></author> <author><surname>Danta</surname> <given-names>M</given-names></author> <title>Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men</title> <source>Gastroenterology</source> <year>2009</year> <volume>136</volume> <fpage>1609</fpage> - <lpage>1617</lpage>
<author><surname>Gerberding</surname> <given-names>JL</given-names></author> <title>Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: Final report from a longitudinal study</title> <source>J Infect Dis</source> <year>1994</year> <volume>170</volume> <fpage>1410</fpage> - <lpage>1417</lpage>
<author><surname>Goedert</surname> <given-names>JJ</given-names></author> <author><surname>Chen</surname> <given-names>BE</given-names></author> <author><surname>Preiss</surname> <given-names>L</given-names></author> <author><surname>Aledort</surname> <given-names>LM</given-names></author> <author><surname>Rosenberg</surname> <given-names>PS</given-names></author> <title>Reconstruction of the Hepatitis C Virus Epidemic in the US Hemophilia Population, 1940-1990</title> <source>Am J Epidemiol</source> <year>2007</year>
<author><surname>Ticehurst</surname> <given-names>JR</given-names></author> <author><surname>Hamzeh</surname> <given-names>FM</given-names></author> <author><surname>Thomas</surname> <given-names>DL</given-names></author> <title>Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis</title> <source>J Clin Microbiol</source> <year>2007</year> <volume>45</volume> <fpage>2426</fpage> - <lpage>2433</lpage>
<author><surname>Mellors</surname> <given-names>JW</given-names></author> <author><surname>Rinaldo</surname> <given-names>CRJ</given-names></author> <author><surname>Gupta</surname> <given-names>P</given-names></author> <author><surname>White</surname> <given-names>RM</given-names></author> <author><surname>Todd</surname> <given-names>JA</given-names></author> <author><surname>Kingsley</surname> <given-names>LA</given-names></author> <title>Prognosis in HIV-1 infection predicted by the quantity of virus in plasma</title> <source>Science</source> <year>1996</year> <volume>272</volume> <fpage>1167</fpage> - <lpage>1170</lpage>
<author><surname>Drucker</surname> <given-names>E</given-names></author> <author><surname>Alcabes</surname> <given-names>PG</given-names></author> <author><surname>Marx</surname> <given-names>PA</given-names></author> <title>The injection century: massive unsterile injections and the emergence of human pathogens</title> <source>Lancet</source> <year>2001</year> <volume>358</volume> <fpage>1989</fpage> - <lpage>1992</lpage>
<author><surname>Magiorkinis</surname> <given-names>G</given-names></author> <author><surname>Magiorkinis</surname> <given-names>E</given-names></author> <author><surname>Paraskevis</surname> <given-names>D</given-names></author> <author><surname>Ho</surname> <given-names>SY</given-names></author> <author><surname>Shapiro</surname> <given-names>B</given-names></author> <author><surname>Pybus</surname> <given-names>OG</given-names></author> <author><surname>Allain</surname> <given-names>JP</given-names></author> <author><surname>Hatzakis</surname> <given-names>A</given-names></author> <title>The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis</title> <source>PLoS Med</source> <year>2009</year> <volume>6</volume> <fpage>e1000198</fpage>
<author><surname>Frank</surname> <given-names>C</given-names></author> <author><surname>Mohamed</surname> <given-names>MK</given-names></author> <author><surname>Strickland</surname> <given-names>GT</given-names></author> <author><surname>Lavanchy</surname> <given-names>D</given-names></author> <author><surname>Arthur</surname> <given-names>RR</given-names></author> <author><surname>Magder</surname> <given-names>LS</given-names></author> <author><surname>El Khoby</surname> <given-names>T</given-names></author> <author><surname>Abdel-Wahab</surname> <given-names>Y</given-names></author> <author><surname>Aly Ohn</surname> <given-names>ES</given-names></author> <author><surname>Anwar</surname> <given-names>W</given-names></author> <author><surname>Sallam</surname> <given-names>I</given-names></author> <title>The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt</title> <source>Lancet</source> <year>2000</year> <volume>355</volume> <fpage>887</fpage> - <lpage>891</lpage>
<author><surname>Garfein</surname> <given-names>RS</given-names></author> <author><surname>Doherty</surname> <given-names>MC</given-names></author> <author><surname>Monterroso</surname> <given-names>ER</given-names></author> <author><surname>Thomas</surname> <given-names>DL</given-names></author> <author><surname>Nelson</surname> <given-names>KE</given-names></author> <author><surname>Vlahov</surname> <given-names>D</given-names></author> <title>Prevalence and incidence of hepatitis C virus infection among young adult injection drug users</title> <source>J Acquir Immune Defic Syndr Hum Retrovirol</source> <year>1998</year> <volume>18</volume> <issue>Suppl 1</issue> <fpage>S11</fpage> - <lpage>19</lpage>
<author><surname>Quinn</surname> <given-names>TC</given-names></author> <author><surname>Groseclose</surname> <given-names>SL</given-names></author> <author><surname>Spence</surname> <given-names>M</given-names></author> <author><surname>Provost</surname> <given-names>V</given-names></author> <author><surname>Hook</surname> <given-names>EW</given-names></author> <title>III Evolution of the human immunodeficiency virus epidemic among patients attending sexually transmitted disease clinics: a decade of experience</title> <source>J Infect Dis</source> <year>1992</year> <volume>165</volume> <fpage>541</fpage> - <lpage>544</lpage>
<author><surname>Kelen</surname> <given-names>GD</given-names></author> <author><surname>Green</surname> <given-names>GB</given-names></author> <author><surname>Purcell</surname> <given-names>RH</given-names></author> <author><surname>Chan</surname> <given-names>DW</given-names></author> <author><surname>Qaqish</surname> <given-names>BF</given-names></author> <author><surname>Sivertson</surname> <given-names>KT</given-names></author> <author><surname>Quinn</surname> <given-names>TC</given-names></author> <author><surname>Hepatitis</surname> <given-names>B</given-names></author> <title>and hepatitis C in emergency department patients</title> <source>N Engl J Med</source> <year>1992</year> <volume>326</volume> <fpage>1399</fpage> - <lpage>1404</lpage>
<author><surname>Thomas</surname> <given-names>DL</given-names></author> <author><surname>Astemborski</surname> <given-names>J</given-names></author> <author><surname>Rai</surname> <given-names>RM</given-names></author> <author><surname>Anania</surname> <given-names>FA</given-names></author> <author><surname>Schaeffer</surname> <given-names>M</given-names></author> <author><surname>Galai</surname> <given-names>N</given-names></author> <author><surname>Nolt</surname> <given-names>K</given-names></author> <author><surname>Nelson</surname> <given-names>KE</given-names></author> <author><surname>Strathdee</surname> <given-names>SA</given-names></author> <author><surname>Johnson</surname> <given-names>L</given-names></author> <author><surname>Laeyendecker</surname> <given-names>O</given-names></author> <author><surname>Boitnott</surname> <given-names>J</given-names></author> <author><surname>Wilson</surname> <given-names>LE</given-names></author> <author><surname>Vlahov</surname> <given-names>D</given-names></author> <title>The natural history of hepatitis C virus infection: host, viral, and environmental factors</title> <source>JAMA</source> <year>2000</year> <volume>284</volume> <fpage>450</fpage> - <lpage>456</lpage>
<author><surname>Thomas</surname> <given-names>DL</given-names></author> <author><surname>Astemborski</surname> <given-names>J</given-names></author> <author><surname>Vlahov</surname> <given-names>D</given-names></author> <author><surname>Strathdee</surname> <given-names>SA</given-names></author> <author><surname>Ray</surname> <given-names>SC</given-names></author> <author><surname>Nelson</surname> <given-names>KE</given-names></author> <author><surname>Galai</surname> <given-names>N</given-names></author> <author><surname>Nolt</surname> <given-names>KR</given-names></author> <author><surname>Laeyendecker</surname> <given-names>O</given-names></author> <author><surname>Todd</surname> <given-names>JA</given-names></author> <title>Determinants of the quantity of hepatitis C virus RNA</title> <source>J Infect Dis</source> <year>2000</year> <volume>181</volume> <fpage>844</fpage> - <lpage>851</lpage>
<author><surname>Torriani</surname> <given-names>FJ</given-names></author> <author><surname>Rodriguez-Torres</surname> <given-names>M</given-names></author> <author><surname>Rockstroh</surname> <given-names>JK</given-names></author> <author><surname>Lissen</surname> <given-names>E</given-names></author> <author><surname>Gonzalez-Garcia</surname> <given-names>J</given-names></author> <author><surname>Lazzarin</surname> <given-names>A</given-names></author> <author><surname>Carosi</surname> <given-names>G</given-names></author> <author><surname>Sasadeusz</surname> <given-names>J</given-names></author> <author><surname>Katlama</surname> <given-names>C</given-names></author> <author><surname>Montaner</surname> <given-names>J</given-names></author> <author><surname>Sette</surname> <given-names>H</given-names></author> <author><surname>Passe</surname> <given-names>S</given-names></author> <author><surname>De Pamphilis</surname> <given-names>J</given-names></author> <author><surname>Duff</surname> <given-names>F</given-names></author> <author><surname>Schrenk</surname> <given-names>UM</given-names></author> <author><surname>Dieterich</surname> <given-names>DT</given-names></author> <title>Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients</title> <source>N Engl J Med</source> <year>2004</year> <volume>351</volume> <fpage>438</fpage> - <lpage>450</lpage>
<author><surname>Hadziyannis</surname> <given-names>SJ</given-names></author> <author><surname>Sette</surname> <given-names>H</given-names></author> <author><surname>Morgan</surname> <given-names>TR</given-names></author> <author><surname>Balan</surname> <given-names>V</given-names></author> <author><surname>Diago</surname> <given-names>M</given-names></author> <author><surname>Marcellin</surname> <given-names>P</given-names></author> <author><surname>Ramadori</surname> <given-names>G</given-names></author> <author><surname>Bodenheimer</surname> <given-names>H</given-names></author> <author><surname>Bernstein</surname> <given-names>D</given-names></author> <author><surname>Rizzetto</surname> <given-names>M</given-names></author> <author><surname>Zeuzem</surname> <given-names>S</given-names></author> <author><surname>Pockros</surname> <given-names>PJ</given-names></author> <author><surname>Lin</surname> <given-names>A</given-names></author> <author><surname>Ackrill</surname> <given-names>AM</given-names></author> <title>Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose</title> <source>Ann Intern Med</source> <year>2004</year> <volume>140</volume> <fpage>346</fpage> - <lpage>355</lpage>
<author><surname>Graham</surname> <given-names>CS</given-names></author> <author><surname>Baden</surname> <given-names>LR</given-names></author> <author><surname>Yu</surname> <given-names>E</given-names></author> <author><surname>Mrus</surname> <given-names>JM</given-names></author> <author><surname>Carnie</surname> <given-names>J</given-names></author> <author><surname>Heeren</surname> <given-names>T</given-names></author> <author><surname>Koziel</surname> <given-names>MJ</given-names></author> <title>Influence of human immunodeficiency virus infection on the course of hepatitis c virus infection: a meta-analysis</title> <source>Clin Infect Dis</source> <year>2001</year> <volume>33</volume> <fpage>562</fpage> - <lpage>569</lpage>
<author><surname>Goedert</surname> <given-names>JJ</given-names></author> <author><surname>Eyster</surname> <given-names>ME</given-names></author> <author><surname>Lederman</surname> <given-names>MM</given-names></author> <author><surname>Mandalaki</surname> <given-names>T</given-names></author> <author><surname>De Moerloose</surname> <given-names>P</given-names></author> <author><surname>White</surname> <given-names>GC</given-names></author> <author><surname>Angiolillo</surname> <given-names>AL</given-names></author> <author><surname>Luban</surname> <given-names>NL</given-names></author> <author><surname>Sherman</surname> <given-names>KE</given-names></author> <author><surname>Manco-Johnson</surname> <given-names>M</given-names></author> <author><surname>Preiss</surname> <given-names>L</given-names></author> <author><surname>Leissinger</surname> <given-names>C</given-names></author> <author><surname>Kessler</surname> <given-names>CM</given-names></author> <author><surname>Cohen</surname> <given-names>AR</given-names></author> <author><surname>DiMichele</surname> <given-names>D</given-names></author> <author><surname>Hilgartner</surname> <given-names>MW</given-names></author> <author><surname>Aledort</surname> <given-names>LM</given-names></author> <author><surname>Kroner</surname> <given-names>BL</given-names></author> <author><surname>Rosenberg</surname> <given-names>PS</given-names></author> <author><surname>Hatzakis</surname> <given-names>A</given-names></author> <title>End-stage liver disease in persons with hemophilia and transfusion- associated infections</title> <source>Blood</source> <year>2002</year> <volume>100</volume> <fpage>1584</fpage> - <lpage>1589</lpage>
<author><surname>Chung</surname> <given-names>RT</given-names></author> <author><surname>Evans</surname> <given-names>SR</given-names></author> <author><surname>Yang</surname> <given-names>Y</given-names></author> <author><surname>Theodore</surname> <given-names>D</given-names></author> <author><surname>Valdez</surname> <given-names>H</given-names></author> <author><surname>Clark</surname> <given-names>R</given-names></author> <author><surname>Shikuma</surname> <given-names>C</given-names></author> <author><surname>Nevin</surname> <given-names>T</given-names></author> <author><surname>Sherman</surname> <given-names>KE</given-names></author> <title>AIDS Clinical Trials Groups 383 Study Team Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects</title> <source>AIDS</source> <year>2002</year> <volume>16</volume> <fpage>1915</fpage> - <lpage>1923</lpage>
<author><surname>Lohse</surname> <given-names>N</given-names></author> <author><surname>Hansen</surname> <given-names>AB</given-names></author> <author><surname>Pedersen</surname> <given-names>G</given-names></author> <author><surname>Kronborg</surname> <given-names>G</given-names></author> <author><surname>Gerstoft</surname> <given-names>J</given-names></author> <author><surname>Sorensen</surname> <given-names>HT</given-names></author> <author><surname>Vaeth</surname> <given-names>M</given-names></author> <author><surname>Obel</surname> <given-names>N</given-names></author> <title>Survival of persons with and without HIV infection in Denmark, 1995-2005</title> <source>Ann Intern Med</source> <year>2007</year> <volume>146</volume> <fpage>87</fpage> - <lpage>95</lpage>
<author><surname>Weber</surname> <given-names>R</given-names></author> <author><surname>Sabin</surname> <given-names>CA</given-names></author> <author><surname>Friis-Moller</surname> <given-names>N</given-names></author> <author><surname>Reiss</surname> <given-names>P</given-names></author> <author><surname>El Sadr</surname> <given-names>WM</given-names></author> <author><surname>Kirk</surname> <given-names>O</given-names></author> <author><surname>Dabis</surname> <given-names>F</given-names></author> <author><surname>Law</surname> <given-names>MG</given-names></author> <author><surname>Pradier</surname> <given-names>C</given-names></author> <author><surname>De Wit</surname> <given-names>S</given-names></author> <author><surname>Akerlund</surname> <given-names>B</given-names></author> <author><surname>Calvo</surname> <given-names>G</given-names></author> <author><surname>Monforte</surname> <given-names>A</given-names></author> <author><surname>Rickenbach</surname> <given-names>M</given-names></author> <author><surname>Ledergerber</surname> <given-names>B</given-names></author> <author><surname>Phillips</surname> <given-names>AN</given-names></author> <author><surname>Lundgren</surname> <given-names>JD</given-names></author> <title>Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study</title> <source>Arch Intern Med</source> <year>2006</year> <volume>166</volume> <fpage>1632</fpage> - <lpage>1641</lpage>
<author><surname>Bica</surname> <given-names>I</given-names></author> <author><surname>McGovern</surname> <given-names>B</given-names></author> <author><surname>Dhar</surname> <given-names>R</given-names></author> <author><surname>Stone</surname> <given-names>D</given-names></author> <author><surname>McGowan</surname> <given-names>K</given-names></author> <author><surname>Scheib</surname> <given-names>R</given-names></author> <author><surname>Snydman</surname> <given-names>DR</given-names></author> <title>Increasing Mortality Due to End-Stage Liver Disease in Patients with</title> <source>Human Immunodeficiency Virus Infection Clin Infect Dis</source> <year>2001</year> <volume>32</volume> <fpage>492</fpage> - <lpage>497</lpage>
<author><surname>Janke</surname> <given-names>EA</given-names></author> <author><surname>McGraw</surname> <given-names>S</given-names></author> <author><surname>Garcia-Tsao</surname> <given-names>G</given-names></author> <author><surname>Fraenkel</surname> <given-names>L</given-names></author> <title>Psychosocial issues in hepatitis C: a qualitative analysis</title> <source>Psychosomatics</source> <year>2008</year> <volume>49</volume> <fpage>494</fpage> - <lpage>501</lpage>
<author><surname>Marcellin</surname> <given-names>F</given-names></author> <author><surname>Preau</surname> <given-names>M</given-names></author> <author><surname>Ravaux</surname> <given-names>I</given-names></author> <author><surname>Dellamonica</surname> <given-names>P</given-names></author> <author><surname>Spire</surname> <given-names>B</given-names></author> <author><surname>Carrieri</surname> <given-names>MP</given-names></author> <title>Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research</title> <source>HIV Clin Trials</source> <year>2007</year> <volume>8</volume> <fpage>320</fpage> - <lpage>327</lpage>
<author><surname>Mahoney</surname> <given-names>FJ</given-names></author> <author><surname>Stewart</surname> <given-names>K</given-names></author> <author><surname>Hu</surname> <given-names>HX</given-names></author> <author><surname>Coleman</surname> <given-names>P</given-names></author> <author><surname>Alter</surname> <given-names>MJ</given-names></author> <title>Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States</title> <source>Arch Intern Med</source> <year>1997</year> <volume>157</volume> <fpage>2601</fpage> - <lpage>2605</lpage>
<author><surname>Rockstroh</surname> <given-names>JK</given-names></author> <author><surname>Bhagani</surname> <given-names>S</given-names></author> <author><surname>Benhamou</surname> <given-names>Y</given-names></author> <author><surname>Bruno</surname> <given-names>R</given-names></author> <author><surname>Mauss</surname> <given-names>S</given-names></author> <author><surname>Peters</surname> <given-names>L</given-names></author> <author><surname>Puoti</surname> <given-names>M</given-names></author> <author><surname>Soriano</surname> <given-names>V</given-names></author> <author><surname>Tural</surname> <given-names>C</given-names></author> <title>Europeans AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults</title> <source>HIV Med</source> <year>2008</year> <volume>9</volume> <fpage>82</fpage> - <lpage>88</lpage>
<author><surname>Ghany</surname> <given-names>MG</given-names></author> <author><surname>Strader</surname> <given-names>DB</given-names></author> <author><surname>Thomas</surname> <given-names>DL</given-names></author> <author><surname>Seeff</surname> <given-names>LB</given-names></author> <title>Diagnosis, management, and treatment of hepatitis C: An update</title> <source>Hepatology</source> <year>2009</year> <volume>49</volume> <issue>4</issue> <fpage>1335</fpage> - <lpage>1374</lpage>
<title>Centers for Disease Control and Prevention Guidelines for Preventing Opportunistic Infections in HIV-Infected Adults and Adolescents - Recommendations from the CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious</title> <source>Diseases Society of America MMWR</source> <year>2009</year> <volume>58</volume> <fpage>1</fpage> - <lpage>206</lpage>
<author><surname>Zhou</surname> <given-names>J</given-names></author> <author><surname>Dore</surname> <given-names>GJ</given-names></author> <author><surname>Zhang</surname> <given-names>F</given-names></author> <author><surname>Lim</surname> <given-names>PL</given-names></author> <author><surname>Chen</surname> <given-names>YM</given-names></author> <author><surname>Hepatitis</surname> <given-names>B</given-names></author> <author><surname>and</surname> <given-names>C</given-names></author> <title>virus coinfection in The TREAT Asia HIV Observational</title> <source>Database J Gastroenterol Hepatol</source> <year>2007</year> <volume>22</volume> <fpage>1510</fpage> - <lpage>1518</lpage>
<author><surname>Lee</surname> <given-names>SR</given-names></author> <author><surname>Yearwood</surname> <given-names>GD</given-names></author> <author><surname>Guillon</surname> <given-names>GB</given-names></author> <author><surname>Kurtz</surname> <given-names>LA</given-names></author> <author><surname>Fischl</surname> <given-names>M</given-names></author> <author><surname>Friel</surname> <given-names>T</given-names></author> <author><surname>Berne</surname> <given-names>CA</given-names></author> <author><surname>Kardos</surname> <given-names>KW</given-names></author> <title>Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection</title> <source>J Clin Virol</source> <year>2010</year> <volume>48</volume> <fpage>15</fpage> - <lpage>17</lpage>
<author><surname>Soriano</surname> <given-names>V</given-names></author> <author><surname>Maida</surname> <given-names>I</given-names></author> <author><surname>Nunez</surname> <given-names>M</given-names></author> <author><surname>Garcia-Samaniego</surname> <given-names>J</given-names></author> <author><surname>Barreiro</surname> <given-names>P</given-names></author> <author><surname>Martin-Carbonero</surname> <given-names>L</given-names></author> <author><surname>Gonzalez-Lahoz</surname> <given-names>J</given-names></author> <title>Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies</title> <source>Antivir Ther</source> <year>2004</year> <volume>9</volume> <fpage>987</fpage> - <lpage>992</lpage>
<author><surname>Berenguer</surname> <given-names>J</given-names></author> <author><surname>Alvarez-Pellicer</surname> <given-names>J</given-names></author> <author><surname>Martin</surname> <given-names>PM</given-names></author> <author><surname>Lopez-Aldeguer</surname> <given-names>J</given-names></author> <author><surname>Von-Wichmann</surname> <given-names>MA</given-names></author> <author><surname>Quereda</surname> <given-names>C</given-names></author> <author><surname>Mallolas</surname> <given-names>J</given-names></author> <author><surname>Sanz</surname> <given-names>J</given-names></author> <author><surname>Tural</surname> <given-names>C</given-names></author> <author><surname>Bellon</surname> <given-names>JM</given-names></author> <author><surname>Gonzalez-Garcia</surname> <given-names>J</given-names></author> <title>Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus</title> <source>Hepatology</source> <year>2009</year> <volume>50</volume> <fpage>407</fpage> - <lpage>413</lpage>
<author><surname>McHutchison</surname> <given-names>JG</given-names></author> <author><surname>Everson</surname> <given-names>GT</given-names></author> <author><surname>Gordon</surname> <given-names>SC</given-names></author> <author><surname>Jacobson</surname> <given-names>IM</given-names></author> <author><surname>Sulkowski</surname> <given-names>M</given-names></author> <author><surname>Kauffman</surname> <given-names>R</given-names></author> <author><surname>McNair</surname> <given-names>L</given-names></author> <author><surname>Alam</surname> <given-names>J</given-names></author> <author><surname>Muir</surname> <given-names>AJ</given-names></author> <title>Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection</title> <source>N Engl J Med</source> <year>2009</year> <volume>360</volume> <fpage>1827</fpage> - <lpage>1838</lpage>
<author><surname>Villano</surname> <given-names>SA</given-names></author> <author><surname>Vlahov</surname> <given-names>D</given-names></author> <author><surname>Nelson</surname> <given-names>KE</given-names></author> <author><surname>Lyles</surname> <given-names>CM</given-names></author> <author><surname>Cohn</surname> <given-names>S</given-names></author> <author><surname>Thomas</surname> <given-names>DL</given-names></author> <title>Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland</title> <source>J Clin Microbiol</source> <year>1997</year> <volume>35</volume> <fpage>3274</fpage> - <lpage>7</lpage>
<author><surname>Thomas</surname> <given-names>DL</given-names></author> <title>Curing hepatitis C with pills: a step toward global control</title> <source>Lancet</source> <year>2010</year> <volume>376</volume> <fpage>1441</fpage> - <lpage>2</lpage>
<author><surname>Scott</surname> <given-names>M.P</given-names></author>. <author><surname>Trucksess</surname> <given-names>W.M</given-names></author>. <title>Application of immunoaffinity columns to mycotoxin analysis</title> <source>J. AOAC Intl</source> <year>1997</year> <volume>80</volume> <fpage>941</fpage> - <lpage>955</lpage>
<title>Evaluation of certain Mycotoxins: Ochratoxin A, WHO</title> <source>Food Additives Series 47/FAO Food Nutrition Paper</source> <year>2001</year> <volume>74</volume>
<author><surname>Valenta</surname> <given-names>H</given-names></author> <title>Chromatographic methods for the determination of ochratoxin A in animal and human tissues and fluids</title> <source>J. Chromatogr. A</source> <year>1998</year> <volume>815</volume> <fpage>75</fpage> - <lpage>92</lpage>
<author><surname>Monaci</surname> <given-names>L</given-names></author> <author><surname>Palmisano</surname> <given-names>F</given-names></author> <author><surname>Ochratoxin</surname> <given-names>A</given-names></author> <title>determination in paired kidneys and muscle samples from swines slaughtered in southern</title> <source>Italy Anal. Bioanal. Chem</source> <year>2004</year> <volume>378</volume> <fpage>86</fpage> - <lpage>71</lpage>
<author><surname>Hancock</surname> <given-names>J.R</given-names></author>. <author><surname>D&#8217;agostino</surname> <given-names>P.A</given-names></author>. <title>Mass spectrometric identification of toxins of biological origin</title> <source>Anal. Chim. Acta</source> <year>2002</year> <volume>457</volume> <fpage>71</fpage> - <lpage>76</lpage>
<author><surname>Losito</surname> <given-names>I</given-names></author> <author><surname>Monaci</surname> <given-names>L</given-names></author> <author><surname>Palmisano</surname> <given-names>F</given-names></author> <author><surname>Tantillo</surname> <given-names>G</given-names></author> <title>Determination of ochratoxin A in meat products by high-performance liquid chromatography coupled to electrospray ionisation sequential mass spectrometry</title> <source>Rapid Commun. Mass Spectrom</source> <year>2004</year> <volume>18</volume> <fpage>1</fpage> - <lpage>7</lpage>
<author><surname>De Saeger</surname> <given-names>D</given-names></author> <author><surname>Dumoulin</surname> <given-names>F</given-names></author> <author><surname>Van Peterghem</surname> <given-names>C</given-names></author> <title>Quantitative determination of ochratoxin A in kidneys by liquid chromatography/mass spectrometry</title> <source>Rapid Commun. Mass Spectrom</source> <year>2004</year> <volume>18</volume> <fpage>2661</fpage> - <lpage>2669</lpage>
<author><surname>Xiao</surname> <given-names>H</given-names></author> <author><surname>Marquardt</surname> <given-names>R.R</given-names></author>. <author><surname>Abramson</surname> <given-names>D</given-names></author> <author><surname>Frohlich</surname> <given-names>A.A</given-names></author>. <title>Metabolites of ochratoxins in rat urine</title> <source>Appl. Envir. Microbiol</source> <year>1996</year> <volume>62</volume> <fpage>648</fpage> - <lpage>655</lpage>
<author><surname>Biselli</surname> <given-names>S</given-names></author> <author><surname>Hartig</surname> <given-names>L</given-names></author> <author><surname>Wegener</surname> <given-names>H</given-names></author> <title>Analysis of. Fusarium Toxins using LC/MS&#8211;MS.: 25&#8211;30 C. LC-GC</title>, <source>Eur</source>. <year>2004</year> <volume>17</volume> <fpage>25</fpage> - <lpage>30</lpage>
<author><surname>Becker</surname> <given-names>M</given-names></author> <author><surname>Degelman</surname> <given-names>P</given-names></author> <author><surname>Herderich</surname> <given-names>M</given-names></author> <author><surname>Schreier</surname> <given-names>P</given-names></author> <author><surname>Humpf</surname> <given-names>H.U</given-names></author>. <title>Determination of ochratoxin A at part-per-trillion level in Italian salami by immunoaffinity clean-up and high-performance liquid chromatography with fluorescence detection</title> <source>J. Chromatogr. A</source> <year>1998</year> <volume>818</volume> <fpage>260</fpage> - <lpage>280</lpage>
<author><surname>Reinsch</surname> <given-names>M</given-names></author> <author><surname>T&#246;pfer</surname> <given-names>A</given-names></author> <author><surname>Lehmann</surname> <given-names>A</given-names></author> <author><surname>Nehls</surname> <given-names>I</given-names></author> <title>Ochratoxin A, wine, tandem mass spectrometry, solid-phase extraction, anion exchange, liquid chromatography</title> <source>Anal. Bional. Chem</source> <year>2005</year> <volume>381</volume> <fpage>1592</fpage> - <lpage>1595</lpage>
<author><surname>Solfrizzo</surname> <given-names>M</given-names></author> <author><surname>Avantaggiato</surname> <given-names>G</given-names></author> <author><surname>Visconti</surname> <given-names>A</given-names></author> <title>Use of various clean-up procedures for the analysis of ochratoxin A in cereals</title> <source>J. Chromatr. A</source> <year>1998</year> <volume>815</volume> <fpage>67</fpage> - <lpage>73</lpage>
<author><surname>Chaturvedi</surname> <given-names>P</given-names></author> <author><surname>Smith</surname> <given-names>T</given-names></author> <author><surname>Zabe</surname> <given-names>T.N</given-names></author>. <author><surname>Kohn</surname> <given-names>B.A</given-names></author>. <title>A new method for simultaneous aflatoxin and ochratoxin clean-up for HPLC analysis in grains</title> <source>Inst. Food Technol. Ann. Mtg</source> <year>1999</year> <other>Chicago IFT 234</other> <publisher>Chicago Abstracts</publisher>
<author><surname>Menezes</surname> <given-names>M.L</given-names></author>. <author><surname>F&#233;lix</surname> <given-names>G</given-names></author> <title>On line extraction and separation of bendiocarb, methomyl, methylparathion and pentachlorophenol pesticides from raw milk</title> <source>J. Liq. Chromatogr</source> <year>1998</year> <volume>21</volume> <fpage>2863</fpage> - <lpage>2871</lpage>
<author><surname>Derlet</surname> <given-names>R. W</given-names></author> <title>Overcrowding in emergency departments: Increased demand and decreased capacity</title> <source>Ann. Emerg. Med</source> <year>2002</year> <volume>39</volume> <issue>4</issue> <fpage>430</fpage> - <lpage>432</lpage>
<author><surname>Fatovich</surname> <given-names>D. M</given-names></author> <author><surname>Nagree</surname> <given-names>Y</given-names></author> <author><surname>Sprivulis</surname> <given-names>P</given-names></author> <title>Access block causes emergency department overcrowding and ambulance diversion in Perth, Western Australia</title> <source>Emerg. Med. J</source> <year>2005</year> <volume>22</volume> <issue>5</issue> <fpage>351</fpage> - <lpage>354</lpage>
<author><surname>Twanmoh</surname> <given-names>J. R</given-names></author> <author><surname>Cunningham</surname> <given-names>G. P</given-names></author> <title>When overcrowding paralyzes an emergency department</title> <source>Manag. Care</source> <year>2006</year> <volume>15</volume> <issue>6</issue> <fpage>54</fpage> - <lpage>59</lpage>
<author><surname>Ackermann</surname> <given-names>R. J</given-names></author> <author><surname>Kemle</surname> <given-names>K. A</given-names></author> <author><surname>Vogel</surname> <given-names>R. L</given-names></author> <author><surname>Griffin</surname> <given-names>R. C</given-names></author> <title>Jr Emergency department use by nursing home residents</title> <source>Ann. Emerg. Med</source> <year>1998</year> <volume>31</volume> <issue>6</issue> <fpage>749</fpage> - <lpage>757</lpage>
<author><surname>Asplin</surname> <given-names>B. R</given-names></author> <author><surname>Magid</surname> <given-names>D. J</given-names></author> <author><surname>Rhodes</surname> <given-names>K. V</given-names></author> <author><surname>Solberg</surname> <given-names>L. I</given-names></author> <author><surname>Lurie</surname> <given-names>N</given-names></author> <author><surname>Camargo</surname> <given-names>C. A</given-names></author> <author><surname>Jr</surname></author> <title>A conceptual model of emergency department crowding</title> <source>Ann. Emerg. Med</source> <year>2003</year> <volume>42</volume> <issue>2</issue> <fpage>173</fpage> - <lpage>180</lpage>
<author><surname>Derlet</surname> <given-names>R. W</given-names></author> <author><surname>Richards</surname> <given-names>J. R</given-names></author> <title>Overcrowding in the nation"s emergency departments: complex causes and disturbing effects</title> <source>Ann. Emerg. Med</source> <year>2000</year> <volume>35</volume> <issue>1</issue> <fpage>63</fpage> - <lpage>68</lpage>
<author><surname>Derlet</surname> <given-names>R. W</given-names></author> <author><surname>Richards</surname> <given-names>J. R</given-names></author> <author><surname>Kravitz</surname> <given-names>R. L</given-names></author> <title>Frequent overcrowding in U.S. emergency departments</title> <source>Acad. Emerg. Med</source> <year>2001</year> <volume>8</volume> <issue>2</issue> <fpage>151</fpage> - <lpage>155</lpage>
<author><surname>Schull</surname> <given-names>M. J</given-names></author> <author><surname>Morrison</surname> <given-names>L. J</given-names></author> <author><surname>Vermeulen</surname> <given-names>M</given-names></author> <author><surname>Redelmeier</surname> <given-names>D. A</given-names></author> <title>Emergency department gridlock and out-of-hospital delays for cardiac patients</title> <source>Acad. Emerg. Med</source> <year>2003</year> <volume>10</volume> <issue>7</issue> <fpage>709</fpage> - <lpage>716</lpage>
<author><surname>Schull</surname> <given-names>M. J</given-names></author> <author><surname>Morrison</surname> <given-names>L. J</given-names></author> <author><surname>Vermeulen</surname> <given-names>M</given-names></author> <author><surname>Redelmeier</surname> <given-names>D. A</given-names></author> <title>Emergency department overcrowding and ambulance transport delays for patients with chest pain</title> <source>CMAJ</source> <year>2003</year> <volume>168</volume> <issue>3</issue> <fpage>277</fpage> - <lpage>283</lpage>
<author><surname>Liu</surname> <given-names>S</given-names></author> <author><surname>Hobgood</surname> <given-names>C</given-names></author> <author><surname>Brice</surname> <given-names>J. H</given-names></author> <title>Impact of critical bed status on emergency department patient flow and overcrowding</title> <source>Acad. Emerg. Med</source> <year>2003</year> <volume>10</volume> <issue>4</issue> <fpage>382</fpage> - <lpage>385</lpage>
<author><surname>Schull</surname> <given-names>M. J</given-names></author> <author><surname>Vermeulen</surname> <given-names>M</given-names></author> <author><surname>Slaughter</surname> <given-names>G</given-names></author> <author><surname>Morrison</surname> <given-names>L</given-names></author> <author><surname>Daly</surname> <given-names>P</given-names></author> <title>Emergency department crowding and thrombolysis delays in acute myocardial infarction</title> <source>Ann. Emerg. Med</source> <year>2004</year> <volume>44</volume> <issue>6</issue> <fpage>577</fpage> - <lpage>585</lpage>
<author><surname>Chen</surname> <given-names>E. H</given-names></author> <author><surname>Mills</surname> <given-names>A. M</given-names></author> <author><surname>Lee</surname> <given-names>B. Y</given-names></author> <author><surname>Robey</surname> <given-names>J. L</given-names></author> <author><surname>Zogby</surname> <given-names>K. E</given-names></author> <author><surname>Shofer</surname> <given-names>F. S</given-names></author> <author><surname>Reilly</surname> <given-names>P. M</given-names></author> <author><surname>Hollander</surname> <given-names>J. E</given-names></author> <title>The impact of a concurrent trauma alert evaluation on time to head computed tomography in patients with suspected stroke</title> <source>Acad. Emerg. Med</source> <year>2006</year> <volume>13</volume> <issue>3</issue> <fpage>349</fpage> - <lpage>352</lpage>
<author><surname>Weiss</surname> <given-names>S. J</given-names></author> <author><surname>Ernst</surname> <given-names>A. A</given-names></author> <author><surname>Derlet</surname> <given-names>R</given-names></author> <author><surname>King</surname> <given-names>R</given-names></author> <author><surname>Bair</surname> <given-names>A. E</given-names></author> <author><surname>Nick</surname> <given-names>T. G</given-names></author> <title>Relationship between the National ED Overcrowding Scale and the number of patients who leave without being seen in an academic</title> <source>ED Am. J. Emerg. Med</source> <year>2005</year> <volume>23</volume> <issue>3</issue> <fpage>288</fpage> - <lpage>294</lpage>
<author><surname>Rowe</surname> <given-names>B. H</given-names></author> <author><surname>Channan</surname> <given-names>P</given-names></author> <author><surname>Bullard</surname> <given-names>M</given-names></author> <author><surname>Blitz</surname> <given-names>S</given-names></author> <author><surname>Saunders</surname> <given-names>L. D</given-names></author> <author><surname>Rosychuk</surname> <given-names>R. J</given-names></author> <author><surname>Lari</surname> <given-names>H</given-names></author> <author><surname>Craig</surname> <given-names>W. R</given-names></author> <author><surname>Holroyd</surname> <given-names>B. R</given-names></author> <title>Characteristics of patients who leave emergency departments without being seen</title> <source>Acad. Emerg. Med</source> <year>2006</year> <volume>13</volume> <issue>8</issue> <fpage>848</fpage> - <lpage>852</lpage>
<author><surname>Hoot</surname> <given-names>N. R</given-names></author> <author><surname>Zhou</surname> <given-names>C</given-names></author> <author><surname>Jones</surname> <given-names>I</given-names></author> <author><surname>Aronsky</surname> <given-names>D</given-names></author> <title>Measuring and forecasting emergency department crowding in real time</title> <source>Ann. Emerg. Med</source> <year>2007</year> <volume>49</volume> <issue>6</issue> <fpage>747</fpage> - <lpage>755</lpage>
<author><surname>Vieth</surname> <given-names>T. L</given-names></author> <author><surname>Rhodes</surname> <given-names>K. V</given-names></author> <title>The effect of crowding on access and quality in an academic</title> <source>ED Am. J. Emerg. Med</source> <year>2006</year> <volume>24</volume> <issue>7</issue> <fpage>787</fpage> - <lpage>794</lpage>
<author><surname>Hoot</surname> <given-names>N. R</given-names></author> <author><surname>Aronsky</surname> <given-names>D</given-names></author> <title>Systematic review of emergency department crowding: causes, effects, and solutions</title> <source>Ann. Emerg. Med</source> <year>2008</year> <volume>52</volume> <issue>2</issue> <fpage>126</fpage> - <lpage>136</lpage>
<author><surname>Baker</surname> <given-names>D. W</given-names></author> <author><surname>Stevens</surname> <given-names>C. D</given-names></author> <author><surname>Brook</surname> <given-names>R. H</given-names></author> <title>Patients who leave a public hospital emergency department without being seen by a physician. Causes and consequences</title> <source>JAMA</source> <year>1991</year> <volume>266</volume> <issue>8</issue> <fpage>1085</fpage> - <lpage>1090</lpage>
<author><surname>Asaro</surname> <given-names>P. V</given-names></author> <author><surname>Lewis</surname> <given-names>L. M</given-names></author> <author><surname>Boxerman</surname> <given-names>S. B</given-names></author> <title>Emergency department overcrowding: analysis of the factors of renege rate</title> <source>Acad. Emerg. Med</source> <year>2007</year> <volume>14</volume> <issue>2</issue> <fpage>157</fpage> - <lpage>162</lpage>
<author><surname>Hobbs</surname> <given-names>D</given-names></author> <author><surname>Kunzman</surname> <given-names>S. C</given-names></author> <author><surname>Tandberg</surname> <given-names>D</given-names></author> <author><surname>Sklar</surname> <given-names>D</given-names></author> <title>Hospital factors associated with emergency center patients leaving without being seen</title> <source>Am. J. Emerg. Med</source> <year>2000</year> <volume>18</volume> <issue>7</issue> <fpage>767</fpage> - <lpage>772</lpage>
<author><surname>Schneider</surname> <given-names>S</given-names></author> <author><surname>Zwemer</surname> <given-names>F</given-names></author> <author><surname>Doniger</surname> <given-names>A</given-names></author> <author><surname>Dick</surname> <given-names>R</given-names></author> <author><surname>Czapranski</surname> <given-names>T</given-names></author> <author><surname>Davis</surname> <given-names>E</given-names></author> <title>Rochester, New York: a decade of emergency department overcrowding</title> <source>Acad. Emerg. Med</source> <year>2001</year> <volume>8</volume> <issue>11</issue> <fpage>1044</fpage> - <lpage>1050</lpage>
<author><surname>Richardson</surname> <given-names>P</given-names></author> <title>An introduction to system dynamics</title> <source>modeling</source> <year>1981</year> <other>New York</other> <publisher>Productivity</publisher>
<author><surname>Banks</surname> <given-names>J</given-names></author> <author><surname>Carson</surname> <given-names>J. S</given-names></author> <author><surname>Nelson</surname> <given-names>B. L</given-names></author> <author><surname>Nicol</surname> <given-names>D. M</given-names></author> <title>Discrete-event system</title> <source>simulation</source> <year>2002</year> <volume>3</volume> <other>New Jersey</other> <publisher>Prentice-Hall</publisher>
<author><surname>Weiss</surname> <given-names>S. J</given-names></author> <author><surname>Derlet</surname> <given-names>R</given-names></author> <author><surname>Arndahl</surname> <given-names>J</given-names></author> <author><surname>Ernst</surname> <given-names>A. A</given-names></author> <author><surname>Richards</surname> <given-names>J</given-names></author> <author><surname>Fern&#225;ndez-Frackelton</surname> <given-names>M</given-names></author> <author><surname>Schwab</surname> <given-names>R</given-names></author> <author><surname>Stair</surname> <given-names>T. O</given-names></author> <author><surname>Vicellio</surname> <given-names>P</given-names></author> <author><surname>Levy</surname> <given-names>D</given-names></author> <author><surname>Brautigan</surname> <given-names>M</given-names></author> <author><surname>Johnson</surname> <given-names>A</given-names></author> <author><surname>Nick</surname> <given-names>T. G</given-names></author> <title>Estimating the degree of emergency department overcrowding in academic medical centers: results of the National ED Overcrowding Study (NEDOCS</title>) <source>Acad. Emerg. Med</source> <year>2004</year> <volume>11</volume> <issue>1</issue> <fpage>38</fpage> - <lpage>50</lpage>
<author><surname>Schlesinger</surname> <given-names>S</given-names></author> <author><surname>Crosbie</surname> <given-names>R. E</given-names></author> <author><surname>Innis</surname> <given-names>G. S</given-names></author> <author><surname>Lalwani</surname> <given-names>C. S</given-names></author> <author><surname>Loch</surname> <given-names>J</given-names></author> <author><surname>Sylvester</surname> <given-names>R. J</given-names></author> <author><surname>Wright</surname> <given-names>R. O</given-names></author> <author><surname>Kheir</surname> <given-names>N</given-names></author> <author><surname>Bartos</surname> <given-names>D</given-names></author> <title>Terminology for model credibility</title> <source>Simulation</source> <year>1979</year> <volume>32</volume> <issue>3</issue> <fpage>103</fpage> - <lpage>104</lpage>
<author><surname>Law</surname> <given-names>A. M</given-names></author> <source>Simulation modeling and analysis</source> <year>2007</year> <other>4 Boston</other> <publisher>McGraw-Hill</publisher>
<author><surname>Shechter</surname> <given-names>S. M</given-names></author> <author><surname>Schaefer</surname> <given-names>A. J</given-names></author> <author><surname>Braithwaite</surname> <given-names>R. S</given-names></author> <author><surname>Roberts</surname> <given-names>M. S</given-names></author> <title>Increasing the efficient of monte carlo cohort simulation with variance reduction techniques</title> <source>Med. Decis. Mak</source> <year>2006</year> <volume>26</volume> <fpage>550</fpage> - <lpage>553</lpage>
<author><surname>Reeder</surname> <given-names>T. J</given-names></author> <author><surname>Garrison</surname> <given-names>H. G</given-names></author> <title>When the safety net is unsafe: real-time assessment of the overcrowded emergency department</title> <source>Acad. Emerg. Med</source> <year>2001</year> <volume>8</volume> <issue>11</issue> <fpage>1070</fpage> - <lpage>1074</lpage>
<author><surname>Reeder</surname> <given-names>T. J</given-names></author> <author><surname>Burleson</surname> <given-names>D. L</given-names></author> <author><surname>Garrison</surname> <given-names>H. G</given-names></author> <title>The overcrowded emergency department: a comparison of staff perceptions</title> <source>Acad. Emerg. Med</source> <year>2003</year> <volume>10</volume> <issue>10</issue> <fpage>1059</fpage> - <lpage>1064</lpage>
<author><surname>Bernstein</surname> <given-names>S. L</given-names></author> <author><surname>Verghese</surname> <given-names>V</given-names></author> <author><surname>Leung</surname> <given-names>W</given-names></author> <author><surname>Lunney</surname> <given-names>A. T</given-names></author> <author><surname>Perez</surname> <given-names>I</given-names></author> <title>Development and validation of a new index to measure emergency department crowding</title> <source>Acad. Emerg. Med</source> <year>2003</year> <volume>10</volume> <issue>9</issue> <fpage>938</fpage> - <lpage>942</lpage>
<author><surname>Asplin</surname> <given-names>B. R</given-names></author> <author><surname>Rhodes</surname> <given-names>K. V</given-names></author> <author><surname>Crain</surname> <given-names>L</given-names></author> <author><surname>Camargo</surname> <given-names>C. A</given-names></author> <title>Measuring emergency department crowding and hospital capacity</title> <source>Acad. Emerg. Med</source> <year>2002</year> <volume>9</volume> <issue>5</issue> <fpage>366</fpage> - <lpage>367</lpage>
<author><surname>Asplin</surname> <given-names>B. R</given-names></author> <author><surname>Rhodes</surname> <given-names>K. V</given-names></author> <author><surname>Flottemesch</surname> <given-names>T. J</given-names></author> <author><surname>Wears</surname> <given-names>R</given-names></author> <author><surname>Camargo</surname> <given-names>C. A</given-names></author> <author><surname>Jr Hwang</surname> <given-names>U</given-names></author> <author><surname>Richards</surname> <given-names>C. R</given-names></author> <author><surname>Tiffany</surname> <given-names>B</given-names></author> <author><surname>O&#8217;Keefe</surname> <given-names>S</given-names></author> <author><surname>Bernstein</surname> <given-names>S</given-names></author> <title>Is this emergency department crowded? A multicenter derivation and evaluation of an emergency department crowding scale (EDCS</title>) <source>Acad. Emerg. Med</source> <year>2004</year> <volume>11</volume> <fpage>484</fpage>
<author><surname>Epstein</surname> <given-names>S. K</given-names></author> <author><surname>Tian</surname> <given-names>L</given-names></author> <title>Development of an emergency department work score to predict ambulance diversion</title> <source>Acad. Emerg. Med</source> <year>2006</year> <volume>13</volume> <issue>4</issue> <fpage>421</fpage> - <lpage>426</lpage>
<author><surname>Jones</surname> <given-names>S. S</given-names></author> <author><surname>Allen</surname> <given-names>T. L</given-names></author> <author><surname>Flottemesch</surname> <given-names>T. J</given-names></author> <author><surname>Welch</surname> <given-names>S. J</given-names></author> <title>An independent evaluation of four quantitative emergency department crowding scales</title> <source>Acad. Emerg. Med</source> <year>2006</year> <volume>13</volume> <issue>11</issue> <fpage>1204</fpage> - <lpage>1011</lpage>
<author><surname>Weiss</surname> <given-names>S. J</given-names></author> <author><surname>Ernst</surname> <given-names>A. A</given-names></author> <author><surname>Nick</surname> <given-names>T. G</given-names></author> <title>Comparison of the National Emergency Department Overcrowding Scale and the Emergency Department Work Index for quantifying emergency department crowding</title> <source>Acad. Emerg. Med</source> <year>2006</year> <volume>13</volume> <issue>5</issue> <fpage>513</fpage> - <lpage>518</lpage>
<author><surname>Chan</surname> <given-names>T. C</given-names></author> <author><surname>Killeen</surname> <given-names>J. P</given-names></author> <author><surname>Kelly</surname> <given-names>D</given-names></author> <author><surname>Guss</surname> <given-names>D. A</given-names></author> <title>Impact of rapid entry and accelerated care at triage on reducing emergency department patient wait times, lengths of stay, and rate of left without being seen</title> <source>Ann. Emerg. Med</source> <year>2005</year> <volume>46</volume> <issue>6</issue> <fpage>491</fpage> - <lpage>497</lpage>
<author><surname>Arav-Boger</surname> <given-names>R</given-names></author> <author><surname>Foster</surname> <given-names>CB</given-names></author> <author><surname>Zong</surname> <given-names>JC</given-names></author> <author><surname>Pass</surname> <given-names>RF</given-names></author> <title>Human cytomegalovirus-encoded &#945;-chemokines exhibit high sequence variability in congenitally infected newborns</title> <source>J Infect Dis</source> <year>2006</year> <volume>193</volume> <fpage>788</fpage> - <lpage>791</lpage>
<author><surname>Arav-Boger</surname> <given-names>R</given-names></author> <author><surname>Zong</surname> <given-names>JC</given-names></author> <author><surname>Foster</surname> <given-names>CB</given-names></author> <title>Loss of linkage disequilibrium and accelerated protein divergence in duplicated cytomegalovirus chemokine genes</title> <source>Virus Genes</source> <year>2005</year> <volume>31</volume> <fpage>65</fpage> - <lpage>72</lpage>
<author><surname>Baggiolini</surname> <given-names>M</given-names></author> <author><surname>Dewald</surname> <given-names>B</given-names></author> <author><surname>Moser</surname> <given-names>B</given-names></author> <title>Human chemokines: An update</title> <source>Annu Rev Immunol</source> <year>1997</year> <volume>15</volume> <fpage>675</fpage> - <lpage>705</lpage>
<author><surname>Beyari</surname> <given-names>MM</given-names></author> <author><surname>Hodgson</surname> <given-names>TA</given-names></author> <author><surname>Kondowe</surname> <given-names>W</given-names></author> <author><surname>Molyneux</surname> <given-names>EM</given-names></author> <author><surname>Scully</surname> <given-names>C</given-names></author> <author><surname>Porter</surname> <given-names>SR</given-names></author> <author><surname>Teo</surname> <given-names>CG</given-names></author> <title>Inter-and intra-person cytomegalovirus infection in Malawian families</title> <source>J Med Virol</source> <year>2005</year> <volume>75</volume> <fpage>575</fpage> - <lpage>582</lpage>
<author><surname>Cha</surname> <given-names>TA</given-names></author> <author><surname>Tom</surname> <given-names>E</given-names></author> <author><surname>Kemble</surname> <given-names>GW</given-names></author> <author><surname>Duke</surname> <given-names>GM</given-names></author> <author><surname>Mocarski</surname> <given-names>ES</given-names></author> <author><surname>Spaete</surname> <given-names>RR</given-names></author> <title>Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains</title> <source>J Virol</source> <year>1996</year> <volume>70</volume> <fpage>78</fpage> - <lpage>83</lpage>
<author><surname>Clark-Lewis</surname> <given-names>I</given-names></author> <author><surname>Schumacher</surname> <given-names>C</given-names></author> <author><surname>Baggiolini</surname> <given-names>M</given-names></author> <author><surname>Moser</surname> <given-names>B</given-names></author> <title>Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities</title> <source>J Biol Chem</source> <year>1991</year> <volume>266</volume> <fpage>23128</fpage> - <lpage>23134</lpage>
<author><surname>Davison</surname> <given-names>AJ</given-names></author> <author><surname>Dolan</surname> <given-names>A</given-names></author> <author><surname>Akter</surname> <given-names>P</given-names></author> <author><surname>Addison</surname> <given-names>C</given-names></author> <author><surname>Dargan</surname> <given-names>DJ</given-names></author> <author><surname>Alcendor</surname> <given-names>DJ</given-names></author> <author><surname>McGeoch</surname> <given-names>DJ</given-names></author> <author><surname>Hayward</surname> <given-names>GS</given-names></author> <title>The human cytomegalovirus genome revisited: Comparison with the chimpanzee cytomegalovirus genome</title> <source>J Gen Virol</source> <year>2003</year> <volume>84</volume> <fpage>17</fpage> - <lpage>28</lpage>
<author><surname>Dedicoat</surname> <given-names>M</given-names></author> <author><surname>Newton</surname> <given-names>R</given-names></author> <author><surname>Alkharsah</surname> <given-names>KR</given-names></author> <author><surname>Sheldon</surname> <given-names>J</given-names></author> <author><surname>Szabados</surname> <given-names>I</given-names></author> <author><surname>Ndlovu</surname> <given-names>B</given-names></author> <author><surname>Page</surname> <given-names>T</given-names></author> <author><surname>Casabonne</surname> <given-names>D</given-names></author> <author><surname>Gilks</surname> <given-names>CF</given-names></author> <author><surname>Cassol</surname> <given-names>SA</given-names></author> <author><surname>Whitby</surname> <given-names>D</given-names></author> <author><surname>Schulz</surname> <given-names>TF</given-names></author> <title>Mother-to-child transmission of human herpesvirus-8 in South Africa</title> <source>J Infect Dis</source> <year>2004</year> <volume>190</volume> <fpage>1068</fpage> - <lpage>1075</lpage>
<author><surname>Dolan</surname> <given-names>A</given-names></author> <author><surname>Cunningham</surname> <given-names>C</given-names></author> <author><surname>Hector</surname> <given-names>RD</given-names></author> <author><surname>Hassan-Walker</surname> <given-names>AF</given-names></author> <author><surname>Lee</surname> <given-names>L</given-names></author> <author><surname>Addison</surname> <given-names>C</given-names></author> <author><surname>Dargan</surname> <given-names>DJ</given-names></author> <author><surname>McGeoch</surname> <given-names>DJ</given-names></author> <author><surname>Gatherer</surname> <given-names>D</given-names></author> <author><surname>Emery</surname> <given-names>VC</given-names></author> <author><surname>Griffiths</surname> <given-names>PD</given-names></author> <author><surname>Sinzger</surname> <given-names>C</given-names></author> <author><surname>McSharry</surname> <given-names>BP</given-names></author> <author><surname>Wilkinson</surname> <given-names>GW</given-names></author> <author><surname>Davison</surname> <given-names>AJ</given-names></author> <title>Genetic content of wild-type human cytomegalovirus</title> <source>J Gen Virol</source> <year>2004</year> <volume>85</volume> <fpage>1301</fpage> - <lpage>1312</lpage>
<author><surname>Hassan-Walker</surname> <given-names>AF</given-names></author> <author><surname>Okwuadi</surname> <given-names>S</given-names></author> <author><surname>Lee</surname> <given-names>L</given-names></author> <author><surname>Griffiths</surname> <given-names>PD</given-names></author> <author><surname>Emery</surname> <given-names>VC</given-names></author> <title>Sequence variability of the &#945;-chemokine UL146 from clinical strains of human cytomegalovirus</title> <source>J Med Virol</source> <year>2004</year> <volume>74</volume> <fpage>573</fpage> - <lpage>579</lpage>
<author><surname>He</surname> <given-names>R</given-names></author> <author><surname>Ruan</surname> <given-names>Q</given-names></author> <author><surname>Qi</surname> <given-names>Y</given-names></author> <author><surname>Ma</surname> <given-names>YP</given-names></author> <author><surname>Huang</surname> <given-names>YJ</given-names></author> <author><surname>Sun</surname> <given-names>ZR</given-names></author> <author><surname>Ji</surname> <given-names>YH</given-names></author> <title>Sequence variability of human cytomegalovirus UL146 and UL147 genes in low-passage clinical isolates</title> <source>Intervirology</source> <year>2006</year> <volume>49</volume> <fpage>215</fpage> - <lpage>223</lpage>
<author><surname>Iwasenko</surname> <given-names>JM</given-names></author> <author><surname>Scott</surname> <given-names>GM</given-names></author> <author><surname>Ziegler</surname> <given-names>J</given-names></author> <author><surname>Rawlinson</surname> <given-names>WD</given-names></author> <title>Emergence and persistence of multiple antiviral resistant CMV strains in a highly immunocompromised child</title> <source>J Clin Virol</source> <year>2007</year> <volume>40</volume> <fpage>152</fpage> - <lpage>155</lpage>
<author><surname>Kall</surname> <given-names>L</given-names></author> <author><surname>Krogh</surname> <given-names>A</given-names></author> <author><surname>Sonnhammer</surname> <given-names>EL</given-names></author> <title>A combined transmembrane topology and signal peptide prediction method</title> <source>J Mol Biol</source> <year>2004</year> <volume>338</volume> <fpage>1027</fpage> - <lpage>1036</lpage>
<author><surname>Katoh</surname> <given-names>K</given-names></author> <author><surname>Kuma</surname> <given-names>K</given-names></author> <author><surname>Toh</surname> <given-names>H</given-names></author> <author><surname>Miyata</surname> <given-names>T</given-names></author> <title>MAFFT version 5: Improvement in accuracy of multiple sequence alignment</title> <source>Nucleic Acids Res</source> <year>2005</year> <volume>33</volume> <fpage>511</fpage> - <lpage>518</lpage>
<author><surname>Lurain</surname> <given-names>NS</given-names></author> <author><surname>Fox</surname> <given-names>AM</given-names></author> <author><surname>Lichy</surname> <given-names>HM</given-names></author> <author><surname>Bhorade</surname> <given-names>SM</given-names></author> <author><surname>Ware</surname> <given-names>CF</given-names></author> <author><surname>Huang</surname> <given-names>DD</given-names></author> <author><surname>Kwan</surname> <given-names>SP</given-names></author> <author><surname>Garrity</surname> <given-names>ER</given-names></author> <author><surname>Chou</surname> <given-names>S</given-names></author> <title>Analysis of the human cytomegalovirus genomic region from UL146 through UL147A reveals sequence hypervariability, genotypic stability, and overlapping transcripts</title> <source>Virol J</source> <year>2006</year> <volume>3</volume> <fpage>4</fpage>
<author><surname>Mattick</surname> <given-names>C</given-names></author> <author><surname>Dewin</surname> <given-names>D</given-names></author> <author><surname>Polley</surname> <given-names>S</given-names></author> <author><surname>Sevilla-Reyes</surname> <given-names>E</given-names></author> <author><surname>Pignatelli</surname> <given-names>S</given-names></author> <author><surname>Rawlinson</surname> <given-names>W</given-names></author> <author><surname>Wilkinson</surname> <given-names>G</given-names></author> <author><surname>Dal Monte</surname> <given-names>P</given-names></author> <author><surname>Gompels</surname> <given-names>UA</given-names></author> <title>Linkage of human cytomegalovirus glycoprotein gO variant groups identified from worldwide clinical isolates with gN genotypes, implications for disease associations and evidence for N-terminal sites of positive selection</title> <source>J Virol</source> <year>2004</year> <volume>318</volume> <fpage>582</fpage> - <lpage>597</lpage>
<author><surname>McGeoch</surname> <given-names>DJ</given-names></author> <author><surname>Rixon</surname> <given-names>FJ</given-names></author> <author><surname>Davison</surname> <given-names>AJ</given-names></author> <title>Topics in herpesvirus genomics and evolution</title> <source>Virus Res</source> <year>2006</year> <volume>117</volume> <fpage>90</fpage> - <lpage>104</lpage>
<author><surname>Murphy</surname> <given-names>E</given-names></author> <author><surname>Yu</surname> <given-names>D</given-names></author> <author><surname>Grimwood</surname> <given-names>J</given-names></author> <author><surname>Schmutz</surname> <given-names>J</given-names></author> <author><surname>Dickson</surname> <given-names>M</given-names></author> <author><surname>Jarvis</surname> <given-names>MA</given-names></author> <author><surname>Hahn</surname> <given-names>G</given-names></author> <author><surname>Nelson</surname> <given-names>JA</given-names></author> <author><surname>Myers</surname> <given-names>RM</given-names></author> <author><surname>Shenk</surname> <given-names>TE</given-names></author> <title>Coding potential of laboratory and clinical strains of human cytomegalovirus</title> <source>Proc Natl Acad Sci USA</source> <year>2003</year> <volume>100</volume> <fpage>14976</fpage> - <lpage>14981</lpage>
<author><surname>Penfold</surname> <given-names>ME</given-names></author> <author><surname>Dairaghi</surname> <given-names>DJ</given-names></author> <author><surname>Duke</surname> <given-names>GM</given-names></author> <author><surname>Saederup</surname> <given-names>N</given-names></author> <author><surname>Mocarski</surname> <given-names>ES</given-names></author> <author><surname>Kemble</surname> <given-names>GW</given-names></author> <author><surname>Schall</surname> <given-names>TJ</given-names></author> <title>Cytomegalovirus encodes a potent &#945; chemokine</title> <source>Proc Natl Acad Sci USA</source> <year>1999</year> <volume>96</volume> <fpage>9839</fpage> - <lpage>9844</lpage>
<author><surname>Pignatelli</surname> <given-names>S</given-names></author> <author><surname>Dal Monte</surname> <given-names>P</given-names></author> <author><surname>Landini</surname> <given-names>MP</given-names></author> <title>gpUL73 (gN) genomic variants of human cytomegalovirus isolates are clustered into four distinct genotypes</title> <source>J Gen Virol</source> <year>2001</year> <volume>82</volume> <fpage>2777</fpage> - <lpage>2784</lpage>
<author><surname>Pignatelli</surname> <given-names>S</given-names></author> <author><surname>Dal Monte</surname> <given-names>P</given-names></author> <author><surname>Rossini</surname> <given-names>G</given-names></author> <author><surname>Chou</surname> <given-names>S</given-names></author> <author><surname>Gojobori</surname> <given-names>T</given-names></author> <author><surname>Hanada</surname> <given-names>K</given-names></author> <author><surname>Guo</surname> <given-names>JJ</given-names></author> <author><surname>Rawlinson</surname> <given-names>W</given-names></author> <author><surname>Britt</surname> <given-names>W</given-names></author> <author><surname>Mach</surname> <given-names>M</given-names></author> <author><surname>Landini</surname> <given-names>MP</given-names></author> <title>Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: Identification of a novel subgroup, geographical distribution and evidence of positive selective pressure</title> <source>J Gen Virol</source> <year>2003</year> <volume>84</volume> <fpage>647</fpage> - <lpage>655</lpage>
<author><surname>Pignatelli</surname> <given-names>S</given-names></author> <author><surname>Dal Monte</surname> <given-names>P</given-names></author> <author><surname>Rossini</surname> <given-names>G</given-names></author> <author><surname>Landini</surname> <given-names>MP</given-names></author> <title>Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains</title> <source>Rev Med Virol</source> <year>2004</year> <volume>14</volume> <fpage>383</fpage> - <lpage>410</lpage>
<author><surname>Poncet</surname> <given-names>C</given-names></author> <author><surname>Frances</surname> <given-names>V</given-names></author> <author><surname>Gristina</surname> <given-names>R</given-names></author> <author><surname>Scheiner</surname> <given-names>C</given-names></author> <author><surname>Pellissier</surname> <given-names>JF</given-names></author> <author><surname>Figarella-Branger</surname> <given-names>D</given-names></author> <title>CD24, a glyosylphosphatidylinositol-anchored molecule, is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors</title> <source>Acta Neuropathol</source> <year>1996</year> <volume>91</volume> <fpage>400</fpage> - <lpage>408</lpage>
<author><surname>Prichard</surname> <given-names>MN</given-names></author> <author><surname>Penfold</surname> <given-names>MET</given-names></author> <author><surname>Duke</surname> <given-names>GM</given-names></author> <author><surname>Spaete</surname> <given-names>RR</given-names></author> <author><surname>Kemble</surname> <given-names>GW</given-names></author> <title>A review of genetic differences between limited and extensively passaged human cytomegalovirus strains</title> <source>Rev Med Virol</source> <year>2001</year> <volume>11</volume> <fpage>191</fpage> - <lpage>200</lpage>
<author><surname>Pride</surname> <given-names>DT</given-names></author> <year>2004</year> <title>Swaap 1.0.1: A tool for analyzing substitutions and similarity in multiple alignments</title>.
<author><surname>Puchhammer-St&#246;ckl</surname> <given-names>E</given-names></author> <author><surname>G&#246;rzer</surname> <given-names>I</given-names></author> <title>Cytomegalovirus and Epstein-Barr virus subtypes&#8212;The search for clinical significance</title> <source>J Clin Virol</source> <year>2006</year> <volume>36</volume> <fpage>239</fpage> - <lpage>248</lpage>
<author><surname>Puchhammer-St&#246;ckl</surname> <given-names>E</given-names></author> <author><surname>G&#246;rzer</surname> <given-names>I</given-names></author> <author><surname>Zoufaly</surname> <given-names>A</given-names></author> <author><surname>Jaksch</surname> <given-names>P</given-names></author> <author><surname>Bauer</surname> <given-names>CC</given-names></author> <author><surname>Klepetko</surname> <given-names>W</given-names></author> <author><surname>Popow-Kraupp</surname> <given-names>T</given-names></author> <title>Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients</title> <source>Transplantation</source> <year>2006</year> <volume>81</volume> <fpage>187</fpage> - <lpage>194</lpage>
<author><surname>Qi</surname> <given-names>Y</given-names></author> <author><surname>Mao</surname> <given-names>ZQ</given-names></author> <author><surname>Ruan</surname> <given-names>Q</given-names></author> <author><surname>He</surname> <given-names>R</given-names></author> <author><surname>Ma</surname> <given-names>YP</given-names></author> <author><surname>Sun</surname> <given-names>ZR</given-names></author> <author><surname>Ji</surname> <given-names>YH</given-names></author> <author><surname>Huang</surname> <given-names>Y</given-names></author> <title>Human cytomegalovirus (HCMV) UL139 open reading frame: Sequence variants are clustered into three major genotypes</title> <source>J Med Virol</source> <year>2006</year> <volume>78</volume> <fpage>517</fpage> - <lpage>522</lpage>
<author><surname>Rasmussen</surname> <given-names>L</given-names></author> <author><surname>Geissler</surname> <given-names>A</given-names></author> <author><surname>Cowan</surname> <given-names>C</given-names></author> <author><surname>Chase</surname> <given-names>A</given-names></author> <author><surname>Winters</surname> <given-names>M</given-names></author> <title>The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates</title> <source>J Virol</source> <year>2002</year> <volume>76</volume> <fpage>10841</fpage> - <lpage>10848</lpage>
<author><surname>Rasmussen</surname> <given-names>L</given-names></author> <author><surname>Geissler</surname> <given-names>A</given-names></author> <author><surname>Winters</surname> <given-names>M</given-names></author> <title>Inter-and intragenic variations complicate molecular epidemiology of human cytomegalovirus</title> <source>J Infect Dis</source> <year>2003</year> <volume>187</volume> <fpage>809</fpage> - <lpage>819</lpage>
<author><surname>Rozas</surname> <given-names>J</given-names></author> <author><surname>S&#225;nchez-DelBarrio</surname> <given-names>JC</given-names></author> <author><surname>Messeguer</surname> <given-names>X</given-names></author> <author><surname>Rozas</surname> <given-names>R</given-names></author> <title>DnaSP, DNA polymorphism analyses by the coalescent and other methods</title> <source>Bioinformatics</source> <year>2003</year> <volume>19</volume> <fpage>2496</fpage> - <lpage>2497</lpage>
<author><surname>Schabath</surname> <given-names>H</given-names></author> <author><surname>Runz</surname> <given-names>S</given-names></author> <author><surname>Joumaa</surname> <given-names>S</given-names></author> <author><surname>Altevogt</surname> <given-names>P</given-names></author> <title>CD24 affects CXCR4 function in pre-B lymphoytes and breast carcinoma cells</title> <source>J Cell Sci</source> <year>2006</year> <volume>119</volume> <fpage>314</fpage> - <lpage>325</lpage>
<author><surname>Smith</surname> <given-names>SC</given-names></author> <author><surname>Oxford</surname> <given-names>G</given-names></author> <author><surname>Wu</surname> <given-names>Z</given-names></author> <author><surname>Nitz</surname> <given-names>MD</given-names></author> <author><surname>Conaway</surname> <given-names>M</given-names></author> <author><surname>Frierson</surname> <given-names>HF</given-names></author> <author><surname>Hampton</surname> <given-names>G</given-names></author> <author><surname>Theodorescu</surname> <given-names>D</given-names></author> <title>The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer</title> <source>Cancer Res</source> <year>2006</year> <volume>66</volume> <fpage>1917</fpage> - <lpage>1922</lpage>
<author><surname>Staden</surname> <given-names>R</given-names></author> <author><surname>Beal</surname> <given-names>KF</given-names></author> <author><surname>Bonfield</surname> <given-names>JK</given-names></author> <title>The Staden package, 1998</title> <source>Methods Mol Biol</source> <year>2000</year> <volume>132</volume> <fpage>115</fpage> - <lpage>130</lpage>
<author><surname>Stanton</surname> <given-names>R</given-names></author> <author><surname>Westmoreland</surname> <given-names>D</given-names></author> <author><surname>Fox</surname> <given-names>JD</given-names></author> <author><surname>Davison</surname> <given-names>AJ</given-names></author> <author><surname>Wilkinson</surname> <given-names>GW</given-names></author> <title>Stability of human cytomegalovirus genotypes in persistently infected renal transplant recipients</title> <source>J Med Virol</source> <year>2005</year> <volume>75</volume> <fpage>42</fpage> - <lpage>46</lpage>
<author><surname>Tamura</surname> <given-names>K</given-names></author> <author><surname>Dudley</surname> <given-names>J</given-names></author> <author><surname>Nei</surname> <given-names>M</given-names></author> <author><surname>Kumar</surname> <given-names>S</given-names></author> <title>MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0</title> <source>Mol Biol Evol</source> <year>2007</year> <volume>24</volume> <fpage>1596</fpage> - <lpage>1599</lpage>
<author><surname>Thompson</surname> <given-names>JD</given-names></author> <author><surname>Higgins</surname> <given-names>DG</given-names></author> <author><surname>Gibson</surname> <given-names>TJ</given-names></author> <author><surname>CLUSTAL</surname> <given-names>W</given-names></author> <title>Improving the sensitivity of progressive multiple sequencing alignment through sequence weighting, position-specific gap penalties and weight matrix choice</title> <source>Nucleic Acids Res</source> <year>1994</year> <volume>22</volume> <fpage>4673</fpage> - <lpage>4680</lpage>
<author><surname>Agulleiro</surname> <given-names>MJ</given-names></author> <author><surname>Roy</surname> <given-names>S</given-names></author> <author><surname>Sanchez</surname> <given-names>E</given-names></author> <author><surname>Puchol</surname> <given-names>S</given-names></author> <author><surname>Gallo-Payet</surname> <given-names>N</given-names></author> <author><surname>Cerda-Reverter</surname> <given-names>JM</given-names></author> <title>Role of melanocortin receptor accessory proteins in the function of zebrafish melanocortin receptor type 2 Molecular and Cellular Endocrinology 320 2010 145-152</title> doi: 10.1016/j.mce.2010.01.032
<author><surname>Chan</surname> <given-names>LF</given-names></author> <author><surname>Webb</surname> <given-names>TR</given-names></author> <author><surname>Chung</surname> <given-names>TT</given-names></author> <author><surname>Meimaridou</surname> <given-names>E</given-names></author> <author><surname>Cooray</surname> <given-names>SN</given-names></author> <author><surname>Guasti</surname> <given-names>L</given-names></author> <author><surname>Chapple</surname> <given-names>JP</given-names></author> <author><surname>Egertova</surname> <given-names>M</given-names></author> <author><surname>Elphick</surname> <given-names>MR</given-names></author> <author><surname>Cheetham</surname> <given-names>ME</given-names></author> <title>MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family</title> <source>PNAS 106</source> <year>2009</year> <volume>6146-6151</volume> doi: 10.1073/pnas.0809918106
<author><surname>Chan</surname> <given-names>LF</given-names></author> <author><surname>Metherell</surname> <given-names>LA</given-names></author> <author><surname>Clark</surname> <given-names>AJ</given-names></author> <title>Effects of melanocortins on adrenal gland physiology</title> <source>European Journal of Pharmacology</source> <year>2011</year> (In Press) doi: 10.1016/j.ejphar.2010.11.041
<author><surname>Clark</surname> <given-names>AJ</given-names></author> <author><surname>Weber</surname> <given-names>A</given-names></author> <title>Adrenocorticotropin insensitivity syndromes</title> <source>Endocrine Reviews 19</source> <year>1998</year> <other>828-843 doi</other> <fpage>10</fpage> - <lpage>1210</lpage> - <fpage>19</fpage> - <lpage>6</lpage> - <lpage>828</lpage>
<author><surname>Coll</surname> <given-names>AP</given-names></author> <author><surname>Challis</surname> <given-names>BG</given-names></author> <author><surname>Yeo</surname> <given-names>GS</given-names></author> <author><surname>Snell</surname> <given-names>K</given-names></author> <author><surname>Piper</surname> <given-names>SJ</given-names></author> <author><surname>Halsall</surname> <given-names>D</given-names></author> <author><surname>Thresher</surname> <given-names>RR</given-names></author> <author><surname>O"Rahilly</surname> <given-names>S</given-names></author> <title>The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin</title> <source>Endocrinology 145</source> <year>2004</year> <volume>4721-4727</volume> doi: 10.1210/en.2004-0491
<author><surname>Cooray</surname> <given-names>SN</given-names></author> <author><surname>Almiro</surname> <given-names>Do</given-names></author> <author><surname>Vale</surname> <given-names>I</given-names></author> <author><surname>Leung</surname> <given-names>KY</given-names></author> <author><surname>Webb</surname> <given-names>TR</given-names></author> <author><surname>Chapple</surname> <given-names>JP</given-names></author> <author><surname>Egertova</surname> <given-names>M</given-names></author> <author><surname>Cheetham</surname> <given-names>ME</given-names></author> <author><surname>Elphick</surname> <given-names>MR</given-names></author> <author><surname>Clark</surname> <given-names>AJ</given-names></author> <title>The melanocortin 2 receptor accessory protein exists as a homodimer and is essential for the function of the melanocortin 2 receptor in the mouse Y1 cell line</title> <source>Endocrinology 149 2008 1935-1941</source> <other>doi: 10.1210/en.2007-1463</other>
<author><surname>Guasti</surname> <given-names>L</given-names></author> <author><surname>Paul</surname> <given-names>A</given-names></author> <author><surname>Laufer</surname> <given-names>E</given-names></author> <author><surname>King</surname> <given-names>P</given-names></author> <title>Localization of Sonic hedgehog secreting and receiving cells in the developing and adult rat adrenal cortex</title> <source>Molecular and Cellular Endocrinology</source> <year>336</year> <volume>2010</volume> <fpage>117</fpage> - <lpage>122</lpage> doi: 10.1016/j.mce.2010.11.010
<author><surname>Karpac</surname> <given-names>J</given-names></author> <author><surname>Ostwald</surname> <given-names>D</given-names></author> <author><surname>Bui</surname> <given-names>S</given-names></author> <author><surname>Hunnewell</surname> <given-names>P</given-names></author> <author><surname>Shankar</surname> <given-names>M</given-names></author> <author><surname>Hochgeschwender</surname> <given-names>U</given-names></author> <title>Development, maintenance, and function of the adrenal gland in early postnatal proopiomelanocortin-null mutant mice</title> <source>Endocrinology</source> <year>146</year> <title>2005 2555-2562 doi: 10.1210/en.2004-1290</title>
<author><surname>Karpac</surname> <given-names>J</given-names></author> <author><surname>Kern</surname> <given-names>A</given-names></author> <author><surname>Hochgeschwender</surname> <given-names>U</given-names></author> <title>Pro-opiomelanocortin peptides and the adrenal gland</title> <source>Molecular and Cellular Endocrinology 265&#8211;266</source> <year>2007</year> <other>29-33</other> doi: 10.1016/j.mce.2006.12.035
<author><surname>Lefkowitz</surname> <given-names>RJ</given-names></author> <author><surname>Roth</surname> <given-names>J</given-names></author> <author><surname>Pricer</surname> <given-names>W</given-names></author> <author><surname>Pastan</surname> <given-names>I</given-names></author> <title>ACTH receptors in the adrenal: specific binding of ACTH-125I and its relation to adenyl cyclase</title> <source>PNAS 65</source> <year>1970</year> <volume>745-752</volume> doi: <fpage>10</fpage> - <lpage>1073</lpage> - <fpage>65</fpage> - <lpage>3</lpage> - <lpage>745</lpage>
<author><surname>Lehoux</surname> <given-names>JG</given-names></author> <author><surname>Fleury</surname> <given-names>A</given-names></author> <author><surname>Ducharme</surname> <given-names>L</given-names></author> <title>The acute and chronic effects of adrenocorticotropin on the levels of messenger ribonucleic acid and protein of steroidogenic enzymes in rat adrenal in vivo</title> <source>Endocrinology</source> <year>139</year> <volume>1998</volume> <issue>3913-3922</issue> <other>doi</other>: <fpage>10</fpage> - <fpage>1210</fpage> - <lpage>139</lpage> - <fpage>9</fpage> - <lpage>3913</lpage>
<author><surname>Metherell</surname> <given-names>LA</given-names></author> <author><surname>Chapple</surname> <given-names>JP</given-names></author> <author><surname>Cooray</surname> <given-names>S</given-names></author> <author><surname>David</surname> <given-names>A</given-names></author> <author><surname>Becker</surname> <given-names>C</given-names></author> <author><surname>Ruschendorf</surname> <given-names>F</given-names></author> <author><surname>Naville</surname> <given-names>D</given-names></author> <author><surname>Begeot</surname> <given-names>M</given-names></author> <author><surname>Khoo</surname> <given-names>B</given-names></author> <author><surname>Nurnberg</surname> <given-names>P</given-names></author> <title>Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2</title> <source>Nature Genetics 37</source> <year>2005</year> <issue>166-170</issue> <other>doi</other>: <fpage>10</fpage> - <fpage>1038</fpage> - <lpage>1501</lpage>
<author><surname>Mitani</surname> <given-names>F</given-names></author> <author><surname>Mukai</surname> <given-names>K</given-names></author> <author><surname>Miyamoto</surname> <given-names>H</given-names></author> <author><surname>Suematsu</surname> <given-names>M</given-names></author> <author><surname>Ishimura</surname> <given-names>Y</given-names></author> <title>The undifferentiated cell zone is a stem cell zone in adult rat adrenal cortex</title> <source>Biochimica et Biophysica Acta 1619</source> <year>2003</year> <title>317-324 doi: 10.1016/S0304-4165 (02</title>) <fpage>00490</fpage> - <lpage>7</lpage>
<author><surname>Robinson</surname> <given-names>PM</given-names></author> <author><surname>Comline</surname> <given-names>RS</given-names></author> <author><surname>Fowden</surname> <given-names>AL</given-names></author> <author><surname>Silver</surname> <given-names>M</given-names></author> <title>Adrenal cortex of fetal lamb: changes after hypophysectomy and effects of Synacthen on cytoarchitecture and secretory activity</title> <source>Quarterly Journal of Experimental Physiology</source> <year>68</year> <volume>1983</volume> <fpage>15</fpage> - <lpage>27</lpage>
<author><surname>Roy</surname> <given-names>S</given-names></author> <author><surname>Rached</surname> <given-names>M</given-names></author> <author><surname>Gallo-Payet</surname> <given-names>N</given-names></author> <title>Differential regulation of the human adrenocorticotropin receptor [melanocortin-2 receptor (MC2R)] by human MC2R accessory protein isoforms alpha and beta in isogenic human embryonic kidney 293 cells</title> <source>Molecular Endocrinology 21 2007 1656-1669</source> <other>doi</other>: <fpage>10</fpage> - <lpage>1210</lpage> - <fpage>2007</fpage> - <lpage>0041</lpage>
<author><surname>Sebag</surname> <given-names>JA</given-names></author> <author><surname>Hinkle</surname> <given-names>PM</given-names></author> <title>Melanocortin-2 receptor accessory protein MRAP forms antiparallel homodimers</title> <source>PNAS 104</source> <year>2007</year> <other>20244-20249 doi</other> <fpage>10</fpage> - <fpage>1073</fpage> - <lpage>0708916105</lpage>
<author><surname>Sebag</surname> <given-names>JA</given-names></author> <author><surname>Hinkle</surname> <given-names>PM</given-names></author> <title>Regions of melanocortin 2 (MC2) receptor accessory protein necessary for dual topology and MC2 receptor trafficking and signaling</title> <source>Journal of Biological Chemistry 284</source> <year>2009</year> <volume>610-618</volume> doi: <fpage>10</fpage> - <fpage>1074</fpage> - <lpage>804413200</lpage>
<author><surname>Sebag</surname> <given-names>JA</given-names></author> <author><surname>Hinkle</surname> <given-names>PM</given-names></author> <title>Regulation of G protein-coupled receptor signaling: specific dominant-negative effects of melanocortin 2 receptor accessory protein 2 Science Signaling 3 2010 ra28 doi: 10.1126/scisignal.2000593</title>
<author><surname>Wright</surname> <given-names>N</given-names></author> <author><surname>Voncina</surname> <given-names>D</given-names></author> <title>Studies on the postnatal growth of the rat adrenal cortex</title> <source>Journal of Anatomy</source> <year>123</year> <volume>1977</volume> <fpage>147</fpage> - <lpage>156</lpage>
<author><surname>Warburg</surname> <given-names>O</given-names></author> <title>On the origin of cancer cells</title> <source>Science</source> <year>1956</year> <volume>123</volume> <fpage>309</fpage> - <lpage>314</lpage>
<author><surname>Frezza</surname> <given-names>C</given-names></author> <author><surname>Gottlieb</surname> <given-names>E</given-names></author> <title>Mitochondria in cancer: not just innocent bystanders</title> <source>Semin Cancer Biol</source> <year>2009</year> <volume>19</volume> <fpage>4</fpage> - <lpage>11</lpage>
<author><surname>Tennant</surname> <given-names>DA</given-names></author> <author><surname>Duran</surname> <given-names>RV</given-names></author> <author><surname>Gottlieb</surname> <given-names>E</given-names></author> <title>Targeting metabolic transformation for cancer therapy</title> <source>Nat Rev Cancer</source> <year>2010</year> <volume>10</volume> <fpage>267</fpage> - <lpage>277</lpage>
<author><surname>Kaelin</surname> <given-names>WG Jr</given-names></author> <title>SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling</title> <source>Cancer Cell</source> <year>2009</year> <volume>16</volume> <fpage>180</fpage> - <lpage>182</lpage>
<author><surname>Frezza</surname> <given-names>C</given-names></author> <author><surname>Tennant</surname> <given-names>DA</given-names></author> <author><surname>Gottlieb</surname> <given-names>E</given-names></author> <title>IDH1 mutations in gliomas: when an enzyme loses its grip</title> <source>Cancer Cell</source> <year>2010</year> <volume>17</volume> <fpage>7</fpage> - <lpage>9</lpage>
<author><surname>Baysal</surname> <given-names>BE</given-names></author> <author><surname>Ferrell</surname> <given-names>RE</given-names></author> <author><surname>Willett-Brozick</surname> <given-names>JE</given-names></author> <author><surname>Lawrence</surname> <given-names>EC</given-names></author> <author><surname>Myssiorek</surname> <given-names>D</given-names></author> <author><surname>Bosch</surname> <given-names>A</given-names></author> <author><surname>Mey</surname> <given-names>A</given-names></author> <author><surname>Taschner</surname> <given-names>PE</given-names></author> <author><surname>Rubinstein</surname> <given-names>WS</given-names></author> <author><surname>Myers</surname> <given-names>EN</given-names></author> <author><surname>Richard</surname> <given-names>CW</given-names></author> <author><surname>3rd Cornelisse</surname> <given-names>CJ</given-names></author> <author><surname>Devilee</surname> <given-names>P</given-names></author> <author><surname>Devlin</surname> <given-names>B</given-names></author> <title>Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma</title> <source>Science</source> <year>2000</year> <volume>287</volume> <fpage>848</fpage> - <lpage>851</lpage>
<author><surname>Niemann</surname> <given-names>S</given-names></author> <author><surname>Muller</surname> <given-names>U</given-names></author> <title>Mutations in SDHC cause autosomal dominant paraganglioma, type 3</title> <source>Nat Genet</source> <year>2000</year> <volume>26</volume> <fpage>268</fpage> - <lpage>270</lpage>
<author><surname>Astuti</surname> <given-names>D</given-names></author> <author><surname>Latif</surname> <given-names>F</given-names></author> <author><surname>Dallol</surname> <given-names>A</given-names></author> <author><surname>Dahia</surname> <given-names>PL</given-names></author> <author><surname>Douglas</surname> <given-names>F</given-names></author> <author><surname>George</surname> <given-names>E</given-names></author> <author><surname>Skoldberg</surname> <given-names>F</given-names></author> <author><surname>Husebye</surname> <given-names>ES</given-names></author> <author><surname>Eng</surname> <given-names>C</given-names></author> <author><surname>Maher</surname> <given-names>ER</given-names></author> <title>Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma</title> <source>Am J Hum Genet</source> <year>2001</year> <volume>69</volume> <fpage>49</fpage> - <lpage>54</lpage>
<author><surname>Hao</surname> <given-names>HX</given-names></author> <author><surname>Khalimonchuk</surname> <given-names>O</given-names></author> <author><surname>Schraders</surname> <given-names>M</given-names></author> <author><surname>Dephoure</surname> <given-names>N</given-names></author> <author><surname>Bayley</surname> <given-names>JP</given-names></author> <author><surname>Kunst</surname> <given-names>H</given-names></author> <author><surname>Devilee</surname> <given-names>P</given-names></author> <author><surname>Cremers</surname> <given-names>CW</given-names></author> <author><surname>Schiffman</surname> <given-names>JD</given-names></author> <author><surname>Bentz</surname> <given-names>BG</given-names></author> <author><surname>Gygi</surname> <given-names>SP</given-names></author> <author><surname>Winge</surname> <given-names>DR</given-names></author> <author><surname>Kremer</surname> <given-names>H</given-names></author> <author><surname>Rutter</surname> <given-names>J</given-names></author> <title>SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma</title> <source>Science</source> <year>2009</year> <volume>325</volume> <fpage>1139</fpage> - <lpage>1142</lpage>
<author><surname>Bayley</surname> <given-names>JP</given-names></author> <author><surname>Kunst</surname> <given-names>HP</given-names></author> <author><surname>Cascon</surname> <given-names>A</given-names></author> <author><surname>Sampietro</surname> <given-names>ML</given-names></author> <author><surname>Gaal</surname> <given-names>J</given-names></author> <author><surname>Korpershoek</surname> <given-names>E</given-names></author> <author><surname>Hinojar-Gutierrez</surname> <given-names>A</given-names></author> <author><surname>Timmers</surname> <given-names>HJ</given-names></author> <author><surname>Hoefsloot</surname> <given-names>LH</given-names></author> <author><surname>Hermsen</surname> <given-names>MA</given-names></author> <author><surname>Suarez</surname> <given-names>C</given-names></author> <author><surname>Hussain</surname> <given-names>AK</given-names></author> <author><surname>Vriends</surname> <given-names>AH</given-names></author> <author><surname>Hes</surname> <given-names>FJ</given-names></author> <author><surname>Jansen</surname> <given-names>JC</given-names></author> <author><surname>Tops</surname> <given-names>CM</given-names></author> <author><surname>Corssmit</surname> <given-names>EP</given-names></author> <author><surname>Knijff</surname> <given-names>P</given-names></author> <author><surname>Lenders</surname> <given-names>JW</given-names></author> <author><surname>Cremers</surname> <given-names>CW</given-names></author> <author><surname>Devilee</surname> <given-names>P</given-names></author> <author><surname>Dinjens</surname> <given-names>WN</given-names></author> <author><surname>Krijger</surname> <given-names>RR</given-names></author> <author><surname>Robledo</surname> <given-names>M</given-names></author> <title>SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma</title> <source>Lancet Oncol</source> <year>2010</year> <volume>11</volume> <fpage>366</fpage> - <lpage>372</lpage>
<author><surname>Burnichon</surname> <given-names>N</given-names></author> <author><surname>Briere</surname> <given-names>JJ</given-names></author> <author><surname>Libe</surname> <given-names>R</given-names></author> <author><surname>Vescovo</surname> <given-names>L</given-names></author> <author><surname>Riviere</surname> <given-names>J</given-names></author> <author><surname>Tissier</surname> <given-names>F</given-names></author> <author><surname>Jouanno</surname> <given-names>E</given-names></author> <author><surname>Jeunemaitre</surname> <given-names>X</given-names></author> <author><surname>Benit</surname> <given-names>P</given-names></author> <author><surname>Tzagoloff</surname> <given-names>A</given-names></author> <author><surname>Rustin</surname> <given-names>P</given-names></author> <author><surname>Bertherat</surname> <given-names>J</given-names></author> <author><surname>Favier</surname> <given-names>J</given-names></author> <author><surname>Gimenez-Roqueplo</surname> <given-names>AP</given-names></author> <title>SDHA is a tumor suppressor gene causing paraganglioma</title> <source>Hum Mol Genet</source> <year>2010</year> <volume>19</volume> <fpage>3011</fpage> - <lpage>3020</lpage>
<author><surname>Housley</surname> <given-names>SL</given-names></author> <author><surname>Lindsay</surname> <given-names>RS</given-names></author> <author><surname>Young</surname> <given-names>B</given-names></author> <author><surname>McConachie</surname> <given-names>M</given-names></author> <author><surname>Mechan</surname> <given-names>D</given-names></author> <author><surname>Baty</surname> <given-names>D</given-names></author> <author><surname>Christie</surname> <given-names>L</given-names></author> <author><surname>Rahilly</surname> <given-names>M</given-names></author> <author><surname>Qureshi</surname> <given-names>K</given-names></author> <author><surname>Fleming</surname> <given-names>S</given-names></author> <title>Renal carcinoma with giant mitochondria associated with germ-line mutation and somatic loss of the succinate dehydrogenase</title> <source>B gene Histopathology</source> <year>2010</year> <volume>56</volume> <fpage>405</fpage> - <lpage>408</lpage>
<author><surname>Ricketts</surname> <given-names>C</given-names></author> <author><surname>Woodward</surname> <given-names>ER</given-names></author> <author><surname>Killick</surname> <given-names>P</given-names></author> <author><surname>Morris</surname> <given-names>MR</given-names></author> <author><surname>Astuti</surname> <given-names>D</given-names></author> <author><surname>Latif</surname> <given-names>F</given-names></author> <author><surname>Maher</surname> <given-names>ER</given-names></author> <title>Germline SDHB mutations and familial renal cell carcinoma</title> <source>J Natl Cancer Inst</source> <year>2008</year> <volume>100</volume> <fpage>1260</fpage> - <lpage>1262</lpage>
<author><surname>Henderson</surname> <given-names>A</given-names></author> <author><surname>Douglas</surname> <given-names>F</given-names></author> <author><surname>Perros</surname> <given-names>P</given-names></author> <author><surname>Morgan</surname> <given-names>C</given-names></author> <author><surname>Maher</surname> <given-names>ER</given-names></author> <title>SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis</title> <source>Fam Can</source> <year>2009</year> <volume>8</volume> <fpage>257</fpage> - <lpage>260</lpage>
<author><surname>Gottlieb</surname> <given-names>E</given-names></author> <author><surname>Tomlinson</surname> <given-names>IP</given-names></author> <title>Mitochondrial tumour suppressors: a genetic and biochemical update</title> <source>Nat Rev Cancer</source> <year>2005</year> <volume>5</volume> <fpage>857</fpage> - <lpage>866</lpage>
<author><surname>Nederveen</surname> <given-names>FH</given-names></author> <author><surname>Korpershoek</surname> <given-names>E</given-names></author> <author><surname>Lenders</surname> <given-names>JW</given-names></author> <author><surname>Krijger</surname> <given-names>RR</given-names></author> <author><surname>Dinjens</surname> <given-names>WN</given-names></author> <title>Somatic SDHB mutation in an extraadrenal pheochromocytoma</title> <source>N Engl J Med</source> <year>2007</year> <volume>357</volume> <fpage>306</fpage> - <lpage>308</lpage>
<author><surname>Stratakis</surname> <given-names>CA</given-names></author> <author><surname>Carney</surname> <given-names>JA</given-names></author> <title>The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney&#8211;Stratakis syndrome): molecular genetics and clinical implications</title> <source>J Intern Med</source> <year>2009</year> <volume>266</volume> <fpage>43</fpage> - <lpage>52</lpage>
<author><surname>Launonen</surname> <given-names>V</given-names></author> <author><surname>Vierimaa</surname> <given-names>O</given-names></author> <author><surname>Kiuru</surname> <given-names>M</given-names></author> <author><surname>Isola</surname> <given-names>J</given-names></author> <author><surname>Roth</surname> <given-names>S</given-names></author> <author><surname>Pukkala</surname> <given-names>E</given-names></author> <author><surname>Sistonen</surname> <given-names>P</given-names></author> <author><surname>Herva</surname> <given-names>R</given-names></author> <author><surname>Aaltonen</surname> <given-names>LA</given-names></author> <title>Inherited susceptibility to uterine leiomyomas and renal cell cancer</title> <source>Proc Natl Acad Sci USA</source> <year>2001</year> <volume>98</volume> <fpage>3387</fpage> - <lpage>3392</lpage>
<author><surname>Tomlinson</surname> <given-names>IP</given-names></author> <author><surname>Alam</surname> <given-names>NA</given-names></author> <author><surname>Rowan</surname> <given-names>AJ</given-names></author> <author><surname>Barclay</surname> <given-names>E</given-names></author> <author><surname>Jaeger</surname> <given-names>EE</given-names></author> <author><surname>Kelsell</surname> <given-names>D</given-names></author> <author><surname>Leigh</surname> <given-names>I</given-names></author> <author><surname>Gorman</surname> <given-names>P</given-names></author> <author><surname>Lamlum</surname> <given-names>H</given-names></author> <author><surname>Rahman</surname> <given-names>S</given-names></author> <author><surname>Roylance</surname> <given-names>RR</given-names></author> <author><surname>Olpin</surname> <given-names>S</given-names></author> <author><surname>Bevan</surname> <given-names>S</given-names></author> <author><surname>Barker</surname> <given-names>K</given-names></author> <author><surname>Hearle</surname> <given-names>N</given-names></author> <author><surname>Houlston</surname> <given-names>RS</given-names></author> <author><surname>Kiuru</surname> <given-names>M</given-names></author> <author><surname>Lehtonen</surname> <given-names>R</given-names></author> <author><surname>Karhu</surname> <given-names>A</given-names></author> <author><surname>Vilkki</surname> <given-names>S</given-names></author> <author><surname>Laiho</surname> <given-names>P</given-names></author> <author><surname>Eklund</surname> <given-names>C</given-names></author> <author><surname>Vierimaa</surname> <given-names>O</given-names></author> <author><surname>Aittomaki</surname> <given-names>K</given-names></author> <author><surname>Hietala</surname> <given-names>M</given-names></author> <author><surname>Sistonen</surname> <given-names>P</given-names></author> <author><surname>Paetau</surname> <given-names>A</given-names></author> <author><surname>Salovaara</surname> <given-names>R</given-names></author> <author><surname>Herva</surname> <given-names>R</given-names></author> <author><surname>Launonen</surname> <given-names>V</given-names></author> <author><surname>Aaltonen</surname> <given-names>LA</given-names></author> <title>Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer</title> <source>Nat Genet</source> <year>2002</year> <volume>30</volume> <fpage>406</fpage> - <lpage>410</lpage>
<author><surname>Carvajal-Carmona</surname> <given-names>LG</given-names></author> <author><surname>Alam</surname> <given-names>NA</given-names></author> <author><surname>Pollard</surname> <given-names>PJ</given-names></author> <author><surname>Jones</surname> <given-names>AM</given-names></author> <author><surname>Barclay</surname> <given-names>E</given-names></author> <author><surname>Wortham</surname> <given-names>N</given-names></author> <author><surname>Pignatelli</surname> <given-names>M</given-names></author> <author><surname>Freeman</surname> <given-names>A</given-names></author> <author><surname>Pomplun</surname> <given-names>S</given-names></author> <author><surname>Ellis</surname> <given-names>I</given-names></author> <author><surname>Poulsom</surname> <given-names>R</given-names></author> <author><surname>El-Bahrawy</surname> <given-names>MA</given-names></author> <author><surname>Berney</surname> <given-names>DM</given-names></author> <author><surname>Tomlinson</surname> <given-names>IP</given-names></author> <title>Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations</title> <source>J Clin Endocrinol Metab</source> <year>2006</year> <volume>91</volume> <fpage>3071</fpage> - <lpage>3075</lpage>
<author><surname>Lehtonen</surname> <given-names>HJ</given-names></author> <author><surname>Kiuru</surname> <given-names>M</given-names></author> <author><surname>Ylisaukko-Oja</surname> <given-names>SK</given-names></author> <author><surname>Salovaara</surname> <given-names>R</given-names></author> <author><surname>Herva</surname> <given-names>R</given-names></author> <author><surname>Koivisto</surname> <given-names>PA</given-names></author> <author><surname>Vierimaa</surname> <given-names>O</given-names></author> <author><surname>Aittomaki</surname> <given-names>K</given-names></author> <author><surname>Pukkala</surname> <given-names>E</given-names></author> <author><surname>Launonen</surname> <given-names>V</given-names></author> <author><surname>Aaltonen</surname> <given-names>LA</given-names></author> <title>Increased risk of cancer in patients with fumarate hydratase germline mutation</title> <source>J Med Genet</source> <year>2006</year> <volume>43</volume> <fpage>523</fpage> - <lpage>526</lpage>
<author><surname>Marcucci</surname> <given-names>G</given-names></author> <author><surname>Maharry</surname> <given-names>K</given-names></author> <author><surname>Wu</surname> <given-names>YZ</given-names></author> <author><surname>Radmacher</surname> <given-names>MD</given-names></author> <author><surname>Mrozek</surname> <given-names>K</given-names></author> <author><surname>Margeson</surname> <given-names>D</given-names></author> <author><surname>Holland</surname> <given-names>KB</given-names></author> <author><surname>Whitman</surname> <given-names>SP</given-names></author> <author><surname>Becker</surname> <given-names>H</given-names></author> <author><surname>Schwind</surname> <given-names>S</given-names></author> <author><surname>Metzeler</surname> <given-names>KH</given-names></author> <author><surname>Powell</surname> <given-names>BL</given-names></author> <author><surname>Carter</surname> <given-names>TH</given-names></author> <author><surname>Kolitz</surname> <given-names>JE</given-names></author> <author><surname>Wetzler</surname> <given-names>M</given-names></author> <author><surname>Carroll</surname> <given-names>AJ</given-names></author> <author><surname>Baer</surname> <given-names>MR</given-names></author> <author><surname>Caligiuri</surname> <given-names>MA</given-names></author> <author><surname>Larson</surname> <given-names>RA</given-names></author> <author><surname>Bloomfield</surname> <given-names>CD</given-names></author> <title>IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study</title> <source>J Clin Oncol</source> <year>2010</year> <volume>28</volume> <fpage>2348</fpage> - <lpage>2355</lpage>
<author><surname>Balss</surname> <given-names>J</given-names></author> <author><surname>Meyer</surname> <given-names>J</given-names></author> <author><surname>Mueller</surname> <given-names>W</given-names></author> <author><surname>Korshunov</surname> <given-names>A</given-names></author> <author><surname>Hartmann</surname> <given-names>C</given-names></author> <author><surname>Deimling</surname> <given-names>A</given-names></author> <title>Analysis of the IDH1 codon 132 mutation in brain tumors</title> <source>Acta Neuropathol</source> <year>2008</year> <volume>116</volume> <fpage>597</fpage> - <lpage>602</lpage>
<author><surname>Parsons</surname> <given-names>DW</given-names></author> <author><surname>Jones</surname> <given-names>S</given-names></author> <author><surname>Zhang</surname> <given-names>X</given-names></author> <author><surname>Lin</surname> <given-names>JC</given-names></author> <author><surname>Leary</surname> <given-names>RJ</given-names></author> <author><surname>Angenendt</surname> <given-names>P</given-names></author> <author><surname>Mankoo</surname> <given-names>P</given-names></author> <author><surname>Carter</surname> <given-names>H</given-names></author> <author><surname>Siu</surname> <given-names>IM</given-names></author> <author><surname>Gallia</surname> <given-names>GL</given-names></author> <author><surname>Olivi</surname> <given-names>A</given-names></author> <author><surname>McLendon</surname> <given-names>R</given-names></author> <author><surname>Rasheed</surname> <given-names>BA</given-names></author> <author><surname>Keir</surname> <given-names>S</given-names></author> <author><surname>Nikolskaya</surname> <given-names>T</given-names></author> <author><surname>Nikolsky</surname> <given-names>Y</given-names></author> <author><surname>Busam</surname> <given-names>DA</given-names></author> <author><surname>Tekleab</surname> <given-names>H</given-names></author> <author><surname>Diaz</surname> <given-names>LA</given-names></author> <author><surname>Jr Hartigan</surname> <given-names>J</given-names></author> <author><surname>Smith</surname> <given-names>DR</given-names></author> <author><surname>Strausberg</surname> <given-names>RL</given-names></author> <author><surname>Marie</surname> <given-names>SK</given-names></author> <author><surname>Shinjo</surname> <given-names>SM</given-names></author> <author><surname>Yan</surname> <given-names>H</given-names></author> <author><surname>Riggins</surname> <given-names>GJ</given-names></author> <author><surname>Bigner</surname> <given-names>DD</given-names></author> <author><surname>Karchin</surname> <given-names>R</given-names></author> <author><surname>Papadopoulos</surname> <given-names>N</given-names></author> <author><surname>Parmigiani</surname> <given-names>G</given-names></author> <author><surname>Vogelstein</surname> <given-names>B</given-names></author> <author><surname>Velculescu</surname> <given-names>VE</given-names></author> <author><surname>Kinzler</surname> <given-names>KW</given-names></author> <title>An integrated genomic analysis of human glioblastoma multiforme</title> <source>Science</source> <year>2008</year> <volume>321</volume> <fpage>1807</fpage> - <lpage>1812</lpage>
<author><surname>Bleeker</surname> <given-names>FE</given-names></author> <author><surname>Lamba</surname> <given-names>S</given-names></author> <author><surname>Leenstra</surname> <given-names>S</given-names></author> <author><surname>Troost</surname> <given-names>D</given-names></author> <author><surname>Hulsebos</surname> <given-names>T</given-names></author> <author><surname>Vandertop</surname> <given-names>WP</given-names></author> <author><surname>Frattini</surname> <given-names>M</given-names></author> <author><surname>Molinari</surname> <given-names>F</given-names></author> <author><surname>Knowles</surname> <given-names>M</given-names></author> <author><surname>Cerrato</surname> <given-names>A</given-names></author> <author><surname>Rodolfo</surname> <given-names>M</given-names></author> <author><surname>Scarpa</surname> <given-names>A</given-names></author> <author><surname>Felicioni</surname> <given-names>L</given-names></author> <author><surname>Buttitta</surname> <given-names>F</given-names></author> <author><surname>Malatesta</surname> <given-names>S</given-names></author> <author><surname>Marchetti</surname> <given-names>A</given-names></author> <author><surname>Bardelli</surname> <given-names>A</given-names></author> <title>IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumors</title> <source>Hum Mutat</source> <year>2009</year> <volume>30</volume> <fpage>7</fpage> - <lpage>11</lpage>
<author><surname>Yan</surname> <given-names>H</given-names></author> <author><surname>Parsons</surname> <given-names>DW</given-names></author> <author><surname>Jin</surname> <given-names>G</given-names></author> <author><surname>McLendon</surname> <given-names>R</given-names></author> <author><surname>Rasheed</surname> <given-names>BA</given-names></author> <author><surname>Yuan</surname> <given-names>W</given-names></author> <author><surname>Kos</surname> <given-names>I</given-names></author> <author><surname>Batinic-Haberle</surname> <given-names>I</given-names></author> <author><surname>Jones</surname> <given-names>S</given-names></author> <author><surname>Riggins</surname> <given-names>GJ</given-names></author> <author><surname>Friedman</surname> <given-names>H</given-names></author> <author><surname>Friedman</surname> <given-names>A</given-names></author> <author><surname>Reardon</surname> <given-names>D</given-names></author> <author><surname>Herndon</surname> <given-names>J</given-names></author> <author><surname>Kinzler</surname> <given-names>KW</given-names></author> <author><surname>Velculescu</surname> <given-names>VE</given-names></author> <author><surname>Vogelstein</surname> <given-names>B</given-names></author> <author><surname>Bigner</surname> <given-names>DD</given-names></author> <title>IDH1 and IDH2 mutations in gliomas</title> <source>N Engl J Med</source> <year>2009</year> <volume>360</volume> <fpage>765</fpage> - <lpage>773</lpage>
<author><surname>Dang</surname> <given-names>L</given-names></author> <author><surname>White</surname> <given-names>DW</given-names></author> <author><surname>Gross</surname> <given-names>S</given-names></author> <author><surname>Bennett</surname> <given-names>BD</given-names></author> <author><surname>Bittinger</surname> <given-names>MA</given-names></author> <author><surname>Driggers</surname> <given-names>EM</given-names></author> <author><surname>Fantin</surname> <given-names>VR</given-names></author> <author><surname>Jang</surname> <given-names>HG</given-names></author> <author><surname>Jin</surname> <given-names>S</given-names></author> <author><surname>Keenan</surname> <given-names>MC</given-names></author> <author><surname>Marks</surname> <given-names>KM</given-names></author> <author><surname>Prins</surname> <given-names>RM</given-names></author> <author><surname>Ward</surname> <given-names>PS</given-names></author> <author><surname>Yen</surname> <given-names>KE</given-names></author> <author><surname>Liau</surname> <given-names>LM</given-names></author> <author><surname>Rabinowitz</surname> <given-names>JD</given-names></author> <author><surname>Cantley</surname> <given-names>LC</given-names></author> <author><surname>Thompson</surname> <given-names>CB</given-names></author> <author><surname>Vander Heiden</surname> <given-names>MG</given-names></author> <author><surname>Su</surname> <given-names>SM</given-names></author> <title>Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</title> <source>Nature</source> <year>2009</year> <volume>462</volume> <fpage>739</fpage> - <lpage>744</lpage>
<author><surname>Gimenez-Roqueplo</surname> <given-names>AP</given-names></author> <author><surname>Favier</surname> <given-names>J</given-names></author> <author><surname>Rustin</surname> <given-names>P</given-names></author> <author><surname>Mourad</surname> <given-names>JJ</given-names></author> <author><surname>Plouin</surname> <given-names>PF</given-names></author> <author><surname>Corvol</surname> <given-names>P</given-names></author> <author><surname>Rotig</surname> <given-names>A</given-names></author> <author><surname>Jeunemaitre</surname> <given-names>X</given-names></author> <title>The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway</title> <source>Am J Hum Genet</source> <year>2001</year> <volume>69</volume> <fpage>1186</fpage> - <lpage>1197</lpage>
<author><surname>Dahia</surname> <given-names>PL</given-names></author> <author><surname>Ross</surname> <given-names>KN</given-names></author> <author><surname>Wright</surname> <given-names>ME</given-names></author> <author><surname>Hayashida</surname> <given-names>CY</given-names></author> <author><surname>Santagata</surname> <given-names>S</given-names></author> <author><surname>Barontini</surname> <given-names>M</given-names></author> <author><surname>Kung</surname> <given-names>AL</given-names></author> <author><surname>Sanso</surname> <given-names>G</given-names></author> <author><surname>Powers</surname> <given-names>JF</given-names></author> <author><surname>Tischler</surname> <given-names>AS</given-names></author> <author><surname>Hodin</surname> <given-names>R</given-names></author> <author><surname>Heitritter</surname> <given-names>S</given-names></author> <author><surname>Moore</surname> <given-names>F</given-names></author> <author><surname>Dluhy</surname> <given-names>R</given-names></author> <author><surname>Sosa</surname> <given-names>JA</given-names></author> <author><surname>Ocal</surname> <given-names>IT</given-names></author> <author><surname>Benn</surname> <given-names>DE</given-names></author> <author><surname>Marsh</surname> <given-names>DJ</given-names></author> <author><surname>Robinson</surname> <given-names>BG</given-names></author> <author><surname>Schneider</surname> <given-names>K</given-names></author> <author><surname>Garber</surname> <given-names>J</given-names></author> <author><surname>Arum</surname> <given-names>SM</given-names></author> <author><surname>Korbonits</surname> <given-names>M</given-names></author> <author><surname>Grossman</surname> <given-names>A</given-names></author> <author><surname>Pigny</surname> <given-names>P</given-names></author> <author><surname>Toledo</surname> <given-names>SP</given-names></author> <author><surname>Nose</surname> <given-names>V</given-names></author> <author><surname>Li</surname> <given-names>C</given-names></author> <author><surname>Stiles</surname> <given-names>CD</given-names></author> <title>A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas</title> <source>PLoS Genet</source> <year>2005</year> <volume>1</volume> <fpage>72</fpage> - <lpage>80</lpage>
<author><surname>Vanharanta</surname> <given-names>S</given-names></author> <author><surname>Pollard</surname> <given-names>PJ</given-names></author> <author><surname>Lehtonen</surname> <given-names>HJ</given-names></author> <author><surname>Laiho</surname> <given-names>P</given-names></author> <author><surname>Sjoberg</surname> <given-names>J</given-names></author> <author><surname>Leminen</surname> <given-names>A</given-names></author> <author><surname>Aittomaki</surname> <given-names>K</given-names></author> <author><surname>Arola</surname> <given-names>J</given-names></author> <author><surname>Kruhoffer</surname> <given-names>M</given-names></author> <author><surname>Orntoft</surname> <given-names>TF</given-names></author> <author><surname>Tomlinson</surname> <given-names>IP</given-names></author> <author><surname>Kiuru</surname> <given-names>M</given-names></author> <author><surname>Arango</surname> <given-names>D</given-names></author> <author><surname>Aaltonen</surname> <given-names>LA</given-names></author> <title>Distinct expression profile in fumarate-hydratase-deficient uterine fibroids</title> <source>Hum Mol Genet</source> <year>2006</year> <volume>15</volume> <fpage>97</fpage> - <lpage>103</lpage>
<author><surname>Cervera</surname> <given-names>AM</given-names></author> <author><surname>Apostolova</surname> <given-names>N</given-names></author> <author><surname>Crespo</surname> <given-names>FL</given-names></author> <author><surname>Mata</surname> <given-names>M</given-names></author> <author><surname>McCreath</surname> <given-names>KJ</given-names></author> <title>Cells silenced for SDHB expression display characteristic features of the tumor phenotype</title> <source>Cancer Res</source> <year>2008</year> <volume>68</volume> <fpage>4058</fpage> - <lpage>4067</lpage>
<author><surname>Ashrafian</surname> <given-names>H</given-names></author> <author><surname>O"Flaherty</surname> <given-names>L</given-names></author> <author><surname>Adam</surname> <given-names>J</given-names></author> <author><surname>Steeples</surname> <given-names>V</given-names></author> <author><surname>Chung</surname> <given-names>YL</given-names></author> <author><surname>East</surname> <given-names>P</given-names></author> <author><surname>Vanharanta</surname> <given-names>S</given-names></author> <author><surname>Lehtonen</surname> <given-names>H</given-names></author> <author><surname>Nye</surname> <given-names>E</given-names></author> <author><surname>Hatipoglu</surname> <given-names>E</given-names></author> <author><surname>Miranda</surname> <given-names>M</given-names></author> <author><surname>Howarth</surname> <given-names>K</given-names></author> <author><surname>Shukla</surname> <given-names>D</given-names></author> <author><surname>Troy</surname> <given-names>H</given-names></author> <author><surname>Griffiths</surname> <given-names>J</given-names></author> <author><surname>Spencer-Dene</surname> <given-names>B</given-names></author> <author><surname>Yusuf</surname> <given-names>M</given-names></author> <author><surname>Volpi</surname> <given-names>E</given-names></author> <author><surname>Maxwell</surname> <given-names>PH</given-names></author> <author><surname>Stamp</surname> <given-names>G</given-names></author> <author><surname>Poulsom</surname> <given-names>R</given-names></author> <author><surname>Pugh</surname> <given-names>CW</given-names></author> <author><surname>Costa</surname> <given-names>B</given-names></author> <author><surname>Bardella</surname> <given-names>C</given-names></author> <author><surname>Renzo</surname> <given-names>MF</given-names></author> <author><surname>Kotlikoff</surname> <given-names>MI</given-names></author> <author><surname>Launonen</surname> <given-names>V</given-names></author> <author><surname>Aaltonen</surname> <given-names>L</given-names></author> <author><surname>El-Bahrawy</surname> <given-names>M</given-names></author> <author><surname>Tomlinson</surname> <given-names>I</given-names></author> <author><surname>Pollard</surname> <given-names>PJ</given-names></author> <title>Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesis</title> <source>Cancer Res</source> <year>2010</year> <volume>70</volume> <fpage>9153</fpage> - <lpage>9165</lpage>
<author><surname>Selak</surname> <given-names>MA</given-names></author> <author><surname>Armour</surname> <given-names>SM</given-names></author> <author><surname>MacKenzie</surname> <given-names>ED</given-names></author> <author><surname>Boulahbel</surname> <given-names>H</given-names></author> <author><surname>Watson</surname> <given-names>DG</given-names></author> <author><surname>Mansfield</surname> <given-names>KD</given-names></author> <author><surname>Pan</surname> <given-names>Y</given-names></author> <author><surname>Simon</surname> <given-names>MC</given-names></author> <author><surname>Thompson</surname> <given-names>CB</given-names></author> <author><surname>Gottlieb</surname> <given-names>E</given-names></author> <title>Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase</title> <source>Cancer Cell</source> <year>2005</year> <volume>7</volume> <fpage>77</fpage> - <lpage>85</lpage>
<author><surname>Isaacs</surname> <given-names>JS</given-names></author> <author><surname>Jung</surname> <given-names>YJ</given-names></author> <author><surname>Mole</surname> <given-names>DR</given-names></author> <author><surname>Lee</surname> <given-names>S</given-names></author> <author><surname>Torres-Cabala</surname> <given-names>C</given-names></author> <author><surname>Chung</surname> <given-names>YL</given-names></author> <author><surname>Merino</surname> <given-names>M</given-names></author> <author><surname>Trepel</surname> <given-names>J</given-names></author> <author><surname>Zbar</surname> <given-names>B</given-names></author> <author><surname>Toro</surname> <given-names>J</given-names></author> <author><surname>Ratcliffe</surname> <given-names>PJ</given-names></author> <author><surname>Linehan</surname> <given-names>WM</given-names></author> <author><surname>Neckers</surname> <given-names>L</given-names></author> <title>HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability</title> <source>Cancer Cell</source> <year>2005</year> <volume>8</volume> <fpage>143</fpage> - <lpage>153</lpage>
<author><surname>Pollard</surname> <given-names>PJ</given-names></author> <author><surname>Briere</surname> <given-names>JJ</given-names></author> <author><surname>Alam</surname> <given-names>NA</given-names></author> <author><surname>Barwell</surname> <given-names>J</given-names></author> <author><surname>Barclay</surname> <given-names>E</given-names></author> <author><surname>Wortham</surname> <given-names>NC</given-names></author> <author><surname>Hunt</surname> <given-names>T</given-names></author> <author><surname>Mitchell</surname> <given-names>M</given-names></author> <author><surname>Olpin</surname> <given-names>S</given-names></author> <author><surname>Moat</surname> <given-names>SJ</given-names></author> <author><surname>Hargreaves</surname> <given-names>IP</given-names></author> <author><surname>Heales</surname> <given-names>SJ</given-names></author> <author><surname>Chung</surname> <given-names>YL</given-names></author> <author><surname>Griffiths</surname> <given-names>JR</given-names></author> <author><surname>Dalgleish</surname> <given-names>A</given-names></author> <author><surname>McGrath</surname> <given-names>JA</given-names></author> <author><surname>Gleeson</surname> <given-names>MJ</given-names></author> <author><surname>Hodgson</surname> <given-names>SV</given-names></author> <author><surname>Poulsom</surname> <given-names>R</given-names></author> <author><surname>Rustin</surname> <given-names>P</given-names></author> <author><surname>Tomlinson</surname> <given-names>IP</given-names></author> <title>Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations</title> <source>Hum Mol Genet</source> <year>2005</year> <volume>14</volume> <fpage>2231</fpage> - <lpage>2239</lpage>
<author><surname>Hewitson</surname> <given-names>KS</given-names></author> <author><surname>Lienard</surname> <given-names>BM</given-names></author> <author><surname>McDonough</surname> <given-names>MA</given-names></author> <author><surname>Clifton</surname> <given-names>IJ</given-names></author> <author><surname>Butler</surname> <given-names>D</given-names></author> <author><surname>Soares</surname> <given-names>AS</given-names></author> <author><surname>Oldham</surname> <given-names>NJ</given-names></author> <author><surname>McNeill</surname> <given-names>LA</given-names></author> <author><surname>Schofield</surname> <given-names>CJ</given-names></author> <title>Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates</title> <source>J Biol Chem</source> <year>2007</year> <volume>282</volume> <fpage>3293</fpage> - <lpage>3301</lpage>
<author><surname>MacKenzie</surname> <given-names>ED</given-names></author> <author><surname>Selak</surname> <given-names>MA</given-names></author> <author><surname>Tennant</surname> <given-names>DA</given-names></author> <author><surname>Payne</surname> <given-names>LJ</given-names></author> <author><surname>Crosby</surname> <given-names>S</given-names></author> <author><surname>Frederiksen</surname> <given-names>CM</given-names></author> <author><surname>Watson</surname> <given-names>DG</given-names></author> <author><surname>Gottlieb</surname> <given-names>E</given-names></author> <title>Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells</title> <source>Mol Cell Biol</source> <year>2007</year> <volume>27</volume> <fpage>3282</fpage> - <lpage>3289</lpage>
<author><surname>Porcelli</surname> <given-names>AM</given-names></author> <author><surname>Ghelli</surname> <given-names>A</given-names></author> <author><surname>Ceccarelli</surname> <given-names>C</given-names></author> <author><surname>Lang</surname> <given-names>M</given-names></author> <author><surname>Cenacchi</surname> <given-names>G</given-names></author> <author><surname>Capristo</surname> <given-names>M</given-names></author> <author><surname>Pennisi</surname> <given-names>LF</given-names></author> <author><surname>Morra</surname> <given-names>I</given-names></author> <author><surname>Ciccarelli</surname> <given-names>E</given-names></author> <author><surname>Melcarne</surname> <given-names>A</given-names></author> <author><surname>Bartoletti-Stella</surname> <given-names>A</given-names></author> <author><surname>Salfi</surname> <given-names>N</given-names></author> <author><surname>Tallini</surname> <given-names>G</given-names></author> <author><surname>Martinuzzi</surname> <given-names>A</given-names></author> <author><surname>Carelli</surname> <given-names>V</given-names></author> <author><surname>Attimonelli</surname> <given-names>M</given-names></author> <author><surname>Rugolo</surname> <given-names>M</given-names></author> <author><surname>Romeo</surname> <given-names>G</given-names></author> <author><surname>Gasparre</surname> <given-names>G</given-names></author> <title>The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization</title> <source>Hum Mol Genet</source> <year>2010</year> <volume>19</volume> <fpage>1019</fpage> - <lpage>1032</lpage>
<author><surname>Guzy</surname> <given-names>RD</given-names></author> <author><surname>Hoyos</surname> <given-names>B</given-names></author> <author><surname>Robin</surname> <given-names>E</given-names></author> <author><surname>Chen</surname> <given-names>H</given-names></author> <author><surname>Liu</surname> <given-names>L</given-names></author> <author><surname>Mansfield</surname> <given-names>KD</given-names></author> <author><surname>Simon</surname> <given-names>MC</given-names></author> <author><surname>Hammerling</surname> <given-names>U</given-names></author> <author><surname>Schumacker</surname> <given-names>PT</given-names></author> <title>Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing</title> <source>Cell Metab</source> <year>2005</year> <volume>1</volume> <fpage>401</fpage> - <lpage>408</lpage>
<author><surname>Mansfield</surname> <given-names>KD</given-names></author> <author><surname>Guzy</surname> <given-names>RD</given-names></author> <author><surname>Pan</surname> <given-names>Y</given-names></author> <author><surname>Young</surname> <given-names>RM</given-names></author> <author><surname>Cash</surname> <given-names>TP</given-names></author> <author><surname>Schumacker</surname> <given-names>PT</given-names></author> <author><surname>Simon</surname> <given-names>MC</given-names></author> <title>Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation</title> <source>Cell Metab</source> <year>2005</year> <volume>1</volume> <fpage>393</fpage> - <lpage>399</lpage>
<author><surname>Guzy</surname> <given-names>RD</given-names></author> <author><surname>Sharma</surname> <given-names>B</given-names></author> <author><surname>Bell</surname> <given-names>E</given-names></author> <author><surname>Chandel</surname> <given-names>NS</given-names></author> <author><surname>Schumacker</surname> <given-names>PT</given-names></author> <title>Loss of the SdhB, but not the SdhA, subunit of complex II triggers ROS-dependent HIF activation and tumorigenesis</title> <source>Mol Cell Biol</source> <year>2008</year> <volume>28</volume> <fpage>718</fpage> - <lpage>731</lpage>
<author><surname>Sudarshan</surname> <given-names>S</given-names></author> <author><surname>Sourbier</surname> <given-names>C</given-names></author> <author><surname>Kong</surname> <given-names>HS</given-names></author> <author><surname>Block</surname> <given-names>K</given-names></author> <author><surname>Valera Romero</surname> <given-names>VA</given-names></author> <author><surname>Yang</surname> <given-names>Y</given-names></author> <author><surname>Galindo</surname> <given-names>C</given-names></author> <author><surname>Mollapour</surname> <given-names>M</given-names></author> <author><surname>Scroggins</surname> <given-names>B</given-names></author> <author><surname>Goode</surname> <given-names>N</given-names></author> <author><surname>Lee</surname> <given-names>MJ</given-names></author> <author><surname>Gourlay</surname> <given-names>CW</given-names></author> <author><surname>Trepel</surname> <given-names>J</given-names></author> <author><surname>Linehan</surname> <given-names>WM</given-names></author> <author><surname>Neckers</surname> <given-names>L</given-names></author> <title>Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species</title> <source>Mol Cell Biol</source> <year>2009</year> <volume>29</volume> <fpage>4080</fpage> - <lpage>4090</lpage>
<author><surname>Selak</surname> <given-names>MA</given-names></author> <author><surname>Duran</surname> <given-names>RV</given-names></author> <author><surname>Gottlieb</surname> <given-names>E</given-names></author> <title>Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells</title> <source>Biochim Biophys Acta</source> <year>2006</year> <volume>1757</volume> <fpage>567</fpage> - <lpage>572</lpage>
<author><surname>O"Flaherty</surname> <given-names>L</given-names></author> <author><surname>Adam</surname> <given-names>J</given-names></author> <author><surname>Heather</surname> <given-names>LC</given-names></author> <author><surname>Zhdanov</surname> <given-names>AV</given-names></author> <author><surname>Chung</surname> <given-names>YL</given-names></author> <author><surname>Miranda</surname> <given-names>MX</given-names></author> <author><surname>Croft</surname> <given-names>J</given-names></author> <author><surname>Olpin</surname> <given-names>S</given-names></author> <author><surname>Clarke</surname> <given-names>K</given-names></author> <author><surname>Pugh</surname> <given-names>CW</given-names></author> <author><surname>Griffiths</surname> <given-names>J</given-names></author> <author><surname>Papkovsky</surname> <given-names>D</given-names></author> <author><surname>Ashrafian</surname> <given-names>H</given-names></author> <author><surname>Ratcliffe</surname> <given-names>PJ</given-names></author> <author><surname>Pollard</surname> <given-names>PJ</given-names></author> <title>Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism</title> <source>Hum Mol Genet</source> <year>2010</year> <volume>19</volume> <fpage>3844</fpage> - <lpage>3851</lpage>
<author><surname>Lee</surname> <given-names>S</given-names></author> <author><surname>Nakamura</surname> <given-names>E</given-names></author> <author><surname>Yang</surname> <given-names>H</given-names></author> <author><surname>Wei</surname> <given-names>W</given-names></author> <author><surname>Linggi</surname> <given-names>MS</given-names></author> <author><surname>Sajan</surname> <given-names>MP</given-names></author> <author><surname>Farese</surname> <given-names>RV</given-names></author> <author><surname>Freeman</surname> <given-names>RS</given-names></author> <author><surname>Carter</surname> <given-names>BD</given-names></author> <author><surname>Kaelin</surname> <given-names>WG</given-names></author> <author><surname>Jr Schlisio</surname> <given-names>S</given-names></author> <title>Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer</title> <source>Cancer Cell</source> <year>2005</year> <volume>8</volume> <fpage>155</fpage> - <lpage>167</lpage>
<author><surname>Schlisio</surname> <given-names>S</given-names></author> <author><surname>Kenchappa</surname> <given-names>RS</given-names></author> <author><surname>Vredeveld</surname> <given-names>LC</given-names></author> <author><surname>George</surname> <given-names>RE</given-names></author> <author><surname>Stewart</surname> <given-names>R</given-names></author> <author><surname>Greulich</surname> <given-names>H</given-names></author> <author><surname>Shahriari</surname> <given-names>K</given-names></author> <author><surname>Nguyen</surname> <given-names>NV</given-names></author> <author><surname>Pigny</surname> <given-names>P</given-names></author> <author><surname>Dahia</surname> <given-names>PL</given-names></author> <author><surname>Pomeroy</surname> <given-names>SL</given-names></author> <author><surname>Maris</surname> <given-names>JM</given-names></author> <author><surname>Look</surname> <given-names>AT</given-names></author> <author><surname>Meyerson</surname> <given-names>M</given-names></author> <author><surname>Peeper</surname> <given-names>DS</given-names></author> <author><surname>Carter</surname> <given-names>BD</given-names></author> <author><surname>Kaelin</surname> <given-names>WG</given-names></author> <title>Jr The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor</title> <source>Genes Dev</source> <year>2008</year> <volume>22</volume> <fpage>884</fpage> - <lpage>893</lpage>
<author><surname>Raimundo</surname> <given-names>N</given-names></author> <author><surname>Vanharanta</surname> <given-names>S</given-names></author> <author><surname>Aaltonen</surname> <given-names>LA</given-names></author> <author><surname>Hovatta</surname> <given-names>I</given-names></author> <author><surname>Suomalainen</surname> <given-names>A</given-names></author> <title>Downregulation of SRF-FOS-JUNB pathway in fumarate hydratase deficiency and in uterine leiomyomas</title> <source>Oncogene</source> <year>2009</year> <volume>28</volume> <fpage>1261</fpage> - <lpage>1273</lpage>
<author><surname>Schofield</surname> <given-names>CJ</given-names></author> <author><surname>Ratcliffe</surname> <given-names>PJ</given-names></author> <title>Oxygen sensing by HIF hydroxylases</title> <source>Nat Rev Mol Cell Biol</source> <year>2004</year> <volume>5</volume> <fpage>343</fpage> - <lpage>354</lpage>
<author><surname>Cervera</surname> <given-names>AM</given-names></author> <author><surname>Bayley</surname> <given-names>JP</given-names></author> <author><surname>Devilee</surname> <given-names>P</given-names></author> <author><surname>McCreath</surname> <given-names>KJ</given-names></author> <title>Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells</title> <source>Mol Cancer</source> <year>2009</year> <volume>8</volume> <fpage>89</fpage>
<author><surname>Smith</surname> <given-names>EH</given-names></author> <author><surname>Janknecht</surname> <given-names>R</given-names></author> <author><surname>Maher</surname> <given-names>LJ</given-names></author> <title>3rd Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma</title> <source>Hum Mol Genet</source> <year>2007</year> <volume>16</volume> <fpage>3136</fpage> - <lpage>3148</lpage>
<author><surname>Teperino</surname> <given-names>R</given-names></author> <author><surname>Schoonjans</surname> <given-names>K</given-names></author> <author><surname>Auwerx</surname> <given-names>J</given-names></author> <title>Histone methyl transferases and demethylases; can they link metabolism and transcription</title>? <source>Cell Metab</source> <year>2010</year> <volume>12</volume> <fpage>321</fpage> - <lpage>327</lpage>
<author><surname>Pollard</surname> <given-names>PJ</given-names></author> <author><surname>Loenarz</surname> <given-names>C</given-names></author> <author><surname>Mole</surname> <given-names>DR</given-names></author> <author><surname>McDonough</surname> <given-names>MA</given-names></author> <author><surname>Gleadle</surname> <given-names>JM</given-names></author> <author><surname>Schofield</surname> <given-names>CJ</given-names></author> <author><surname>Ratcliffe</surname> <given-names>PJ</given-names></author> <title>Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha</title> <source>Biochem J</source> <year>2008</year> <volume>416</volume> <fpage>387</fpage> - <lpage>394</lpage>
<author><surname>Beyer</surname> <given-names>S</given-names></author> <author><surname>Kristensen</surname> <given-names>MM</given-names></author> <author><surname>Jensen</surname> <given-names>KS</given-names></author> <author><surname>Johansen</surname> <given-names>JV</given-names></author> <author><surname>Staller</surname> <given-names>P</given-names></author> <title>The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor</title> <source>HIF J Biol Chem</source> <year>2008</year> <volume>283</volume> <fpage>36542</fpage> - <lpage>36552</lpage>
<author><surname>Yang</surname> <given-names>J</given-names></author> <author><surname>Jubb</surname> <given-names>AM</given-names></author> <author><surname>Pike</surname> <given-names>L</given-names></author> <author><surname>Buffa</surname> <given-names>FM</given-names></author> <author><surname>Turley</surname> <given-names>H</given-names></author> <author><surname>Baban</surname> <given-names>D</given-names></author> <author><surname>Leek</surname> <given-names>R</given-names></author> <author><surname>Gatter</surname> <given-names>KC</given-names></author> <author><surname>Ragoussis</surname> <given-names>J</given-names></author> <author><surname>Harris</surname> <given-names>AL</given-names></author> <title>The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth</title> <source>Cancer Res</source> <year>2010</year> <volume>70</volume> <fpage>6456</fpage> - <lpage>6466</lpage>
<author><surname>He</surname> <given-names>W</given-names></author> <author><surname>Miao</surname> <given-names>FJ</given-names></author> <author><surname>Lin</surname> <given-names>DC</given-names></author> <author><surname>Schwandner</surname> <given-names>RT</given-names></author> <author><surname>Wang</surname> <given-names>Z</given-names></author> <author><surname>Gao</surname> <given-names>J</given-names></author> <author><surname>Chen</surname> <given-names>JL</given-names></author> <author><surname>Tian</surname> <given-names>H</given-names></author> <author><surname>Ling</surname> <given-names>L</given-names></author> <title>Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors</title> <source>Nature</source> <year>2004</year> <volume>429</volume> <fpage>188</fpage> - <lpage>193</lpage>
<author><surname>Peti-Peterdi</surname> <given-names>J</given-names></author> <title>High glucose and renin release: the role of succinate and GPR91</title> <source>Kidney Int</source> <year>2010</year> <volume>78</volume> <fpage>1214</fpage> - <lpage>1217</lpage>
<author><surname>Sapieha</surname> <given-names>P</given-names></author> <author><surname>Sirinyan</surname> <given-names>M</given-names></author> <author><surname>Hamel</surname> <given-names>D</given-names></author> <author><surname>Zaniolo</surname> <given-names>K</given-names></author> <author><surname>Joyal</surname> <given-names>JS</given-names></author> <author><surname>Cho</surname> <given-names>JH</given-names></author> <author><surname>Honore</surname> <given-names>JC</given-names></author> <author><surname>Kermorvant-Duchemin</surname> <given-names>E</given-names></author> <author><surname>Varma</surname> <given-names>DR</given-names></author> <author><surname>Tremblay</surname> <given-names>S</given-names></author> <author><surname>Leduc</surname> <given-names>M</given-names></author> <author><surname>Rihakova</surname> <given-names>L</given-names></author> <author><surname>Hardy</surname> <given-names>P</given-names></author> <author><surname>Klein</surname> <given-names>WH</given-names></author> <author><surname>Mu</surname> <given-names>X</given-names></author> <author><surname>Mamer</surname> <given-names>O</given-names></author> <author><surname>Lachapelle</surname> <given-names>P</given-names></author> <author><surname>Polo</surname> <given-names>A</given-names></author> <author><surname>Beausejour</surname> <given-names>C</given-names></author> <author><surname>Andelfinger</surname> <given-names>G</given-names></author> <author><surname>Mitchell</surname> <given-names>G</given-names></author> <author><surname>Sennlaub</surname> <given-names>F</given-names></author> <author><surname>Chemtob</surname> <given-names>S</given-names></author> <title>The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis</title> <source>Nat Med</source> <year>2008</year> <volume>14</volume> <fpage>1067</fpage> - <lpage>1076</lpage>
<author><surname>Tian</surname> <given-names>Z</given-names></author> <author><surname>Liu</surname> <given-names>Y</given-names></author> <author><surname>Usa</surname> <given-names>K</given-names></author> <author><surname>Mladinov</surname> <given-names>D</given-names></author> <author><surname>Fang</surname> <given-names>Y</given-names></author> <author><surname>Ding</surname> <given-names>X</given-names></author> <author><surname>Greene</surname> <given-names>AS</given-names></author> <author><surname>Cowley</surname> <given-names>AW</given-names></author> <author><surname>Jr Liang</surname> <given-names>M</given-names></author> <title>Novel role of fumarate metabolism in dahl-salt sensitive hypertension</title> <source>Hypertension</source> <year>2009</year> <volume>54</volume> <fpage>255</fpage> - <lpage>260</lpage>
<author><surname>Mardis</surname> <given-names>ER</given-names></author> <author><surname>Ding</surname> <given-names>L</given-names></author> <author><surname>Dooling</surname> <given-names>DJ</given-names></author> <author><surname>Larson</surname> <given-names>DE</given-names></author> <author><surname>McLellan</surname> <given-names>MD</given-names></author> <author><surname>Chen</surname> <given-names>K</given-names></author> <author><surname>Koboldt</surname> <given-names>DC</given-names></author> <author><surname>Fulton</surname> <given-names>RS</given-names></author> <author><surname>Delehaunty</surname> <given-names>KD</given-names></author> <author><surname>McGrath</surname> <given-names>SD</given-names></author> <author><surname>Fulton</surname> <given-names>LA</given-names></author> <author><surname>Locke</surname> <given-names>DP</given-names></author> <author><surname>Magrini</surname> <given-names>VJ</given-names></author> <author><surname>Abbott</surname> <given-names>RM</given-names></author> <author><surname>Vickery</surname> <given-names>TL</given-names></author> <author><surname>Reed</surname> <given-names>JS</given-names></author> <author><surname>Robinson</surname> <given-names>JS</given-names></author> <author><surname>Wylie</surname> <given-names>T</given-names></author> <author><surname>Smith</surname> <given-names>SM</given-names></author> <author><surname>Carmichael</surname> <given-names>L</given-names></author> <author><surname>Eldred</surname> <given-names>JM</given-names></author> <author><surname>Harris</surname> <given-names>CC</given-names></author> <author><surname>Walker</surname> <given-names>J</given-names></author> <author><surname>Peck</surname> <given-names>JB</given-names></author> <author><surname>Du</surname> <given-names>F</given-names></author> <author><surname>Dukes</surname> <given-names>AF</given-names></author> <author><surname>Sanderson</surname> <given-names>GE</given-names></author> <author><surname>Brummett</surname> <given-names>AM</given-names></author> <author><surname>Clark</surname> <given-names>E</given-names></author> <author><surname>McMichael</surname> <given-names>JF</given-names></author> <author><surname>Meyer</surname> <given-names>RJ</given-names></author> <author><surname>Schindler</surname> <given-names>JK</given-names></author> <author><surname>Pohl</surname> <given-names>CS</given-names></author> <author><surname>Wallis</surname> <given-names>JW</given-names></author> <author><surname>Shi</surname> <given-names>X</given-names></author> <author><surname>Lin</surname> <given-names>L</given-names></author> <author><surname>Schmidt</surname> <given-names>H</given-names></author> <author><surname>Tang</surname> <given-names>Y</given-names></author> <author><surname>Haipek</surname> <given-names>C</given-names></author> <author><surname>Wiechert</surname> <given-names>ME</given-names></author> <author><surname>Ivy</surname> <given-names>JV</given-names></author> <author><surname>Kalicki</surname> <given-names>J</given-names></author> <author><surname>Elliott</surname> <given-names>G</given-names></author> <author><surname>Ries</surname> <given-names>RE</given-names></author> <author><surname>Payton</surname> <given-names>JE</given-names></author> <author><surname>Westervelt</surname> <given-names>P</given-names></author> <author><surname>Tomasson</surname> <given-names>MH</given-names></author> <author><surname>Watson</surname> <given-names>MA</given-names></author> <author><surname>Baty</surname> <given-names>J</given-names></author> <author><surname>Heath</surname> <given-names>S</given-names></author> <author><surname>Shannon</surname> <given-names>WD</given-names></author> <author><surname>Nagarajan</surname> <given-names>R</given-names></author> <author><surname>Link</surname> <given-names>DC</given-names></author> <author><surname>Walter</surname> <given-names>MJ</given-names></author> <author><surname>Graubert</surname> <given-names>TA</given-names></author> <author><surname>DiPersio</surname> <given-names>JF</given-names></author> <author><surname>Wilson</surname> <given-names>RK</given-names></author> <author><surname>Ley</surname> <given-names>TJ</given-names></author> <title>Recurring mutations found by sequencing an acute myeloid leukemia genome</title> <source>N Engl J Med</source> <year>2009</year> <volume>361</volume> <fpage>1058</fpage> - <lpage>1066</lpage>
<author><surname>Gross</surname> <given-names>S</given-names></author> <author><surname>Cairns</surname> <given-names>RA</given-names></author> <author><surname>Minden</surname> <given-names>MD</given-names></author> <author><surname>Driggers</surname> <given-names>EM</given-names></author> <author><surname>Bittinger</surname> <given-names>MA</given-names></author> <author><surname>Jang</surname> <given-names>HG</given-names></author> <author><surname>Sasaki</surname> <given-names>M</given-names></author> <author><surname>Jin</surname> <given-names>S</given-names></author> <author><surname>Schenkein</surname> <given-names>DP</given-names></author> <author><surname>Su</surname> <given-names>SM</given-names></author> <author><surname>Dang</surname> <given-names>L</given-names></author> <author><surname>Fantin</surname> <given-names>VR</given-names></author> <author><surname>Mak</surname> <given-names>TW</given-names></author> <title>Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations</title> <source>J Exp Med</source> <year>2010</year> <volume>207</volume> <fpage>339</fpage> - <lpage>344</lpage>
<author><surname>Ward</surname> <given-names>PS</given-names></author> <author><surname>Patel</surname> <given-names>J</given-names></author> <author><surname>Wise</surname> <given-names>DR</given-names></author> <author><surname>Abdel-Wahab</surname> <given-names>O</given-names></author> <author><surname>Bennett</surname> <given-names>BD</given-names></author> <author><surname>Coller</surname> <given-names>HA</given-names></author> <author><surname>Cross</surname> <given-names>JR</given-names></author> <author><surname>Fantin</surname> <given-names>VR</given-names></author> <author><surname>Hedvat</surname> <given-names>CV</given-names></author> <author><surname>Perl</surname> <given-names>AE</given-names></author> <author><surname>Rabinowitz</surname> <given-names>JD</given-names></author> <author><surname>Carroll</surname> <given-names>M</given-names></author> <author><surname>Su</surname> <given-names>SM</given-names></author> <author><surname>Sharp</surname> <given-names>KA</given-names></author> <author><surname>Levine</surname> <given-names>RL</given-names></author> <author><surname>Thompson</surname> <given-names>CB</given-names></author> <title>The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate</title> <source>Cancer Cell</source> <year>2010</year> <volume>17</volume> <fpage>225</fpage> - <lpage>234</lpage>
<author><surname>Zhao</surname> <given-names>S</given-names></author> <author><surname>Lin</surname> <given-names>Y</given-names></author> <author><surname>Xu</surname> <given-names>W</given-names></author> <author><surname>Jiang</surname> <given-names>W</given-names></author> <author><surname>Zha</surname> <given-names>Z</given-names></author> <author><surname>Wang</surname> <given-names>P</given-names></author> <author><surname>Yu</surname> <given-names>W</given-names></author> <author><surname>Li</surname> <given-names>Z</given-names></author> <author><surname>Gong</surname> <given-names>L</given-names></author> <author><surname>Peng</surname> <given-names>Y</given-names></author> <author><surname>Ding</surname> <given-names>J</given-names></author> <author><surname>Lei</surname> <given-names>Q</given-names></author> <author><surname>Guan</surname> <given-names>KL</given-names></author> <author><surname>Xiong</surname> <given-names>Y</given-names></author> <title>Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce</title> <source>HIF-1alpha Science</source> <year>2009</year> <volume>324</volume> <fpage>261</fpage> - <lpage>265</lpage>
<author><surname>Pollard</surname> <given-names>PJ</given-names></author> <author><surname>Ratcliffe</surname> <given-names>PJ</given-names></author> <title>Cancer. Puzzling patterns of predisposition</title> <source>Science</source> <year>2009</year> <volume>324</volume> <fpage>192</fpage> - <lpage>194</lpage>
<author><surname>Figueroa</surname> <given-names>ME</given-names></author> <author><surname>Abdel-Wahab</surname> <given-names>O</given-names></author> <author><surname>Lu</surname> <given-names>C</given-names></author> <author><surname>Ward</surname> <given-names>PS</given-names></author> <author><surname>Patel</surname> <given-names>J</given-names></author> <author><surname>Shih</surname> <given-names>A</given-names></author> <author><surname>Li</surname> <given-names>Y</given-names></author> <author><surname>Bhagwat</surname> <given-names>N</given-names></author> <author><surname>Vasanthakumar</surname> <given-names>A</given-names></author> <author><surname>Fernandez</surname> <given-names>HF</given-names></author> <author><surname>Tallman</surname> <given-names>MS</given-names></author> <author><surname>Sun</surname> <given-names>Z</given-names></author> <author><surname>Wolniak</surname> <given-names>K</given-names></author> <author><surname>Peeters</surname> <given-names>JK</given-names></author> <author><surname>Liu</surname> <given-names>W</given-names></author> <author><surname>Choe</surname> <given-names>SE</given-names></author> <author><surname>Fantin</surname> <given-names>VR</given-names></author> <author><surname>Paietta</surname> <given-names>E</given-names></author> <author><surname>Lowenberg</surname> <given-names>B</given-names></author> <author><surname>Licht</surname> <given-names>JD</given-names></author> <author><surname>Godley</surname> <given-names>LA</given-names></author> <author><surname>Delwel</surname> <given-names>R</given-names></author> <author><surname>Valk</surname> <given-names>PJ</given-names></author> <author><surname>Thompson</surname> <given-names>CB</given-names></author> <author><surname>Levine</surname> <given-names>RL</given-names></author> <author><surname>Melnick</surname> <given-names>A</given-names></author> <title>Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation</title> <source>Cancer Cell</source> <year>2010</year> <volume>18</volume> <fpage>553</fpage> - <lpage>567</lpage>
<author><surname>Jorgensen</surname> <given-names>G</given-names></author> <title>Kohlberg and Gilligan: duet or duel</title>? <source>J Moral Educ</source> <year>2006</year> <volume>5</volume> <fpage>179</fpage> - <lpage>196</lpage>
<author><surname>Kohlberg</surname> <given-names>L</given-names></author> <title>Moral stages and moralisation. The cognitive-developmental approach</title> <source>Lickona T Moral Development and Behaviour: Theory, Research and Social issues New</source> <other>York</other> <publisher>Holt, Rinehart and Winston</publisher> <year>1976</year> <fpage>31</fpage> - <lpage>53</lpage>
<author><surname>Kohlberg</surname> <given-names>L</given-names></author> <source>The Psychology of Moral Development. The Nature and Validity of Moral Stages</source> <other>San Francisco, CA</other> <publisher>Harper &amp; Row</publisher> <year>1984</year>
<author><surname>Arnold</surname> <given-names>ML</given-names></author> <title>Stage, sequence, and sequels: changing conceptions of morality, post-Kohlberg</title> <source>Educ Psychol Rev</source> <year>2000</year> <volume>12</volume> <fpage>365</fpage> - <lpage>383</lpage>
<author><surname>Gilligan</surname> <given-names>C</given-names></author> <title>In a Different</title> <source>Voice: Psychological Theory and Women&#8217;s Development Cambridge, MA</source> <other>and London</other> <publisher>Harvard University Press</publisher> <fpage>1993</fpage>
<author><surname>Branch</surname> <given-names>WT</given-names></author> <title>Jr Supporting the moral development of medical students</title> <source>J Gen Int Med</source> <year>2000</year> <volume>15</volume> <fpage>503</fpage> - <lpage>508</lpage>
<author><surname>Turiel</surname> <given-names>E</given-names></author> <title>Thoughts, emotions and social interactional processes in moral development</title> <editor>Killen</editor> <given-names>M</given-names> <author><surname>Smetana</surname> <given-names>JG</given-names></author> <source>Handbook of Moral Development Mahway</source> <other>NJ</other> <publisher>Taylor and Francis e-Library</publisher>
<author><surname>Rest</surname> <given-names>J</given-names></author> <author><surname>Narvaez</surname> <given-names>D</given-names></author> <author><surname>Bebeau</surname> <given-names>MJ</given-names></author> <author><surname>Thoma</surname> <given-names>SJ</given-names></author> <author><surname>Post-Conventional</surname> <given-names>Moral</given-names></author> <author><surname>Thinking</surname>. <given-names>A</given-names></author> <author><surname>Neo-Kohlbergian</surname> <given-names>Approach</given-names></author> <other>Mahwah, NJ</other> <publisher>Lawrence Erlbaum</publisher>
<author><surname>Skisland</surname> <given-names>A</given-names></author> <author><surname>Bj&#248;rnestad</surname> <given-names>JO</given-names></author> <author><surname>S&#246;derhamn</surname> <given-names>O</given-names></author> <source>Construction and testing of The Moral Development Scale for Professionals (MDSP) Nurse Educ Today</source> <year>2011</year> In press
<author><surname>Kohlberg</surname> <given-names>L</given-names></author> <author><surname>Power</surname> <given-names>C</given-names></author> <title>Moral development, religious thinking, and the question of a seventh stage</title> <source>Zygon</source> <year>1981</year> <volume>16</volume> <fpage>203</fpage> - <lpage>259</lpage>
<author><surname>Streiner</surname> <given-names>DL</given-names></author> <author><surname>Norman</surname> <given-names>GR</given-names></author> <author><surname>Health</surname> <given-names>Measurement</given-names></author> <author><surname>Scales</surname>: <given-names>A</given-names></author> <source>Practical Guide to Their Development and Use 3rd</source> <issue>ed</issue> <other>Oxford</other> <publisher>Oxford University Press</publisher> <fpage>2003</fpage>
<author><surname>J&#246;reskog</surname> <given-names>KG</given-names></author> <title>Estimating and testing of simplex models</title> <source>British Journal of Mathematics and Statistical Psychology</source> <year>1979</year> <volume>23</volume> <fpage>121</fpage> - <lpage>145</lpage>
<author><surname>Muth&#233;n</surname> <given-names>LK</given-names></author> <author><surname>Muth&#233;n</surname> <given-names>BO</given-names></author> <source>Mplus: The Comprehensive Modelling Program for Applied Researchers. User&#8217;s Guide 3rd ed Los Angeles, CA Muth&#233;n &amp; Muth&#233;n</source> <year>2004</year>
<author><surname>Gustafsson</surname> <given-names>J-E</given-names></author> <author><surname>Stahl</surname> <given-names>PA</given-names></author> <title>STREAMS User&#8217;s Guide, Version 3.0.0 M&#246;lndal</title> <source>MultivariateWare HB</source> <year>2005</year>
<author><surname>Brown</surname> <given-names>MW</given-names></author> <author><surname>Cudeck</surname> <given-names>R</given-names></author> <title>Alternative ways of assessing model fit</title> <source>Bollen KA, Long JS Testing Structural Equation Models</source> <other>Newbury Park, CA</other> <publisher>Sage</publisher> <year>1993</year> <fpage>136</fpage> - <lpage>162</lpage>
<author><surname>Cronbach</surname> <given-names>LJ</given-names></author> <title>Coefficient alpha and the internal structure of tests</title> <source>Psykometrika</source> <year>1951</year> <volume>16</volume> <fpage>297</fpage> - <lpage>334</lpage>
<author><surname>Beauchamp</surname> <given-names>TL</given-names></author> <author><surname>Childress</surname> <given-names>JF</given-names></author> <source>Principles of Biomedical Ethics 6th</source> <issue>ed</issue> <other>Oxford</other> <publisher>Oxford University Press</publisher> <fpage>2009</fpage>
<title>Ethical principles for medical research involving human subjects</title> <source>Tokyo World Medical Association Declaration of Helsinki</source> <year>2008</year>
<author><surname>Dawson</surname> <given-names>TL</given-names></author> <title>New tools, new insights: Kohlberg&#8217;s moral judgement stages revisited</title> <source>International Journal of Behavioural Development</source> <year>2002</year> <volume>26</volume> <fpage>154</fpage> - <lpage>166</lpage>
<author><surname>Rest</surname> <given-names>JR</given-names></author> <publisher>DIT. Defining Issues Test University of Minnesota, Minneapolis</publisher>
<author><surname>Auvinen</surname> <given-names>J</given-names></author> <author><surname>Suominen</surname> <given-names>T</given-names></author> <author><surname>Leino-Kilpi</surname> <given-names>H</given-names></author> <author><surname>Helkama</surname> <given-names>K</given-names></author> <title>The development of moral judgement during nursing education in Finland</title> <source>Nurse Educ Today</source> <year>2004</year> <volume>24</volume> <fpage>538</fpage> - <lpage>546</lpage>
<author><surname>Aboujaoude</surname> <given-names>E</given-names></author> <author><surname>Barry</surname> <given-names>JJ</given-names></author> <author><surname>Gamel</surname> <given-names>N</given-names></author> <title>Memantine augmentation in treatment-resistant obsessive&#8211;compulsive disorder: an open-label trial</title> <source>J Clin Psychopharmacol</source> <year>2009</year> <volume>29</volume> <fpage>51</fpage> - <lpage>55</lpage>
<author><surname>Abramowitz</surname> <given-names>JS</given-names></author> <author><surname>Taylor</surname> <given-names>S</given-names></author> <author><surname>McKay</surname> <given-names>D</given-names></author> <title>Obsessive&#8211;compulsive disorder</title> <source>Lancet</source> <year>2009</year> <volume>374</volume> <fpage>491</fpage> - <lpage>499</lpage>
<author><surname>Amiel</surname> <given-names>JM</given-names></author> <author><surname>Mathew</surname> <given-names>SJ</given-names></author> <title>Glutamate and anxiety disorders</title> <source>Curr Psychiatry Rep</source> <year>2007</year> <volume>9</volume> <fpage>278</fpage> - <lpage>283</lpage>
<author><surname>Anthony</surname> <given-names>EW</given-names></author> <author><surname>Nevins</surname> <given-names>ME</given-names></author> <title>Anxiolytic-like effects of N-methyl-</title> <source>Eur J Pharmacol</source> <year>1993</year> <volume>250</volume> <fpage>317</fpage> - <lpage>324</lpage>
<author><surname>Boyce-Rustay</surname> <given-names>JM</given-names></author> <author><surname>Holmes</surname> <given-names>A</given-names></author> <title>Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice</title> <source>Neuropsychopharmacology</source> <year>2006</year> <volume>31</volume> <fpage>2405</fpage> - <lpage>2414</lpage>
<author><surname>Campeau</surname> <given-names>S</given-names></author> <author><surname>Miserendino</surname> <given-names>MJ</given-names></author> <author><surname>Davis</surname> <given-names>M</given-names></author> <title>Intra-amygdala infusion of the N-methyl-</title> <source>Behav Neurosci</source> <year>1992</year> <volume>106</volume> <fpage>569</fpage> - <lpage>574</lpage>
<author><surname>Coric</surname> <given-names>V</given-names></author> <author><surname>Taskiran</surname> <given-names>S</given-names></author> <author><surname>Pittenger</surname> <given-names>C</given-names></author> <author><surname>Wasylink</surname> <given-names>S</given-names></author> <author><surname>Mathalon</surname> <given-names>DH</given-names></author> <author><surname>Valentine</surname> <given-names>G</given-names></author> <author><surname>Saksa</surname> <given-names>J</given-names></author> <author><surname>Wu</surname> <given-names>YT</given-names></author> <author><surname>Gueorguieva</surname> <given-names>R</given-names></author> <author><surname>Sanacora</surname> <given-names>G</given-names></author> <author><surname>Malison</surname> <given-names>RT</given-names></author> <author><surname>Krystal</surname> <given-names>JH</given-names></author> <title>Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial</title> <source>Biol Psychiatry</source> <year>2005</year> <volume>58</volume> <fpage>424</fpage> - <lpage>428</lpage>
<author><surname>Dunn</surname> <given-names>RW</given-names></author> <author><surname>Corbett</surname> <given-names>R</given-names></author> <author><surname>Fielding</surname> <given-names>S</given-names></author> <title>Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze</title> <source>Eur J Pharmacol</source> <year>1989</year> <volume>169</volume> <fpage>1</fpage> - <lpage>10</lpage>
<author><surname>Emmett</surname> <given-names>MR</given-names></author> <author><surname>Mick</surname> <given-names>SJ</given-names></author> <author><surname>Cler</surname> <given-names>JA</given-names></author> <author><surname>Rao</surname> <given-names>TS</given-names></author> <author><surname>Iyengar</surname> <given-names>S</given-names></author> <author><surname>Wood</surname> <given-names>PL</given-names></author> <source>Actions of Neuropharmacology</source> <year>1991</year> <volume>30</volume> <fpage>1167</fpage> - <lpage>1171</lpage>
<author><surname>Fendt</surname> <given-names>M</given-names></author> <author><surname>Koch</surname> <given-names>M</given-names></author> <author><surname>Schnitzler</surname> <given-names>HU</given-names></author> <title>NMDA receptors in the pontine brainstem are necessary for fear potentiation of the startle response</title> <source>Eur J Pharmacol</source> <year>1996</year> <volume>318</volume> <fpage>1</fpage> - <lpage>6</lpage>
<author><surname>Feusner</surname> <given-names>JD</given-names></author> <author><surname>Kerwin</surname> <given-names>L</given-names></author> <author><surname>Saxena</surname> <given-names>S</given-names></author> <author><surname>Bystritsky</surname> <given-names>A</given-names></author> <title>Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial</title> <source>Psychopharmacol Bull</source> <year>2009</year> <volume>42</volume> <fpage>81</fpage> - <lpage>93</lpage>
<author><surname>Heresco-Levy</surname> <given-names>U</given-names></author> <author><surname>Kremer</surname> <given-names>I</given-names></author> <author><surname>Javitt</surname> <given-names>DC</given-names></author> <author><surname>Goichman</surname> <given-names>R</given-names></author> <author><surname>Reshef</surname> <given-names>A</given-names></author> <author><surname>Blanaru</surname> <given-names>M</given-names></author> <author><surname>Cohen</surname> <given-names>T</given-names></author> <title>Pilot-controlled trial of</title> <source>Int J Neuropsychopharmacol</source> <year>2002</year> <volume>5</volume> <fpage>301</fpage> - <lpage>307</lpage>
<author><surname>Ho</surname> <given-names>YJ</given-names></author> <author><surname>Hsu</surname> <given-names>LS</given-names></author> <author><surname>Wang</surname> <given-names>CF</given-names></author> <author><surname>Hsu</surname> <given-names>WY</given-names></author> <author><surname>Lai</surname> <given-names>TJ</given-names></author> <author><surname>Hsu</surname> <given-names>CC</given-names></author> <author><surname>Tsai</surname> <given-names>YF</given-names></author> <source>Behavioral effects of Brain Res</source> <year>2005</year> <volume>1043</volume> <fpage>179</fpage> - <lpage>185</lpage>
<author><surname>Hood</surname> <given-names>WF</given-names></author> <author><surname>Compton</surname> <given-names>RP</given-names></author> <author><surname>Monahan</surname> <given-names>JB</given-names></author> <source>Neurosci Lett</source> <year>1989</year> <volume>98</volume> <fpage>91</fpage> - <lpage>95</lpage>
<author><surname>Johnson</surname> <given-names>JW</given-names></author> <author><surname>Ascher</surname> <given-names>P</given-names></author> <title>Glycine potentiates the NMDA response in cultured mouse brain neurons</title> <source>Nature</source> <year>1987</year> <volume>325</volume> <fpage>529</fpage> - <lpage>531</lpage>
<author><surname>Kalueff</surname> <given-names>A</given-names></author> <author><surname>Nutt</surname> <given-names>DJ</given-names></author> <title>Role of GABA in memory and anxiety</title> <source>Depress Anxiety</source> <year>1996</year> <volume>4</volume> <fpage>100</fpage> - <lpage>110</lpage>
<author><surname>Karcz-Kubicha</surname> <given-names>M</given-names></author> <author><surname>Jessa</surname> <given-names>M</given-names></author> <author><surname>Nazar</surname> <given-names>M</given-names></author> <author><surname>Pla&#378;nik</surname> <given-names>A</given-names></author> <author><surname>Hartmann</surname> <given-names>S</given-names></author> <author><surname>Parsons</surname> <given-names>CG</given-names></author> <author><surname>Danysz</surname> <given-names>W</given-names></author> <title>Anxiolytic activity of glycine-B antagonists and partial agonists&#8211;no relation to intrinsic activity in the patch clamp</title> <source>Neuropharmacology</source> <year>1997</year> <volume>36</volume> <fpage>1355</fpage> - <lpage>1367</lpage>
<author><surname>Kessler</surname> <given-names>M</given-names></author> <author><surname>Terramani</surname> <given-names>T</given-names></author> <author><surname>Lynch</surname> <given-names>G</given-names></author> <author><surname>Baudry</surname> <given-names>M</given-names></author> <title>A glycine site associated with N-methyl-</title> <source>J Neurochem</source> <year>1989</year> <volume>52</volume> <fpage>1319</fpage> - <lpage>1328</lpage>
<author><surname>Kew</surname> <given-names>JN</given-names></author> <author><surname>Kemp</surname> <given-names>JA</given-names></author> <title>Ionotropic and metabotropic glutamate receptor structure and pharmacology</title> <source>Psychopharmacology (Berl)</source> <year>2005</year> <volume>179</volume> <fpage>4</fpage> - <lpage>29</lpage>
<author><surname>Kleckner</surname> <given-names>NW</given-names></author> <author><surname>Dingledine</surname> <given-names>R</given-names></author> <title>Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes</title> <source>Science</source> <year>1988</year> <volume>241</volume> <fpage>835</fpage> - <lpage>837</lpage>
<author><surname>Kleckner</surname> <given-names>NW</given-names></author> <author><surname>Dingledine</surname> <given-names>R</given-names></author> <title>Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on</title> <source>N-methyl- Mol Pharmacol</source> <year>1989</year> <volume>36</volume> <fpage>430</fpage> - <lpage>436</lpage>
<author><surname>K&#322;odzi&#324;ska</surname> <given-names>A</given-names></author> <author><surname>Chojnacka-W&#243;jcik</surname> <given-names>E</given-names></author> <title>Anticonflict effect of the glycineB receptor partial agonist</title>, <source>Psychopharmacology (Berl)</source> <year>2000</year> <volume>152</volume> <fpage>224</fpage> - <lpage>228</lpage>
<author><surname>Kotli&#324;ska</surname> <given-names>J</given-names></author> <author><surname>Liljequist</surname> <given-names>S</given-names></author> <title>A characterization of anxiolytic-like actions induced by the novel NMDA/glycine site antagonist, L-701, 324</title> <source>Psychopharmacology (Berl)</source> <year>1998</year> <volume>135</volume> <fpage>175</fpage> - <lpage>181</lpage>
<author><surname>Krystal</surname> <given-names>JH</given-names></author> <author><surname>D&#8217;Souza</surname> <given-names>DC</given-names></author> <author><surname>Petrakis</surname> <given-names>IL</given-names></author> <author><surname>Belger</surname> <given-names>A</given-names></author> <author><surname>Berman</surname> <given-names>RM</given-names></author> <author><surname>Charney</surname> <given-names>DS</given-names></author> <author><surname>Abi-Saab</surname> <given-names>W</given-names></author> <author><surname>Madonick</surname> <given-names>S</given-names></author> <title>NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders</title> <source>Harv Rev Psychiatry</source> <year>1999</year> <volume>7</volume> <fpage>125</fpage> - <lpage>143</lpage>
<author><surname>Lipman</surname> <given-names>JJ</given-names></author> <author><surname>Spencer</surname> <given-names>PS</given-names></author> <title>Rapid intracerebroventricular injection assisted by an automatic syringe</title> <source>J Pharmacol Methods</source> <year>1980</year> <volume>4</volume> <fpage>327</fpage> - <lpage>333</lpage>
<author><surname>Lister</surname> <given-names>RG</given-names></author> <title>The use of a plus-maze to measure anxiety in the mouse</title> <source>Psychopharmacology (Berl)</source> <year>1987</year> <volume>92</volume> <fpage>180</fpage> - <lpage>185</lpage>
<author><surname>Lydiard</surname> <given-names>RB</given-names></author> <title>The role of GABA in anxiety disorders</title> <source>J Clin Psychiatry</source> <year>2003</year> <volume>64</volume> <issue>Suppl 3</issue> <fpage>21</fpage> - <lpage>27</lpage>
<author><surname>Mathew</surname> <given-names>SJ</given-names></author> <author><surname>Amiel</surname> <given-names>JM</given-names></author> <author><surname>Coplan</surname> <given-names>JD</given-names></author> <author><surname>Fitterling</surname> <given-names>HA</given-names></author> <author><surname>Sackeim</surname> <given-names>HA</given-names></author> <author><surname>Gorman</surname> <given-names>JM</given-names></author> <title>Open-label trial of riluzole in generalized anxiety disorder</title> <source>Am J Psychiatry</source> <year>2005</year> <volume>162</volume> <fpage>2379</fpage> - <lpage>2381</lpage>
<author><surname>Nemeroff</surname> <given-names>CB</given-names></author> <title>The role of GABA in the pathophysiology and treatment of anxiety disorders</title> <source>Psychopharmacol Bull</source> <year>2003</year> <volume>37</volume> <fpage>133</fpage> - <lpage>146</lpage>
<author><surname>Nutt</surname> <given-names>DJ</given-names></author> <author><surname>Malizia</surname> <given-names>AL</given-names></author> <title>New insights into the role of the GABAA-benzodiazepine receptor in psychiatric disorder</title> <source>Br J Psychiatry</source> <year>2001</year> <volume>179</volume> <fpage>390</fpage> - <lpage>396</lpage>
<author><surname>Parsons</surname> <given-names>CG</given-names></author> <author><surname>Danysz</surname> <given-names>W</given-names></author> <author><surname>Quack</surname> <given-names>G</given-names></author> <title>Glutamate in CNS disorders as a target for drug development: an update</title> <source>Drug News Perspect</source> <year>1998</year> <volume>11</volume> <fpage>523</fpage> - <lpage>569</lpage>
<author><surname>Pellow</surname> <given-names>S</given-names></author> <title>Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid</title>? <source>Methods Find Exp Clin Pharmacol</source> <year>1986</year> <volume>8</volume> <fpage>557</fpage> - <lpage>565</lpage>
<author><surname>Pellow</surname> <given-names>S</given-names></author> <author><surname>Chopin</surname> <given-names>P</given-names></author> <author><surname>File</surname> <given-names>SE</given-names></author> <author><surname>Briley</surname> <given-names>M</given-names></author> <title>Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat</title> <source>J Neurosci Methods</source> <year>1985</year> <volume>14</volume> <fpage>149</fpage> - <lpage>167</lpage>
<author><surname>P&#322;a&#378;nik</surname> <given-names>A</given-names></author> <author><surname>Pa&#322;ejko</surname> <given-names>W</given-names></author> <author><surname>Nazar</surname> <given-names>M</given-names></author> <author><surname>Jessa</surname> <given-names>M</given-names></author> <title>Effects of antagonists at the NMDA receptor complex in two models of anxiety</title> <source>Eur Neuropsychopharmacol</source> <year>1994</year> <volume>4</volume> <fpage>503</fpage> - <lpage>512</lpage>
<author><surname>Poleszak</surname> <given-names>E</given-names></author> <author><surname>Szewczyk</surname> <given-names>B</given-names></author> <author><surname>K&#281;dzierska</surname> <given-names>E</given-names></author> <author><surname>Wla&#378</surname>; <given-names>P</given-names></author> <author><surname>Pilc</surname> <given-names>A</given-names></author> <author><surname>Nowak</surname> <given-names>G</given-names></author> <title>Antidepressant- and anxiolytic-like activity of magnesium in mice</title> <source>Pharmacol Biochem Behav</source> <year>2004</year> <volume>78</volume> <fpage>7</fpage> - <lpage>12</lpage>
<author><surname>Poleszak</surname> <given-names>E</given-names></author> <author><surname>Wla&#378</surname>; <given-names>P</given-names></author> <author><surname>Wr&#243;bel</surname> <given-names>A</given-names></author> <author><surname>Fidecka</surname> <given-names>S</given-names></author> <author><surname>Nowak</surname> <given-names>G</given-names></author> <title>NMDA/glutamate mechanism of magnesium-induced anxiolytic-like behavior in mice</title> <source>Pharmacol Rep</source> <year>2008</year> <volume>60</volume> <fpage>655</fpage> - <lpage>663</lpage>
<author><surname>Przegali&#324;ski</surname> <given-names>E</given-names></author> <author><surname>Tatarczy&#324;ska</surname> <given-names>E</given-names></author> <author><surname>Chojnacka-W&#243;jcik</surname> <given-names>E</given-names></author> <title>Anxiolytic- and antidepressant-like effects of an antagonist at glycineB receptors</title> <source>Pol J Pharmacol</source> <year>1998</year> <volume>50</volume> <fpage>349</fpage> - <lpage>354</lpage>
<author><surname>Przegali&#324;ski</surname> <given-names>E</given-names></author> <author><surname>Tatarczy&#324;ska</surname> <given-names>E</given-names></author> <author><surname>Chojnacka-W&#243;jcik</surname> <given-names>E</given-names></author> <title>The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats</title> <source>Neuropharmacology</source> <year>2000</year> <volume>39</volume> <fpage>1858</fpage> - <lpage>1864</lpage>
<author><surname>Ressler</surname> <given-names>KJ</given-names></author> <author><surname>Rothbaum</surname> <given-names>BO</given-names></author> <author><surname>Tannenbaum</surname> <given-names>L</given-names></author> <author><surname>Anderson</surname> <given-names>P</given-names></author> <author><surname>Graap</surname> <given-names>K</given-names></author> <author><surname>Zimand</surname> <given-names>E</given-names></author> <author><surname>Hodges</surname> <given-names>L</given-names></author> <author><surname>Davis</surname> <given-names>M</given-names></author> <title>Cognitive enhancers as adjuncts to psychotherapy: use of</title> <source>Arch Gen Psychiatry</source> <year>2004</year> <volume>61</volume> <fpage>1136</fpage> - <lpage>1144</lpage>
<author><surname>Sharma</surname> <given-names>AC</given-names></author> <author><surname>Kulkarni</surname> <given-names>SK</given-names></author> <title>Evidence for benzodiazepine receptor interaction with MK 801 in anxiety related behaviour in rats</title> <source>Indian J Exp Biol</source> <year>1993</year> <volume>31</volume> <fpage>191</fpage> - <lpage>193</lpage>
<author><surname>Sieghart</surname> <given-names>W</given-names></author> <title>Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes</title> <source>Pharmacol Rev</source> <year>1995</year> <volume>47</volume> <fpage>181</fpage> - <lpage>234</lpage>
<author><surname>Sieghart</surname> <given-names>W</given-names></author> <author><surname>Fuchs</surname> <given-names>K</given-names></author> <author><surname>Tretter</surname> <given-names>V</given-names></author> <author><surname>Ebert</surname> <given-names>V</given-names></author> <author><surname>Jechlinger</surname> <given-names>M</given-names></author> <author><surname>Hoger</surname> <given-names>H</given-names></author> <author><surname>Adamiker</surname> <given-names>D</given-names></author> <title>Structure and subunit composition of GABAA receptors</title> <source>Neurochem Int</source> <year>1999</year> <volume>34</volume> <fpage>379</fpage> - <lpage>385</lpage>
<author><surname>Stahl</surname> <given-names>SM</given-names></author> <title>Don&#8217;t ask, don&#8217;t tell, but benzodiazepines are still the leading treatments for anxiety disorder</title> <source>J Clin Psychiatry</source> <year>2002</year> <volume>63</volume> <fpage>756</fpage> - <lpage>757</lpage>
<author><surname>Tricklebank</surname> <given-names>MD</given-names></author> <author><surname>Singh</surname> <given-names>L</given-names></author> <author><surname>Oles</surname> <given-names>RJ</given-names></author> <author><surname>Preston</surname> <given-names>C</given-names></author> <author><surname>Iversen</surname> <given-names>SD</given-names></author> <title>The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor</title> <source>Eur J Pharmacol</source> <year>1989</year> <volume>167</volume> <fpage>127</fpage> - <lpage>135</lpage>
<author><surname>Trullas</surname> <given-names>R</given-names></author> <author><surname>Jackson</surname> <given-names>B</given-names></author> <author><surname>Skolnick</surname> <given-names>P</given-names></author> <title>Anxiolytic properties of 1-aminocyclopropanecarboxylic acid, a ligand at strychnine-insensitive glycine receptors</title> <source>Pharmacol Biochem Behav</source> <year>1989</year> <volume>34</volume> <fpage>313</fpage> - <lpage>316</lpage>
<author><surname>Trullas</surname> <given-names>R</given-names></author> <author><surname>Folio</surname> <given-names>T</given-names></author> <author><surname>Young</surname> <given-names>A</given-names></author> <author><surname>Miller</surname> <given-names>R</given-names></author> <author><surname>Boje</surname> <given-names>K</given-names></author> <author><surname>Skolnick</surname> <given-names>P</given-names></author> <source>Eur J Pharmacol</source> <year>1991</year> <volume>203</volume> <fpage>379</fpage> - <lpage>385</lpage>
<author><surname>Uhlenhuth</surname> <given-names>EH</given-names></author> <author><surname>Balter</surname> <given-names>MB</given-names></author> <author><surname>Ban</surname> <given-names>TA</given-names></author> <author><surname>Yang</surname> <given-names>K</given-names></author> <title>International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders</title> <source>J Clin Psychopharmacol</source> <year>1999</year> <volume>19</volume> <fpage>23</fpage> - <lpage>29</lpage> - <lpage></lpage>
<author><surname>Watson</surname> <given-names>GB</given-names></author> <author><surname>Bolanowski</surname> <given-names>MA</given-names></author> <author><surname>Baganoff</surname> <given-names>MP</given-names></author> <author><surname>Deppeler</surname> <given-names>CL</given-names></author> <author><surname>Lanthorn</surname> <given-names>TH</given-names></author> <source>Brain Res</source> <year>1990</year> <volume>510</volume> <fpage>158</fpage> - <lpage>160</lpage>
<author><surname>Willetts</surname> <given-names>J</given-names></author> <author><surname>Balster</surname> <given-names>RL</given-names></author> <author><surname>Leander</surname> <given-names>JD</given-names></author> <title>The behavioral pharmacology of NMDA receptor antagonists</title> <source>Trends Pharmacol Sci</source> <year>1990</year> <volume>11</volume> <fpage>423</fpage> - <lpage>428</lpage>
<author><surname>Wood</surname> <given-names>PL</given-names></author> <author><surname>Emmett</surname> <given-names>MR</given-names></author> <author><surname>Rao</surname> <given-names>TS</given-names></author> <author><surname>Mick</surname> <given-names>S</given-names></author> <author><surname>Cler</surname> <given-names>J</given-names></author> <author><surname>Iyengar</surname> <given-names>S</given-names></author> <title>In vivo modulation of the N-methyl-</title> <source>J Neurochem</source> <year>1989</year> <volume>53</volume> <fpage>979</fpage> - <lpage>981</lpage>
<author><surname>Wood</surname> <given-names>PL</given-names></author> <author><surname>Hawkinson</surname> <given-names>JE</given-names></author> <author><surname>Goodnough</surname> <given-names>DB</given-names></author> <source>Formation of J Neurochem</source> <year>1996</year> <volume>67</volume> <fpage>1485</fpage> - <lpage>1490</lpage>
